The identification, cloning and characterisation of centaurin-alpha2 by Gibbard, Alison Michelle
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 22. May. 2019
T h e  Id e n t if ic a t io n , C l o n in g  a n d  
C h a r a c t e r isa t io n  o f  C e n t a u r in -oi2
Submitted by Alison M Gibbard 
for the degree o f PhD 
o f the University o f  Bath 
2001
COPYRIGHT
Attention is drawn to the fact that copyright o f this thesis rests with its author. 
This copy o f the thesis has been supplied on condition that anyone who consults 
it is understood to recognise that its copyright rests with its author and that no 
quotation from the thesis and no information derived from it may be published 
without the prior written consent o f the author.
This thesis may be made available for consultation within the University Library 
and may be photocopied or lent to other libraries for the purposes o f consultation.
UMI Number: U535B00
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U535300
Published by ProQuest LLC 2014. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346









1.1 Forw ard ..................................................................................................................................................................1
1.2 Lipid Signalling .................................................................................................................................................. 1
1.3 Generation of Phosphoinositides..............................................................................................................2
1.4 The Role of Phosphoinositides in Cellular Functions...................................................................7
1.4.1 The Role o f  Phosphoinositides in Membrane Trafficking...............................................................7
1.5 Lipid B inding  Motifs........................................................................................................................................12
1.5.1 FYVE Dom ains.......................................................................................................................................... 13
1.5.2 PH D om ains................................................................................................................................................ 13
1.6 The Role of ARF Proteins in V esicle Trafficking .......................................................................... 18
1.6.1 A R F1............................................................................................................................................................. 19
1.6.2 A R F6.............................................................................................................................................................20
1.6.3 Coat Assembly and Vesicle Formation...............................................................................................21
1.6.4 ARF-GEF Protein Fam ily .......................................................................................................................23
1.6.5 ARF-GAP Protein Fam ily.......................................................................................................................27
1.6.5.1 The Centaurin-a Protein Family........................................................................................................... 31
1.7 The Role of PtdIns 3-kinase and  PtdIns 3,4,5-P3 in Insulin-Stimulated Glut4
Translocation .................................................................................................................................................. 35
1.8 Experimental A ims and  A pproaches of the Research D escribed Herein............................ 38
2.0 MATERIALS AND METHODS....................................................................................................39
2.1 Ma t e r ia l s ...........................................................................................................................................................39
2.1.1 General Materials...................................................................................................................................... 39
2.1.2 A ntibodies................................................................................................................................................... 40
2.1.3 Phosphoinositides and Inositol Phosphates........................................................................................42
2.2 General Molecular B iology Techniques.......................................................................................... 42
2.2.1 Small Scale Plasmid Preparation from E. coli using the QIAprep Miniprep K it ................... 42
2.2.2 Agarose Gel Electrophoresis..................................................................................................................42
2.2.3 Extraction o f DNA from Agarose G els.............................................................................................. 44
2.2.4 Sequencing..................................................................................................................................................44
2.2.5 Rapid Amplification o f cDNA E nds................................................................................................... 44
ii
2.2.6 Site-Directed M utagenesis.......................................................................................................................45
2.2.7 Preparation o f  Competent C e lls .............................................................................................................45
2.2.8 Transformation o f  Competent C ells......................................................................................................46
2.3 N orthern B lotting ...........................................................................................................................................46
2.3.1 Preparation o f  RNase-free ddH20 ,  Buffers and Apparatus............................................................46
2.3.2 Isolation o f  Total R N A ..............................................................................................................................47
2.3.3 Purification o f PolyA+ RNA from Total R N A ...................................................................................47
2.3.4 Formaldehyde Denaturing Gel Electrophoresis................................................................................ 48
2.3.5 Capillary Transfer o f  Denatured RNA onto a Membrane.............................................................. 49
2.3.6 Random Labelling o f  DNA Probes with 32P ...................................................................................... 50
2.3.7 Hybridisation and Detection o f  Radioactively-Labelled DNA Probes....................................... 51
2.3.8 Generation o f DIG-Labelled Riboprobes............................................................................................ 51
2.3.9 Estimation o f  DIG-Labelled RNA Y ield............................................................................................. 52
2.3.10 Hybridisation and Detection o f  DIG-Labelled Riboprobes............................................................52
2.4 General Protein B iochemistry Techniques..........................................................................................53
2.4.1 BCA Protein A ssa y ....................................................................................................................................53
2.4.2 SDS-PAGE................................................................................................................................................... 54
2.4.3 Coomassie Staining....................................................................................................................................54
2.4.4 Electrotransfer o f Protein from SDS-PAGE Gels to N itrocellulose............................................ 56
2.4.5 Affinity Purification o f  Antiserum........................................................................................................56
2.4.6 Western B lotting ........................................................................................................................................ 57
2.4.7 Confocal M icroscopy................................................................................................................................58
2.4.8 Expression and Purification o f  6xHis-tagged Proteins....................................................................58
2.5 Protein Isolation and  Subcellular Fractionation........................................................................ 59
2.5.1 Isolation o f  Rat Adipocytes..................................................................................................................... 59
2.5.2 Subfractionation o f  Rat A dipocytes..................................................................................................... 60
2.5.3 Separation o f Total Particulate and Cytosolic Fractions................................................................ 62
2.6 A nalysis of PH D omain B inding Characteristics ............................................................................62
2.6.1 Ins 1,3,4,5-P4 Binding Studies................................................................................................................ 62
2.6.2 [3H]BZDC-PtdInsPn Photoaffinity Labelling.....................................................................................63
3.0 IDEN TIFICA TIO N  AND CLO NING  O F C E N T A U R IN -a2 ............................................................64
3.1 Introduction ....................................................................................................................................................... 64
3.1.1 The Discovery o f  a N ovel Partial Clone with Hom ology to the Centaurin-a Fam ily 64
3.1.2 Identification o f  the Human Centaurin-a2 C lon e............................................................................ 65
3.2 5 ’ RACE U sing Marathon-Ready  cD N A ..................................................................................................65
3.2.1 Cloning o f the 5 ’RACE Fragment into pT7Blue Cloning Vector............................................... 68
3.2.2 Characterisation o f  the DNA Inserts....................................................................................................71
3.3 Generation of the Full-Length Rat  Centaurin-oc2 cDNA by  3 ’RACE................................... 72
3.4 Sequence A n a l y sis ............................................................................................................................................75
3.5 D iscussio n ............................................................................................................................................................. 80
iii
4.0 INVESTIGATION OF CENTAURIN-a2 mRNA AND PROTEIN EXPRESSION................. 83
4.1 Introduction ........................................................................................................................................................83
4.2 N orthern B lot A nalysis ................................................................................................................................83
4.2.1 Northern Blot Analysis using Radioactively-Labelled DNA Probes..........................................84
4.2.1.1 Purification of Total RNA..................................................................................................................... 84
4.2.1.2 Preparation of 32P-Labelled DNA Probes............................................................................................. 84
4.2.1.3 Northern Blot Analysis using 32P-Labelled DNA Probes................................................................... 84
4.2.2 Northern Blot Analysis using the DIG Detection System .............................................................. 90
4.2.2.1 Preparation of DIG-Labelled RNA Probes...........................................................................................90
4.2.2.2 Northern Blot Analysis using DIG-Labelled RNA Probes.................................................................93
4.3 W estern B lotting A nalysis of the Tissue D istribution and  Subcellular Localisation
OF THE CENTAURIN-a2 PROTEIN......................................................................................................................99
4.3.1 Affinity Purification o f  the A ntisera.................................................................................................... 99
4.3.2 Optimisation o f  Western Blotting Conditions for Centaurin-a2 A ntisera..............................102
4.3.3 Tissue Distribution o f  the Centaurin-a2 Protein.............................................................................104
4.3.4 Subcellular Localisation o f  Centaurin-a2 in Rat Adipocyte Subcellular Fractions............. 104
4.3.5 Comparison o f  (3-tubulin and Glut4 Subcellular Localisation with that o f  Centaurin-a2 107
4.4 Subcellular  Localisation of Centaurin-cc2 in Rat  Cardiomyocytes as Revealed by
Confocal M icroscopy .................................................................................................................................110
4.4.1 Dual Labelling o f Centaurin-a2 and (3-tubulin...............................................................................110
4.4.2 The Effect o f  Insulin-Stimulation and Colchicine Treatment on the Distribution o f
Centaurin-a2............................................................................................................................................113
4.5 D iscussio n ........................................................................................................................................................... 119
5.0 INVESTIGATION OF THE BINDING SPECIFICITY OF THE CENTAURIN-a2 PH 
DOMAINS...................................................................................................................................... 124
5.1 Introduction ..................................................................................................................................................... 124
5.2 Production of Recombinant CENTAURiN-a2.......................................................................................125
5.2.1 Cloning o f Centaurin-a2 into pET15b.............................................................................................. 125
5.2.2 Introduction o f  Point Mutations in the cD N A ................................................................................. 127
5.3 Expression  and  Purification of Recombinant 6xH is-Centaurin-oc2 Proteins...................127
5.4 Investigation of the B inding Specificity of Centaurin-ci2 using [3H]Ins 1,3,4,5-P4 ........133
5.4.1 Development o f  the Ins 1,3,4,5-P4 Displacement A ssay ..............................................................133
5.4.2 Determination o f Phosphoinositide Binding Specificity o f  Centaurin-a2 using the Ins
1,3,4,5-P4 Displacement A ssa y .......................................................................................................... 137
5.4.3 Determination o f  Phosphoinositide Binding Specificity o f  the Mutant Centaurin-a2
Proteins...................................................................................................................................................... 137
iv
5.5 P h o to a f f in ity  L a b e ll in g  o f  Centaurin-<x2 w ith  [3H ]B Z D C -PtdIns 3,4,5-P3 an d  
-P td In s  3,4-P2.................................................................................................................................... 140
5.5.1 Development of the Photoaffinity Labelling Assay..............................................................140
5.5.2 Photoaffinity Labelling of Mutant Centaurin-a2 Proteins.................................................... 142




A b st r a c t
The principal aim o f this thesis was to investigate whether centaurin-a related proteins 
were present in insulin-sensitive tissues. The screening o f an adipocyte library using a 
centaurin-a probe had identified a partial clone that corresponded to the 3 ’ terminus o f  
centaurin-a sharing 58% identity. Rapid Amplification o f cDNA Ends (RACE) was 
employed to amplify the 5 ’ sequence and subsequently the full-length clone. Analysis 
o f  the deduced amino acid sequence revealed the domain structure o f  this novel clone to 
consist o f  an N-terminal zinc-finger domain (with homology to the ADP ribosylation 
factor-GTPase activating protein (ARF-GAP) domain) and two Pleckstrin Homology 
(PH) domains, PH-N and PH-C. This clone shared 51% and 57-59% identity with 
centaurin-a and centaurin-a 1, respectively. Considering the similarity with the 
centaurin-a family, the novel clone identified herein was named centaurin-a2. 
Interestingly the northern blot analysis indicated centaurin-a2 to be ubiquitously 
expressed, contrasting with the brain specific centaurin-as. Anti-centaurin-a2 
antiserum was raised, purified and used to investigate the protein expression at a cellular 
and subcellular level. Centaurin-a2’s distribution appeared to be quite distinct from the 
other family members, and highly abundant in insulin-sensitive tissues. In contrast to 
centaurin-a and centaurin-a 1, centaurin-a2 was not detected in the cytosolic fraction. 
The constitutive membrane association might be explained by the high-affinity for 
phosphatidylinositol 4,5-bisphosphate (PtdIns 4,5-P2) as well as phosphatidylinositol
3,4,5-trisphosphate (PtdIns 3,4,5-P3). Preliminary binding analysis using centaurin-a2 
proteins with point mutations o f single arginine residues in the PH domains (R151C, 
R275C and R151C/R275C) indicated that PtdIns 3,4,5-P3 and PtdIns 4,5-P2 bind to the 
PH-N domain, whereas phosphatidylinositol 3,4-bisphosphate (PtdIns 3,4-P2) binds to 
PH-C. In conclusion, centaurin-a2 appears to be an interesting new addition to the 
centaurin-a family illustrating that these proteins are not restricted to brain tissue, 
however the cellular importance o f this family remains unclear.
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1.0 In t r o d u c t io n
1.1 Forward
As summarised in the title, this thesis describes the identification and investigation o f  a 
new member o f  the centaurin-a family. The physiological function o f  this family o f  
phosphoinositide-binding proteins remains unclear and this topic will be discussed in 
detail towards the end o f  this introduction. Firstly, I aim to introduce phosphoinositides 
and some o f their varied functions within the cell. I will then discuss the importance o f  
these phospholipids and their interacting proteins within signalling and vesicle 
trafficking before focusing on the centaurin-a protein family. Finally, I will introduce 
the area o f research o f the Holman Laboratory, the insulin-regulated glucose transporter, 
Glut4. This subject area provides a good illustration for the potential role for 
phosphoinositides in vesicle trafficking.
1.2 Lipid Signalling
According to the fluid mosaic model, the basic structure o f biological membranes is 
provided by the lipid bilayer and the membrane proteins perform most o f the specific 
functions such as nutrient uptake, ion transport and signal transduction. However, if  the 
sole function o f membrane lipids is to form a permeability barrier around the cell and its 
organelles, you might expect them to have quite uniform structures. In fact, they are 
highly diverse. Animal cell plasma membranes contain cholesterol, glycolipids and 
phospholipids with the latter group in greatest abundance. Phospholipids have an 
amphipathic structure consisting o f a polar head group and two hydrophobic 
hydrocarbon tails. Four major phospholipids predominate in the plasma membrane o f  
many mammalian cells: phosphatidylcholine, spingomyelin, phosphotidylserine and 
phosphatidylethanolamine. The lipid composition o f membranes differs between cells, 
organelles and the two halves o f the lipid bilayer. Inositol containing phospholipids are 
minor constituents o f  eukaryotic cell membranes (2 to 8% by weight), and are 
predominantly localised to the cytoplasmic face o f cellular membranes (Majerus et al. 
1986). Phosphatidylinositol (PtdIns) represents the highest proportion (more than 80%)
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o f these phosphoinositides. PtdIns can undergo reversible phosphorylation at multiple 
sites on the inositol ring (positions D-3, D-4 and D-5) generating a variety 
phosphoinositides. Seven phosphoinositides are currently known {Figure 1.1). The 
inositol head group is linked via a phosphodiester phosphate group at the D -l position 
to the 3-carbon o f  the glycerol backbone. PtdIns usually contains a high proportion o f  
stearic acid (saturated fatty acid, Cig) at the 1-carbon and a high proportion o f  
arachidonic acid (unsaturated fatty acid, C20) at the 2-carbon {Figure 1.1).
For many years the principle function o f  phospholipids was considered to be as 
precursors for second messengers in the signalling pathways conveying information into 
the cell from receptors located on the plasma membrane (PM). The classic example 
being phospholipase C (PLC)-mediated hydrolysis o f phosphatidylinositol 4,5- 
bisphosphate (PtdIns 4,5-P2). This yields the water-soluble head group moiety, inositol
1.4.5-trisphosphate (Ins 1,4,5-Ps) that triggers mobilisation o f intracellular Ca2+, and 
diacylglycerol (DAG), the lipid portion that activates protein kinase C (PKC) (Berridge 
and Irvine 1989). In addition to being precursors o f inositol phosphates, more recently, 
phosphoinositides have been identified as key signalling molecules in their own right, 
acting as site-specific signals on membranes that recruit and regulate protein complexes. 
Moreover, membrane phosphoinositides are reported to function in signalling 
transduction, cytoskeletal assembly and membrane budding, docking and fusion 
processes {Section 1.4).
1.3 Generation of Phosphoinositides
PtdIns, the precursor o f all phosphoinositides, is synthesised in the endoplasmic 
reticulum (ER) and transported to the cellular membranes. The synthesis and turnover 
o f  phosphoinositides can be spatially and temporally regulated by a series o f kinases, 
phosphatases and phospholipases {Figure 1.2). The localisation o f  these enzymes to 
discrete membrane sites restricts signalling to a specific membrane or domain within the 
membrane. Novel enzymes continue to be identified and characterised, thus adding to 
the complexity o f what is already an intricate network o f reactions.
The classical research into phosphatidylinositol 4-phosphate (PtdIns 4-P) and PtdIns




PtdIns PtdIns 3-P PtdIns 4-P PtdIns 5-P
PtdIns 3,4-P2 PtdIns 3,5-P2 PtdIns 4,5-P2 Ins 1,3,4,5-P4
Figure 1.1. Phosphatidylinositol (PtdIns) and phosphorylated phosphoinositide 
derivatives. (A) The inositol head group o f PtdIns can be phosphorylated in the D-3, 
D-4 and D-5 positions (OH). Stearic acid and arachidonic acid are located at the 
1-carbon and 2-carbon positions on the glycerol backbone, respectively. (B) The 
inositol ring o f the seven known phosphoinositides are depicted, with the phosphates 
shown in red (P). The phosphate at position 1 links the inositol head group to the 
glycerol moiety. Also shown is the inositol phosphate, Ins 1,3,4,5-P4, which is the 
inositol head group analogue o f PtdIns 3,4,5-P3.
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/
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PtdIns 3-kinase 
PtdIns 4-P 5-kinase type I 
PtdIns 4-P 5-kinase type II 




Figure 1.2. A scheme showing synthetic pathways for phosphoinositides. Solid 
lines represent kinase reactions, dotted arrows indicate phosphatase reactions. 
Several PtdIns 3-kinase isoforms have been identified with different substrate 
specificity. PtdIns 4-P 5-kinase type I also acts on PtdIns 3-P as well as PtdIns 4-P 
and PtdIns 3,4-P2. PtdIns 4-P 5-kinase type II is really a PtdIns 4-kinase. Fablp and 
PIKfyve are yeast and mammalian PtdIns 3-P 5-kinase orthologues. The phosphatase 
reactions are shown but are not discussed further.
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these phospholipids (Grado and Ballou 1960). For many years the accepted synthesis 
route for PtdIns 4,5-P2 has been via the phosphorylation o f PtdIns by PtdIns 4-kinases, 
generating PtdIns 4-P which in turn was phosphorylated by PtdIns 4-P 5-kinases. More 
recently an alternative pathway has been identified. The type II PtdIns 4-P 5-kinase was 
shown to phosphorylate the D-4 position o f phosphatidylinositol 5-phosphate (PtdIns 5- 
P), a lipid not previously known to exist (Rameh et al. 1997a). Consequently it has 
been proposed that these enzymes are renamed phosphatidylinositol phosphate 4- 
kinases (PIP 4-kinases) (Toker 1998).
Some phosphoinositides, such as PtdIns 4,5-P2 and phosphatidylinositol 3-phosphate 
(PtdIns 3-P), are ubiquitously expressed and remain at relatively constant levels, 
whereas the D-3 phosphoinositide products phosphatidylinositol 3,4-bisphosphate 
(PtdIns 3,4-P2) and phosphatidylinositol 3,4,5-trisphosphate (PtdIns 3,4,5-Ps) 
dramatically increase upon activation o f  PtdIns 3-kinase. The D-3 phosphoinositides 
are generated by the multiple isoforms o f PtdIns 3-kinase which can be sub-divided into 
three classes on the basis o f  homology, structure and substrate specificity 
(Vanhaesebroeck et al. 1997; Vanhaesebroeck and Waterfield 1999). Class I enzymes 
are heterodimers consisting o f an adaptor subunit and a 110 kDa catalytic subunit 
(pi 10) and utilise PtdIns, PtdIns 4-P and PtdIns 4,5-P2 as substrates in vitro. The latter 
phospholipid is thought to be the preferred substrate in vivo , thus generating PtdIns
3,4,5-P3. This class is further divided into class IA, which are activated by the 
recruitment to tyrosine-phosphorylated proteins and interact with a 85 kDa adaptor 
subunit (p85), and class IB that are activated by heterotrimeric G proteins. Class II 
enzymes contain a characteristic C-terminal C2 domain and have been shown to utilise 
PtdIns > PtdIns 4-P » >  PtdIns 4,5-P2. Class III enzymes that only phosphorylate 
PtdIns, consist o f  heterodimers o f a catalytic subunit (Vps34p in yeast) associated with 
a serine/threonine protein kinase (Vpsl5p in yeast).
Basal levels o f  PtdIns 3,4,5-P3 are generally low and increase dramatically in response 
to a variety o f extracellular signals (Conricode 1995; Cross et al. 1997; Hawkins et al. 
1992; Stephens et al. 1991; van der Kaay et al. 1997). Agonist binding stimulates 
receptor autophosphorylation generating phosphotyrosine residues that recruit and 
activate downstream signalling proteins resulting in the activation o f class IA PtdIns 3- 
kinase (insulin-stimulated PtdIns 3-kinase activity is discussed further in Section 1.7). 
The cellular levels o f PtdIns 3,4-P2 also increase upon agonist stimulation, however the
accumulation is slightly delayed and more sustained than that o f  PtdIns 3,4,5-P3 
(Stephens et al. 1993). The slow time-course can be explained by the proposal that 
growth factor stimulated PtdIns 3,4-P2 production results from 5’-phosphatase action on 
PtdIns 3,4,5-P3 and not the phosphorylation o f PtdIns 4-P by PtdIns 3-kinase (Hawkins 
et al. 1992). Several 5 ’-phosphatases are able to act on PtdIns 3,4,5-P3, and one 
isoform, SHIP2, is reported to be regulated by growth factors and insulin (Guilherme et 
al. 1996; Habib et al. 1998). More recently PtdIns 3,4-P2 production has been 
postulated to occur without the preceding PtdIns 3,4,5-P3 accumulation. In platelets a 
novel integrin-activated pathway leads to the transient PtdIns 3-P formation that is then 
a substrate for PtdIns 3-P 4-kinase (Banfic et al. 1998). Similarly, in mouse fibroblasts 
oxidative stress induced relatively selective and sustained accumulation o f  PtdIns 3,4-P2 
independently o f PtdIns 3,4,5-P3 (van der Kaay et al. 1999). Furthermore the type II 
PtdIns 4-P 5-kinase (PIP 4-kinase) shown to phosphorylate PtdIns 5-P at the D-4 
position can also phosphorylate PtdIns 3-P (Rameh et al. 1997a).
As described above there appears to be several synthesis pathways for PtdIns 4,5-P2 and 
PtdIns 3,4-P2. Similarly, further to the classical agonist stimulated PtdIns 3,4,5-P3 
synthesis by PtdIns 3-kinase, the type I and II PtdIns 5-kinases are reported to act 
concurrently, generating PtdIns 3,4,5-P3 from PtdIns 3-P (Zhang et al. 1997). Type II 
phosphorylates PtdIns 3-P at the D-4 position generating PtdIns 3,4-P2, which in turn is 
phosphorylated at the D-5 position by type I thus producing PtdIns 3,4,5-P3.
Recently a fourth D-3 phosphatidylinositol, phosphatidylinositol 3,5-bisphosphate 
(PtdIns 3,5-P2), was discovered in yeast and mammalian cells (Dove et al. 1997; 
Whiteford et al. 1997). In yeast the PtdIns 3-P 5-kinase, Fablp, phosphorylates the 
Vps34p product PtdIns 3-P (Cooke et al. 1998; Gary et al. 1998) and a similar reaction 
is performed by the mammalian orthologue PIKfyve in vitro (Sbrissa et al. 1999). In 
1997, Rameh and colleagues demonstrated two synthesis pathways for PtdIns 3,5-P2. 
First, type I PtdIns 4-P 5-kinase can also utilise PtdIns 3-P as a substrate, and secondly 
class IA PtdIns 3-kinase is able to phosphorylate the novel lipid PtdIns 5-P in vitro.
In addition to the kinase reactions, interconversion o f  phosphoinositides by the many 
phosphatases adds to the complexity o f phosphoinositide generation (Majerus et al. 
1999). Most o f  the phosphatases are substrate specific and remove the phosphate at one 
position on the inositol ring. For example PtdIns 3,4,5-P3 can be dephosphorylated at
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the D-5 position by the SHIP enzymes (Krystal et al. 1999; Majerus et al. 1999) or at 
the D-3 position by a phosphatase encoded by the human tumour suppressor gene PTEN 
(Vazquez and Sellers 2000). Finally, further to kinases and phosphatases, there are 
phospholipase enzymes that hydrolyse phosphoinositides generating inositol 
phosphates. However, PtdIns 3,4,5-P3 is not a substrate for any known phospholipases 
and thus is not the precursor o f  inositol 1,3,4,5-tetrakisphosphate (Ins 1,3,4,5-P4) 
{Figure 1.1, B) which is generated by D-3 phosphorylation o f Ins 1,4,5-P3.
1.4 The Role of Phosphoinositides in Cellular Functions
Phosphoinositides have been implicated as key regulators in a diverse range o f  cellular 
functions. These include vesicle trafficking, insulin-stimulated translocation o f  the 
glucose transporter Glut4, chemotaxis, membrane ruffling, cytoskeletal assembly and 
apoptosis (reviewed in Corvera et al. 1999; Czech 1995; Martin 1998; Rameh and 
Cantley 1999; Toker 1998; Toker and Cantley 1997).
1.4.1 The Role of Phosphoinositides in Membrane Trafficking
It is now a quarter o f  a century since George Palade proposed that the homeostasis o f  
eukaryotic membranous organelles is maintained through the exchange o f membrane 
vesicles (Palade 1975). Transport vesicles containing specific ‘cargo’ o f  proteins and 
lipids, bud from the donor membrane and are driven along microtubules and actin 
filaments by motor proteins, and then dock and fuse with the acceptor membrane 
(reviewed by Rogers and Gelfand 2000). A  simplified model o f this complex transport 
system is shown in Figure 1.3. In all cells a constitutive biosynthetic pathway 
transports components from the ER via the Golgi to the plasma membrane (constitutive 
exocytosis). In specialised cells vesicles can remain in intracellular pools and only fuse 
with the plasma membrane in response to stimulation (regulated exocytosis). Examples 
include the release o f histamine from mast cells, neurotransmitters from synapses and 
the translocation o f the glucose transporter Glut4 to the plasma membrane in response 
to insulin. Endocytosis is the converse reaction in which vesicles bud from the plasma 
membrane and fuse with the early endosome where the cargo is sorted and can either be 
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Figure 1.3. Simplified model of membrane trafficking. Vesicles bud from a 
donor membrane and fuse with an acceptor membrane transporting cargo proteins 
and lipids. The constitutive biosynthetic pathway transports cargo from the endo­
plasmic reticulum (ER) to through to the Golgi, trans-Golgi network (TGN) and 
finally to the plasma membrane. Exocytosis can also occur via the regulated pathway 
in which vesicles fuse with the plasma membrane in response to stimulation. 
Vesicles can also transport cargo into the cell by endocytosis. Vesicles bud off from 
the plasma membrane and fuse with the early endosome where the cargo is sorted 
and either recycled back to the plasma membrane or transported to the lysosome via 
the late endosome.
endosome. The fidelity o f the vectorial transport is governed by a network o f complex 
interactions between regulatory molecules and mechanical components during the 
budding and docking/fusion stages.
Formation o f  transport vesicles is initiated by the assembly o f coat proteins at specific 
sites on the cytoplasmic face o f  the membrane. As well as inducing curvature into the 
membrane, coat proteins are involved in the selection and concentration o f  the cargo 
(Rothman and Wieland 1996). Several coat proteins have been identified and appear to 
be localised to specific trafficking pathways. Coat protein complex-I (COPI)-coated 
vesicles carry proteins within the early secretory pathway (ER and Golgi), COP-II 
vesicles allow exit from the ER, and clathrin-coated vesicles mediate transport from the 
trans-Golgi network (TGN) and endocytic transport from the plasma membrane 
(Rothman and Wieland 1996; Wieland and Harter 1999). GTPases are known to 
regulate both the formation and docking/fusion stages o f  membrane transport. ADP- 
ribosylation factors (ARFs) form part o f the primer in the vesicle budding o f  many 
vesicles and Rabs are implicated to function in targeting and fusion with acceptor 
membranes (Chavrier and Goud 1999). Docking and fusion stages are controlled by the 
protein-protein interactions o f  the components o f the fusion apparatus, such as the 
SNARE proteins. The SNARE hypothesis for membrane fusion postulates that a v- 
SNARE on the vesicle must interact with a t-SNARE on the acceptor membrane to form 
the 'core complex' and mediate fusion (Sollner et al. 1993). In the last few years a series 
o f experiments analysing the interaction o f phosphoinositides with the mechanical and 
regulatory components o f vesicle trafficking has generated considerable evidence 
supporting the importance o f phosphoinositides as site-specific signals that recruit and 
possibly activate proteins essential in the budding, docking and fusion processes.
The first direct evidence implicating a critical role for phosphoinositides in membrane 
trafficking was the discovery that the yeast gene VPS34, which is important in 
trafficking to the vacuole, encoded a PtdIns 3-kinase (Schu et al. 1993). The protein 
product, Vps34p, phosphorylates PtdIns generating PtdIns 3-P, and temperature- 
sensitive Vps34p mutant cells exhibit a defect in protein sorting to the vacuole at non- 
permissive temperatures (Stack et al. 1995). The serine/threonine protein kinase 
V psl5p mediates membrane association and activation o f Vps34p. Together they are 
localised on Golgi or endosome-enriched membrane fractions. These studies suggest a 
functional role for the Vps34p/Vpsl5p complex in the trafficking o f  hydrolytic enzymes
to the vacuole. The equivalent trafficking pathway in mammalian cells, from the Golgi 
to lysosomes, was blocked by wortmannin, a potent inhibitor o f  PtdIns 3-kinase (Brown 
et al. 1995; Davidson 1995). Following many years o f  research it is now generally 
accepted that PtdIns 3-kinases and PtdIns 3,4,5-P3 play a pivotal role in the insulin- 
stimulated translocation o f the glucose transporter, Glut4 from internal storage pools to 
the plasma membrane. However, the precise signalling pathway remains uncertain 
(Section 1.7).
In 1997 Patki et al. undertook experiments to identify downstream effectors o f PtdIns 3- 
kinase by searching for peripheral membrane proteins that bind to membranes in a 
wortmannin-sensitive manner. These studies lead to the identification o f  mammalian 
early-endosomal autoantigen-1 (EEA1) (Patki et al. 1997), which directly binds PtdIns 
3-P through a 70-residue motif, referred to as the FYVE domain {Section 1.5.1). EEA1 
also binds to Rab5 GTPase and stimulates homotypic endosome fusion (Simonsen et al. 
1998). Similarly, Vaclp, the yeast orthologue o f EEA1, interacts with the yeast Rab5 
GTPase (Vps21p) and the endosomal t-SNARE Pepl2p, thus co-ordinating the 
endosome fusion process (Peterson et al. 1999; Tall et al. 1999 and reviewed in 
Odorizzi et al. 2000; Wurmser et al. 1999).
Recent studies to determine the localisation o f PtdIns 3-P in both mammalian and yeast 
cells confirmed that this phospholipid is highly enriched on early endosomes and in the 
internal vesicles o f multivesicular endosomes (Gillooly et al. 2000). These vesicles, 
together with PtdIns 3-P are degraded by the hydrolases in the vacuole/lysosome. 
Although the bulk o f  PtdIns 3-P is metabolised via this route, Fablp also uses it as a 
substrate to generate PtdIns 3,5-P2 (Gary et al. 1998). Fablp also contains a FYVE 
domain that binds PtdIns 3-P and may function to recruit this kinase to membranes 
containing its substrate. Golgi to vacuole trafficking is unaffected in FAB1 deletion 
mutants, however the vacuole in these cells is dramatically enlarged suggesting a 
distinct role for PtdIns 3,5-P2 in regulating vacuole morphology. A model proposed by 
Gary and colleagues suggests that whereas Vps34p and PtdIns 3-P are essential for 
anterograde trafficking o f  membranes and cargoes to the vacuole, Fablp and PtdIns 3,5- 
P2 may play an important compensatory role in the efflux o f  vacuolar membranes (Gary 
et al. 1998).
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Vesicle formation begins with the recruitment o f a GTPase, ARFs (Section 1.6), to the 
donor membrane (Springer et al. 1999). ARF effector proteins that regulate its 
activation state, guanine nucleotide exchange factors (GEFs; Section 1.6.4) and GTPase 
activating proteins (GAPs; Section 1.6.5), contain a pleckstrin homology (PH) domain 
{Section 1.5.2) that bind phosphoinositides, namely PtdIns 3,4,5-P3 and PtdIns 4,5-P2. 
These findings agree with the proposed role o f phosphoinositides as local modulators 
that recruit and may activate effector proteins involved in membrane trafficking. 
Additional evidence to support this theory came from experiments indicating the 
interaction between phosphoinositides and proteins involved in coat assembly. Adaptor 
protein-2 (AP-2), which is involved in clathrin coat formation and selection o f cargo for 
internalisation at the plasma membrane, specifically binds PtdIns 3,4,5-P3 resulting in 
the inhibition o f clathrin coat assembly (Gaidarov et al. 1996). Similarly adaptor 
protein-3 (AP-3), which is thought to function in synaptic vesicles biogenesis, and a -  
COP, one o f the seven subunits that make up the complex o f  COPI, also display specific 
interactions with PtdIns 3,4,5-P3 (Chaudhary et al. 1998; Hao et al. 1997). p-arrestin 
and p-arrestin-2 are also thought to function as adaptors by linking agonist-activated G- 
protein coupled receptors with the clathrin-coated pit machinery and thus mediating 
their internalisation (Gaidarov et al. 1999; Lin et al. 1997). p-arrestin proteins contain a 
PH domain that could bind PtdIns 3,4,5-P3 or PtdIns 4,5-P2 in vitro, however p-arrestin 
recruitment to coated pits was shown to be wortmannin-insensitive and therefore PtdIns
4,5-P2 is the more likely binding candidate (Gaidarov et al. 1999).
There is now considerable evidence implicating PtdIns 4,5-P2 in vesicle trafficking. 
Firstly, the binding o f PtdIns 4,5-P2 to ARF1 is proposed to promote its interaction with 
ARF-GAP (Randazzo 1997a). Secondly, in an assay measuring the formation o f AP-2 
mediated clathrin coated vesicle formation, the introduction o f  PH domains that 
specifically bind PtdIns 4,5-P2 inhibits the formation (Jost et a l  1998). Furthermore, 
the PtdIns 4,5-P2-sequestering PH domain also inhibits dynamin mediated coated pit 
formation and the dynamin mutant unable to bind PtdIns 4,5-P2 leads to inhibition o f  
endocytosis (Achiriloaie et a l  1999; Lee et al. 1999; Vallis et al. 1999).
As well as functioning in endocytosis, evidence indicates a role for PtdIns 4,5-P2 in
regulated exocytosis. Synaptotagmin, a synaptic vesicle membrane protein that
interacts with SNARE proteins contains a C2B domain {Section 1.5) which binds both
PtdIns 3,4,5-P3 and PtdIns 4,5-P2. However, in the presence o f  calcium, at levels
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indicative o f  those required for neurotransmitter release, the specificity o f  binding 
switches to PtdIns 4,5-P2 (Schiavo et al. 1996). Another synaptic vesicle protein 
rabphilin-3A, an effector o f Rab3A, contains two C2 domains that bind PtdIns 3,4,5-P3 
and PtdIns 4,5-P2. In vitro liposome-binding assays revealed calcium-dependent PtdIns
4,5-P2 binding (Chung et al. 1998; Schiavo et al. 1996). It is proposed that these 
proteins may function concertedly in PtdIns 4,5-P2-dependent docking o f  synaptic 
vesicles at the plasma membrane following calcium activation (Corvera et al. 1999).
1.5 Lipid Binding Motifs
There are several lipid-binding motifs that interact with phosphoinositides and inositol 
phosphates including: C2 domains (cysteine-rich regions), Src homology 2 (SH2) 
domains, FYVE domains {Section 1.5.1), PH domains {Section 1.5.2) and 
phosphotyrosine binding (PTB) domains. As described above for synaptotagmin and 
rabphilin-3A, C2 domains can bind to phosphoinositides in a calcium-dependent 
manner and are found in a number o f  other proteins including PKCs and phospholipase 
A (Hurley and Misra 2000). SH2 domains bind primarily to tryosine-phosphorylated 
proteins. However, the SH2 domains o f  phospholipase Cy, Src tyrosine kinase, and the 
p85 regulatory subunit o f PtdIns 3-kinase have also been shown to bind specifically to 
PtdIns 3,4,5-P3 (Rameh et al. 1995). The in vivo relevance o f  this interaction is 
supported by the observation that inhibition o f  PtdIns 3,4,5-P3 production resulted in 
enhanced association o f p85 with phosphotyrosine residues on upstream effectors such 
as the insulin receptor and the insulin receptor substrates (IRSs). Thus suggesting that 
PtdIns 3,4,5-P3 binds directly to the SH2 domains o f  p85 and causes dissociation o f  
PtdIns 3-kinase from tyrosine-phosphorylated proteins, thereby providing a negative 
feedback control. Similarly PtdIns 3,4,5-P3 was shown to bind to the SH2 domains o f  
PLCy and enhanced its phospholipase activity toward PtdIns 4,5-P2 (Bae et al. 1998). 
However more recently, structural and biochemical evidence argues against the theory 
o f phosphoinositides binding to SH2 domains (Surdo et al. 1999).
PTB domains are related to PH domains and as their name suggests they bind 
phosphotyrosine proteins (reviewed by Lemmon and Ferguson 2000). The PTB domain 
o f She was found to bind PtdIns 3,4,5-P3 and PtdIns 4,5-P2 (Rameh et al. 1997b).
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Interestingly the binding o f the latter phosphoinositide was shown to be displaced with 
phosphopeptides, analogous to the results observed with SH2 domains.
Since both FYVE domains and PH domains retain their lipid recognition properties 
when expressed independent from the complete protein, these domains can be utilised 
as experimental tools for studying the spatial and temporal characteristics o f  
phosphoinositides (Balia et al. 2000). Using confocal microscopy, green fluorescent 
protein (GFP)-coupled domains, with specific binding, can be used to identify sites o f  
synthesis o f  the phosphoinositides and examine changes in location in response to 
stimuli. One such experiment employed the PtdIns 3,4,5-P3 specific PH domains o f  the 
ARF effector proteins ARNO (ARF nucleotide-binding site opener) and GRP1 (general 
receptor for phosphoinositides-1) {Section 1.6.4). Localisation changes o f these PH 
domains were studies in response to insulin and platelet-derived growth factor (PDGF) 
stimulation (Oatey et a l  1999).
1.5.1 FYVE Domains
FYVE domains acquired their name from the first letters o f  the founding members o f  
this family (Fabl, Y G 023, YPS27 and EEA1) (Stenmark et a l  1996). These domains, 
o f  60-80 residues, contain eight conserved cysteines that form two zinc co-ordination 
centres, with a characteristic motif surrounding the third cysteine that is involved in 
binding the inositol head group o f PtdIns 3-P. Structural investigations support the 
biochemical binding studies that reveal selectivity for PtdIns 3-P (Fruman et al. 1999). 
The importance o f this lipid in recruiting proteins to the early endosome in vesicle 
trafficking is now well accepted and there may be many more cellular functions in 
which PtdIns 3-P and FYVE domain containing proteins are involved.
1.5.2 PH Domains
PH domains are protein modules o f  around 120 amino acids located in a large number 
o f proteins involved in cellular signalling, cytoskeletal organisation, regulation o f  
membrane trafficking, and modification o f membrane phospholipids (Lemmon and 
Ferguson 1998). These domains were first identified as a protein region present at the 
N- and C-termini o f pleckstrin, the major substrate o f  PKC in platelets (Haslam et al.
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1993; Mayer et al. 1993). Nuclear magnetic resonance (NMR) or crystal structures are 
now known for several PH domains. In each case, the structure o f the domain is 
remarkably similar, despite quite divergent sequence homology. The conserved 
structure contains two orthogonal antiparallel p-sheets (four P-strands, p l-p4 and three 
P-strands P5-p7, respectively), and a C-terminal amphipathic a-helix (reviewed by 
Lemmon and Ferguson 2000) {Figure 1.4, A). Despite the lack o f conserved sequence 
homology there is an invariant tryptophan residue situated in the C-terminal a-helix. 
The strands o f  each p-sheet are arranged as a p-meander, with each strand re-entering 
the sheet at the same side from which it left, with the strands occurring in the same 
order along the sheet as they do in the sequence. The connecting loops between p l/p2, 
p3/p4 and p6/p7 were found to be most variable in length. Sequence alignments 
suggest (by analogy to immunoglobulins) that these regions serve as variable loops and 
may constitute a ligand-binding site.
It was in 1994 that Harlan and colleagues demonstrated phosphoinositides binding to 
PH domains and proposed that this interaction may be important for membrane 
localisation o f  proteins containing these domains (Harlan et a l  1994). Subsequent 
crystallography analysis o f PH domains bound to phosphoinositides or inositol 
phosphates provided valuable information o f  this interaction. In the crystal structure o f  
the PLCy PH domain bound to the head group o f  Ptdlns 4,5-P2, the inositol moiety was 
located in a pocket flanked by the p i/p2 and p3/p4 loops (Ferguson et a l  1995). 
Specific basic residues in the pi and p2 strands were identified as sites o f  interaction 
with the phosphate groups. Similarly the crystal structure o f  the Bruton’s tyrosine 
kinase (Btk) PH domain in complex with Ins 1,3,4,5-P4 has been used to identify critical 
residues that interact with the phosphates on the inositol ring. An arginine residue at 
position 28 in the Btk PH domain (Arg-28), that interacts with the 3-phosphate o f  Ins
1,3,4,5-P4 was found to be mutated to a cysteine in X-linked immunodeficiency 
(Fukuda et a l  1996).
In 1997, Rameh et a l  compared the ability o f six PH domains to bind five different 
phosphoinositides. Four distinct PH domain subgroups were created on the basis o f  
substrate specificity (Rameh et a l  1997b) {Figure 1.4, B). Group I PH domains display 
high affinity for Ptdlns 3,4,5-P3, Btk and GRP1 are examples o f such PH domains. 
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Figure 1.4. Pleckstrin homology domains. (A) Ribbon diagram o f the structure o f  
the PH domain from human pleckstrin protein, (http://www-cryst.bioc.cam.ac.uk/ 
-robert/cpgs/introduction/PHstructure.html.) The C-terminal amphipathic a-helix, 
common to all PH domains, is shown in blue; p-strands are shown in green and 
labelled 1-7; The N and C termini are also indicated. (B) Subdivision of PH domains 
into four groups according to the binding specificity, adapted from Rameh et al., 
(1997). (C) PPBM motif, showing the six conserved residues where ‘Arg’ is arginine, 
‘Lys’ is lysine, ‘Xaa’ is any amino acid, ‘Sma’ is a small uncharged amino acid and 
‘Hyd’ is a hydrophobic amino acid (Dowler et al., 2000). (D) “Signature m otif’ for PH 
domains known and/or predicted to bind 3-phosphoinositide with high affinity. A list 
o f residues enclosed in square brackets represents the observed range o f sequence 
variability at a given position; X denotes any residue; m= 5-10; n= 6-13; (Lietzke et 
al., 2000).
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over Ptdlns 4,5-P2. The PH domains o f  protein kinase B (PKB, also known as Akt) and 
DAPP1 make up group III, which bind both Ptdlns 3,4-P2 and Ptdlns 3,4,5-P3. A final 
group o f  PH domains displayed low affinity for phosphoinositides, group IV. This 
group includes the dynamin PH domain that is unable to bind phosphoinositides unless 
it is dimerised. Oligomerisation is proposed to promote binding to membranes 
containing phosphoinositides which is critical for stimulation o f its GTPase activity and 
its ability to perform scission o f endocytic vesicles from the plasma membrane (Klein et 
al. 1998).
An in vitro assay called TOPIS (Targets o f  Ptdlns 3-kinase Identification System) was 
devised by Skolnik and colleagues to identify proteins that bind to the plasma 
membrane in a Ptdlns 3-kinase-dependent manner (Isakoff et al. 1998). A  temperature 
sensitive yeast strain was transformed with a construct that expresses a constitutively 
active form o f the GTPase Ras, fused with a PH domain o f interest. This strain can only 
grow at restrictive temperatures if  the Ras is targeted to the plasma membrane. This 
was achieved using the PLCy PH domain, which drives membrane localisation by 
binding to Ptdlns 4,5-P2, thus rescuing the temperature-sensitive phenotype. Co­
expression o f  a constitutively active form o f  Ptdlns 3-kinase results in accumulation o f  
Ptdlns 3,4,5-P3 and Ptdlns 3,4-P2 at the plasma membrane enabling analysis o f  Ptdlns 3- 
kinase-dependent localisation o f  the different PH domains. From this study, a 
consensus sequence for high affinity binding to Ptdlns 3,4-P2 and/or Ptdlns 3,4,5-P3 was 
derived (Isakoff et al. 1998). More recently Dowler and colleagues noted that all o f the 
specific Ptdlns 3,4,5-P3-binding proteins possessed a common sequence at the N- 
terminal regions o f the PH domains, the putative Ptdlns 3,4,5-P3 binding m otif (PPBM) 
(Figure 1.4, Q . The expressed sequence tag (EST) database was searched for proteins 
possessing a PH domain containing this consensus sequence o f  six basic residues that 
appears to correlate with high-affinity Ptdlns 3,4,5-P3 binding (Dowler et al. 2000). 
Surprisingly this search to identify novel proteins that interact with Ptdlns 3,4,5-P3 
identified several proteins that do not bind this phosphoinositide, but instead posses 
novel and unexpected in vitro phosphoinositide-binding specificity. Until the discovery 
o f  PEPP1 (ghosphatidylinositol-three-ghosphate-binding PH-domain protein-1), no PH 
domains were known to bind Ptdlns 3-P, the exclusive ligand o f FYVE domains. 
Likewise centaurin-p2 (Section 1.6.5) was the first PH domain protein found to exhibit 
selective binding for Ptdlns 3,5-P2 and FAPP1 (phosphatidylinositol-four-phosphate 
adaptor protein-1) for Ptdlns 4-P (Dowler et al. 2000). Sequence analysis o f the PPBM
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region o f  these novel proteins revealed that one residue o f  the consensus sequence was 
altered. However, not all PH domains containing the six residues o f  the consensus 
sequence were able to bind Ptdlns 3 ,4 ,5 -P3, thus emphasising the importance o f residues 
outside the PPBM.
Lietzke and colleagues observed that some o f the invariant basic residues are also 
conserved in the PLC8  PH domain which binds Ptdlns 4,5-P2 rather than 3- 
phosphoinositides, but that a tyrosine residue located in the p3 strand was strictly 
conserved to PH domain that bind 3-phophoinositides with high affinity. The 
“signature m otif’ for 3-phosphoinositide binding was redefined (Lietzke et al. 2000) 
(Figure 1.4, D).
The structural basis o f  3-phosphoinositides recognition by PH domains, and the 
discrimination between phospholipids, has been most clearly revealed by X-ray 
crystallography studies. Structural analysis o f  the PH domains o f GRP1 {Section 1.6.4), 
(which is specific for Ptdlns 3,4,5-Ps) and DAPP1 (that binds both Ptdlns 3 ,4 ,5 -P3 and 
Ptdlns 3 ,4 -P2) identified key differences in the residues that interact with the phosphates 
(Ferguson et al. 2000). Although the two PH domains share the common core structure 
o f  seven p-strands and an a-helix, there is a 20 amino acid insertion in the p6/p7 loop 
o f  GRP1 (Lietzke et al. 2000). This insertion forms two additional p-strands, P6 ’ and 
p6 ” , and appears to deepen the inositol phosphate-binding site. Hydrogen bonding, 
common to both PH domains, only occurs with the 1-, 3-, and 4-phosphates o f Ins
1 ,3 ,4 ,5 -P4 . In addition to these shared bonds, DAPP1-PH and GRP 1-PH make three 
unique side-chain hydrogen bonds. All o f  the interactions unique to DAPP1 are made 
with the 4-phosphate, whereas GRP1 connects with both the 4- and 5-phosphates. This 
variation explains how only Ins 1 ,3 ,4 ,5 -P4 or Ptdlns 3 ,4 ,5 -P3 satisfy the phosphate group 
recognition requirements for GRP1-PH, while Ptdlns 3 ,4 ,5 -P3, Ptdlns 3 ,4 -P2 and their 
inositol phosphate equivalents are able to satisfy the requirements for DAPP1-PH.
Since cellular levels o f Ptdlns 4 ,5 -P2 are considerably higher than Ptdlns 3 ,4 ,5 -P3 it is
estimated that in order to achieve Ptdlns 3-kinase dependent membrane recruitment, a
PH domain must display substantially higher (at least 25-fold) affinity for Ptdlns 3,4,5-
P3 over Ptdlns 4 ,5 -P2 (Lemmon and Ferguson 2000). All PH domains o f  groups I and
III satisfy these conditions, including those o f  GRP1, PKB and DAPP1. Whereas all
three o f  these PH domains are recruited to the plasma membrane following stimulation
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o f  Ptdlns 3-kinase, Ptdlns 3,4-P2 accumulation in response to oxidative stress stimulates 
the translocation o f PKB but not GRP1 (Gray et al. 1999; Isakoff et al. 1998; 
Venkateswarlu et al. 1998a). Thus, it can be concluded that a PH domain which 
recognises only Ptdlns 3,4,5-P3 (such as GRP1) will be recruited transiently to the 
plasma membrane, whereas one that binds both Ptdlns 3,4,5-P3 and Ptdlns 3,4-P2 (PKB 
and DAPP1) may have more sustained binding.
1.6 The Role of ARF Proteins in Vesicle Trafficking
ARFs are 20 kDa guanine nucleotide-binding proteins, members o f  the Ras GTPase 
superfamily, that were initially isolated because o f  their ability to stimulate the ADP- 
ribosyltransferase activity o f  the cholera toxin A subunit (Kahn and Gilman 1986). 
ARFs function as molecular switches, cycling between inactive GDP- and active GTP- 
bound states. The cycle is controlled by two sets o f  regulatory proteins, GEFs that 
facilitate the exchange o f GDP for GTP, thereby activating ARF, and GAPs that 
stimulate GTP hydrolysis. Since ARFs possess a low intrinsic GTPase activity, ARF- 
GAP proteins are essential for ARF function.
Mammalian ARFs, o f  which there are six, can be divided into three classes: Class I, 
(ARF1-ARF3), Class II (ARF4 and ARF5) and Class III (ARF6) (Moss and Vaughan 
1995). It is well established that mammalian Class I ARFs regulate coat assembly in 
vesicle formation from the ER, Golgi and TGN {Section 1.6.1). The function o f Class II 
ARFs remains unknown. ARF6, the least conserved ARF protein, localises to the 
plasma membrane and endosomal compartments and is proposed to regulate membrane 
transport and cytoskeletal organisation (D'Souza-Schorey et al. 1998; Radhakrishna et 
al. 1999) {Section 1.6.2). In the yeast Saccharomyces cerevisiae, there are three ARF 
proteins. ARF1 and ARF2 are functionally interchangeable, and yeast cells require at 
least one o f these proteins for viability. Yeast ARF3 is not essential for growth and 
probably corresponds to the mammalian ARF6.
In its inactive GDP-bound form ARF is predominantly cytosolic, whereas the GTP- 
bound conformation is membrane associated. ARF proteins possess a 17-residue 
myristolated amphipathic a-helix at their N-terminus and tight binding to the membrane 
requires that this myristate insert into the lipid bilayer. Early models o f ARF function
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proposed that, in the GDP-bound form, the N-terminal helix would be packed against 
the protein core and that the exchange for GTP would induce a conformational change 
allowing the helix to insert into the lipid bilayer (Amor et al. 1994). Therefore the site 
o f ARF activity would be determined by the location o f  the GEF protein responsible for 
the release o f  GDP, thus dictating the location o f vesicle formation. However, 
subsequent studies have established that the myristate group is exposed and interacts 
with the phospholipids when ARF is in the GDP-bound conformation (Franco et al. 
1995; Goldberg 1998). However, the conformational change induced by GDP/GTP 
exchange was found to expose several hydrophobic residues in the N-terminal helix, 
thus facilitating the insertion into the lipid bilayer and stabilising ARFs membrane 
association (Antonny et a l  1997). These authors went on to demonstrate a requirement 
for membrane association o f  ARF 1-GDP for the stable interaction with a GEF and the 
subsequent GTP exchange (Beraud-Dufour et a l  1999). Moreover, the conformational 
switch o f  amino-terminal helix (from a hydrophobic pocket in ARF-GDP to tight 
association with lipids) was found to occur early in the exchange reaction, before the 
release o f  GDP. Many GEFs are cytosolic proteins that associate with specific 
membrane phosphoinositides via their PH domains (Section 1.6.4) and an important 
conclusion o f this study was that ARF-GDP and the GEFs must each contain 
membrane-targeting information. Therefore localisation o f  the GEFs controls the site o f  
ARF activation thus governing the locality o f  vesicle formation.
1.6.1 ARF1
ARF1, the best characterised ARF protein, was originally found to be localised to the 
Golgi complex where it mediates the interaction o f coatomer into COPI vesicles 
(Palmer et al. 1993). Interestingly, in addition to the involvement in the biosynthetic 
pathway, there is growing evidence implicating ARF1 and endosomal COPs in 
endosomal membrane transport (Gu and Gruenberg 2000). In addition there is evidence 
to suggest a role for ARF1 in the formation o f  clathrin-coated vesicles. ARF1 was 
shown to be required for the binding o f  adaptor protein-1 (AP-1) o f  clathrin-coated 
vesicles to the Golgi membranes (Stamnes and Rothman 1993) and TGN (Zhu et al.
1998), and for the membrane recruitment o f AP-3 (Ooi et al. 1998).
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Using a cell free system Schekman and colleagues demonstrated coatomer, ARF1- 
GTPyS (non-hydrolysable GTP analogue) and liposomes to be sufficient components to 
reproduce Golgi vesicle budding (Spang et al. 1998). Confirmation o f ARF’s regulatory 
role in vesicle trafficking in vivo was achieved using ARF1 mutants that were defective 
in either the binding or hydrolysis o f GTP. The mutant defective in GTP-binding 
prevented coat proteins from binding to the Golgi membrane, resulting in the retrograde 
transport o f  these membranes back to the ER. Intriguingly, the mutant defective in 
GTP-hydrolysis caused irreversible binding o f COPI to the membranes, thus preventing 
uncoating and fusion with acceptor membranes (reviewed in Rothman and Wieland 
1996; Schekman and Orci 1996).
1.6.2 ARF6
Initial studies by D ’Souza-Schorey et al. demonstrated that ARF6 was localised to the 
plasma membrane and intracellular endosomal compartments (D'Souza-Schorey et al. 
1995). Subsequent electron microscopy analysis revealed that at low levels o f  protein 
expression, wild-type ARF6 localised predominantly to intracellular compartments 
around the pericentriolar region o f  the cell (D'Souza-Schorey et al. 1998). Whereas 
other ARF proteins are cytosolic in the GDP-bound form, ARF6-GDP accumulates in 
the pericentriolar region, characteristic o f the recycling endosomal compartment. ARF6 
mutants that are constitutively GDP-bound cause an intracellular accumulation o f  
transferrin receptors. Conversely GTP-bound ARF6 mutants are localised at the plasma 
membrane where they reduce transferrin receptor uptake into the cell and stimulate the 
redistribution o f  receptors back to the cell surface (D'Souza-Schorey et al. 1995). As 
well as functioning in membrane transport, ARF6 is able to stimulate cortical actin 
rearrangement (Radhakrishna and Donaldson 1997). ARF6 co-localises with R acl, a 
Rho family GTPase implicated in cortical actin rearrangements, and is thought to 
control the ability o f lamellipodia formation that is induced by Racl (Radhakrishna et 
al. 1999). ARF6 has also been implicated in the regulation o f  cell surface levels o f  
Glut4, as insulin-stimulated glucose transport and Glut4 translocation were partially 
inhibited (-50% ) using the myristolated N-terminal peptide o f ARF6 in adipocyte cells 
(Millar et al. 1999).
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1.6.3 Coat Assembly and Vesicle Formation
As described above, formation o f the vesicle begins upon activation o f membrane 
associated ARF, which then recruits the coat protein complex coatomer {Figure 1.5). 
Using a yeast two hybrid system this interaction with ARF-GTP was recently shown to 
occur with subunits P- and s-COP (Eugster et a l  2000). Coatomer polymerisation 
induces membrane deformation, in the process cargo proteins and targeting machinery 
are incorporated and budding occurs. Finally, a vesicle associated ARF-GAP stimulates 
hydrolysis o f  bound GTP to release ARF, triggering uncoating o f the vesicle which is 
required prior to docking and fusion with the acceptor membrane. This model describes 
in brief the stages that occur in vesicle formation (reviewed by Chavrier and Goud 
1999; Moss and Vaughan 1998; Roth 1999; Springer et al. 1999), however there may be 
many more proteins involved in the regulation o f  this process.
For vesicles to mediate selective transport, coats must distinguish between cargo and 
resident proteins. Sorting information may be encoded in cytoplasmic sorting signals 
that interact directly with the coat. For example, ER-resident proteins with the dilysine 
trafficking m otif (KKXX) are recognised by coatomer for retrograde Golgi-to-ER 
transport in COPI-coated vesicles (Bremser et a l  1999). Similarly, in COPII vesicle 
transport from ER to Golgi, the coat subunit Sec23/24p complex interacts with the 
GTPase Sarlp-GTP and Betlp  (v-SNARE) (Springer and Schekman 1998). Springer et 
a l  (1999) proposed a model o f vesicle formation that involved the capture o f cargo 
protein into a priming complex with a small GTPase together with one or several other 
subunits o f the vesicular coat, including a GAP protein. The KDEL receptor is a further 
example o f  sorting signal for COPI mediated transport for retrieval from the Golgi to 
the ER. The ligand bound KDEL receptor has been shown to recruit ARF-GAP into the 
priming complex. Using the yeast two-hybrid system described above for the 
identification o f  COPI subunits interacting with ARF-GTP, it was also found that y- and 
p’-COP interact with the ARF-GAP called Glo3p (Eugster et a l  2000). In the same 
study the authors demonstrated that recombinant hexa-His-tagged Glo3p interacts with 
coatomer from cytosol in vitro . Therefore, cargo proteins and targeting machinery may 
play an active role in coat assembly and/or control uncoating through regulation o f  
ARF-GAP activity.
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C argo  R eceptor
Coat Protein
F ig u re  1.5. A  h y p o th e tic a l m o d el fo r  th e  in v o lv em en t o f  A R F  in vesicle 
fo rm a tio n . In the inactive GDP-bound form ARF has low affinity for membrane 
phosphoinositides and shuttles between the membrane and cytosol. ARF-GEF 
proteins promote nucleotide exchange, which induces a conformational change 
resulting in stable association o f ARF-GTP. This interaction is dependent on the 
myristate group, which inserts into the lipid bilayer. Coatomer is recruited and 
assembled through a bivalent interaction with ARF-GTP and the cytosolic sorting 
signal on membrane cargo proteins. An ARF-GAP protein is recruited during this 
process by its interaction with the membrane cargo protein. Coatomer polymerisa­
tion induces membrane deformation and budding occurs. Adapted from Chavrier et 
a l  (1999).
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As described above ARF-GAPs appear to be incorporated into the priming complex 
during vesicle formation, however the point at which they stimulate GTPase activity 
remains unknown. Although GTP hydrolysis is required for the release o f ARF from 
the membrane and the subsequent uncoating o f the vesicles, it may occur prior to 
vesicle scission. In 1999, Goldberg presented the crystal structure o f  ARF1 complexed 
to ARF-GAP. An ARF1 mutant in which the myristolated N-terminal a-helix was 
truncated (termed A R F lt or A17-ARF1) was crystallised in complex with a 130-amino 
acid catalytic fragment o f GAP1 (Goldberg 1999). Unlike Ras GTPases, the GAP- 
binding domain o f ARF1 does not overlap with the effector-binding site. This allows 
ARF 1-GTP to simultaneously interact with coatomer (the effector) and ARF-GAP, 
described as the tripartite model (Goldberg 1999). Biochemical studies have shown that 
coatomer stimulated GTP hydrolysis by 1000-fold in an ARF-GAP-dependent manner, 
further strengthening the tripartite model. More recently, Goldberg suggested that 
coatomer recognition o f  sorting signals on cargo proteins might be a selection 
mechanism conferring differentiation through GTP hydrolysis (Goldberg 2000). 
However, it is important to note that the assays using truncated ARF1 and the catalytic 
domain o f  GAP1 were performed in a membrane-free environment. When these 
experiments were repeated using wild-type myristolated ARF 1-GTP in the presence o f  
phospholipid vesicles, GAP1 stimulated GTP hydrolysis in the absence o f coatomer 
therefore challenging the tripartite model (Szafer et al. 2000). Furthermore, coatomer 
was unable to enhance the GTPase activity. Disruption o f  the vesicle phospholipids 
with detergent resulted in reduced GAP activity, which was coatomer-sensitive, a 
pattern similar to the activity o f A17-ARF1. Taken together these findings indicate that 
coatomer may function to recruit the GAP protein and that the binding o f  both ARF and 
its GAP to membrane phospholipids may be sufficient for the stimulation o f ARF1 
GTPase activity (Eugster et al. 2000; Szafer et al. 2000).
1.6.4 ARF-GEF Protein Family
ARF-GEFs are a family o f proteins that share a common domain o f -2 0 0  amino acids, 
termed the Sec7 domain. Chardin and colleagues established that the guanine exchange 
activity resides in the Sec7 domain and that this domain alone is sufficient for exchange 
activity (Chardin et al. 1996). This highly divergent family o f proteins has been 
subdivided into four distinct subfamilies on the basis o f size and sequence homology
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{Figure 1.6). At present there are two families o f large GEFs (> 100 kDa) and two 
families o f small GEFs (Jackson and Casanova 2000). In addition to the distinct 
domain structure, these proteins also differ in their sensitivity to the fungal metabolite 
brefeldin A (BFA). BFA inhibits protein secretion and induces disassembly o f the 
Golgi complex and redistribution o f resident Golgi markers to the ER (Chardin and 
McCormick 1999). By stabilising the ARF-GDP-GEF complex, BFA inhibits GEF- 
catalysed ARF activation.
The large (>100 kDa) ARF-GEFs o f the Gea and Sec7/BIG subfamilies function in the 
ER-Golgi system, and the majority are BFA-sensitive. In contrast the cytohesin 
(ARNO/cytohesin/GRPl) and EFA6 subfamilies function primarily in the endosomal- 
PM system and are resistant to the adverse effects o f BFA (reviewed by Donaldson and 
Jackson 2000).
ARNO, cytohesin-1 and GRP1 are closely related in size and sequence (77% identity), 
and share a common domain structure. This consists o f an N-terminal coiled coil 
region, a central Sec7 domain, a PH domain and an adjacent carboxyl-terminal 
polybasic domain. GRP1 was first identified from a screen for phosphoinositide- 
binding proteins and its PH domain specifically binds to Ptdlns 3,4,5-P3 (Klarlund et al. 
1997). Similarly, ARNO and cytohesin-1 display high affinity for Ptdlns 3,4,5-P3 
although they do not exhibit the same degree o f  selectivity for Ptdlns 3,4,5-P3 over 
Ptdlns 4,5-P2 as that exhibited by GRP1 (Klarlund et al. 2000). The remarkable Ptdlns
3,4,5-P3 binding selectivity o f  GRP1 was found to be created by the unique diglycine 
m otif in the p l/p2  loop o f the PH domain, as opposed to the triglycine m otif in ARNO 
and cytohesin-1 (Cullen and Chardin 2000; Klarlund et al. 2000). The addition o f  an 
extra glycine in GRP1 greatly increased the binding affinity o f  Ptdlns 4,5-P2, while 
deletion o f  a single glycine in the ARNO PH domain markedly reduced its binding 
affinity for Ptdlns 4,5-P2. However, in both situations the Ptdlns 3,4,5-P3 binding was 
not altered (Klarlund et al. 2000).
As described above {Section 1.5) PH domains that selectively bind Ptdlns 3,4,5-P3 have 
been utilised for the investigation o f cellular distribution o f this phosphoinositide. 
Moreover, recruitment o f GFP-tagged ARNO to the plasma membrane was 
demonstrated in insulin-stimulated 3T3-L1 adipocytes (Venkateswarlu et al. 1998b). 
Similar studies have shown membrane recruitment in response to Ptdlns 3-kinase
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F ig u re  1.6 T h e  Sec7 fam ily  o f  A R F -G E F s . All proteins share homology in the 
Sec7 domain and have been subdivided into the four subgroups according to their 
size and sequence homology. The small (<100 kDa) ARF-GEFs o f the cytohesin 
(ARNO/cytohesin/GRPl) and EFA6 subfamilies are (at the top o f the figure) are 
relatively insensitive to BFA. In contrast the majority o f the large (>100 kDa) 
ARF-GEFs o f the Gea and Sec7/BIG subfamilies are BFA-sensitive. This diagram 
has been adapted from Jackson and Casanova 2000, with proportional representa­
tion o f the domain size and arrangement.
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stimulation for GRP1 (Langille et al. 1999) and cytohesin-1 (Nagel et al. 1998; 
Venkateswarlu et al. 1999a). It was clear, both from using the Ptdlns 3-kinase 
inhibitors wortmannin and LY294002, and by co-expression with a dominant-negative 
p85 mutant, that the translocation is a consequence o f  agonist-stimulated Ptdlns 3- 
kinase activity. Interestingly, overexpression o f ARNO and A RN 03 (the human 
orthologue o f  GRP1) results in fragmentation o f the Golgi complex, implying a possible 
role in Golgi to ER transport (Franco et al. 1998; Monier et al. 1998). More recently 
the N-terminal coiled coil region o f B2-1 (identical to human cytohesin-1) was shown to 
be responsible for Golgi targeting (Lee and Pohajdak 2000). In agreement with this 
study both endogenous and transfected B2-1 were found to be localised in a perinuclear 
compartment that co-localises with Golgi complex markers (Lee et al. 2000). As 
observed with ARNO and A R N 03, overexpression o f  B2-1 results in disruption o f the 
Golgi complex.
The physiological substrate for the cytohesin family o f  GEFs has been the focus o f  
some debate. GRP1 was found to catalyse guanine nucleotide exchange o f  ARF1 and 
ARF5, but not ARF6 (Klarlund et al. 1998), cytohesin-1 was active towards ARF1 and 
ARF3, but not ARF5 (Meacci et al. 1997) and both ARF1 and ARF6 were substrates for 
ARNO (Frank et al. 1998a). In contrast to these individual studies, Franco and 
colleagues analysed the substrate specificity o f  all three proteins in the cytohesin family 
and found that they all act as ARF1 GEFs in vitro , whereas they had little effect on 
ARF6 (Franco et al. 1998). The relevance o f  the in vitro nucleotide exchange assays 
therefore remains disputable. Nevertheless in vivo data is providing some useful clues 
as to the function o f  these small GEF proteins.
The observation o f plasma membrane localisation o f the cytohesin family o f ARF-GEFs 
has led to the proposal that ARF6 may be their physiological substrate. In support o f  
this hypothesis Frank and colleagues discovered that overexpression o f  ARNO in HeLa 
cells induced disassembly o f actin stress fibres, changes similar to those resulting from 
ARF6 activation (Frank et al. 1998b). Subsequent treatment o f ARNO transfectants 
with a PKC agonist stimulated the dramatic redistribution o f ARNO, ARF6 and actin 
into membrane protrusions that resembled lamellipodia. Moreover, GRP1 was found to 
co-localise with ARF6 in plasma membrane ruffles in response to insulin and epidermal 
growth factor (EGF) stimulation (Dowler et al. 1999). Venkateswarlu and Cullen have 
proposed a link between agonist stimulation o f  Ptdlns 3-kinase and ARF6 activation
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and redistribution to the plasma membrane. Membrane recruitment o f ARNO (through 
Ptdlns 3,4,5-P3 binding) resulted in an increase in ARF6 exchange activity. GDP/GTP 
exchange is thought to occur when the recycling endosomal compartment comes into 
juxtaposition with the plasma membrane bound ARF-GEF (Venkateswarlu and Cullen 
2000). This experiment demonstrates that agonist stimulation o f  Ptdlns 3-kinase 
increases the catalytic activity o f  the cytohesin family ARF-GEFs by inducing their 
recruitment to the plasma membrane.
A  specific ARF6 GEF has been identified and entitled exchange factor for ARF6 
(EFA6). This is structurally distinct from the cytohesin family o f GEFs (Franco et al. 
1999). Studies suggest that EFA may regulate trafficking from the recycling endosome 
to the plasma membrane and the redistribution o f  the actin cytoskeleton. The latter may 
facilitate endosomal trafficking to the cell surface.
1.6.5 ARF-GAP Protein Family
ARF-GAP1, the first ARF-GAP protein to be identified, was cloned from rat liver and 
found to contain an N-terminal zinc-finger m otif that was critical for GAP activity 
(Cukierman et a l  1995). In the last few years a number o f new ARF-GAP proteins 
have been identified and they all share a common GAP domain o f  ~70 amino acids 
which contains the zinc-finger m otif o f CX2CXi6-]7CX2C (where C is cysteine and X is 
any amino acid). In addition to the GAP domain, some ARF-GAP proteins contain 
ankyrin repeats and/or PH domains. The size and arrangement o f the domains are quite 
distinct and allows the multidomain proteins to be divided into sub-groups {Figure 1 .7).
The molecular action o f ARF-GAPs appears to differ to that o f the GAP proteins o f  
other GTPases, such as Ras and Rho. The crystal structure o f ARF 1-GDP complexed to 
ARF-GAP revealed that ARF-GAP binds to an unexpected region away from the 
catalytic site (Goldberg 1999). In addition ARF-GAP does not appear to provide any 
catalytic residues, a principle feature o f Ras-GAP (Scheffzek et al. 1997).
Randazzo and colleagues designed an assay to determine ARF-GAP activity, which 
measured a single round o f hydrolysis (Randazzo and Kahn 1994). In brief, the ARF 
proteins (purified or recombinantly expressed in myristolated and non-myristolated
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Figure 1.7 The ARF-GAP family. All o f these proteins possess the ARF GAP 
domain that contains a zinc-finger binding motif CX2CXi6.17CX2C (where C is cysteine 
and X is any amino acid). Closely related proteins are grouped together. There are four 
subgroups o f centaurin proteins: a, p, 5 and y. Gcsl and Glo3 are from S. cerevisiae. 
This diagram has been adapted from Donaldson and Jackson 2000, with proportional 
representation o f the domain size and arrangement.
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forms) were pre-loaded with [a-32P]GTP and added to a GTPase reaction with the GAP 
protein. Other additions, such as phospholipids, were also tested in the assay. Protein- 
bound nucleotide was trapped on nitrocellulose filters, extracted and fractionated by 
thin-layer chromatography, which was then visualised and quantified for 32P. This 
assay has been used to determine the specificity o f several o f the ARF-GAP proteins.
ARF-GAP1 regulates GTP hydrolysis on ARF1 in the Golgi (Cukierman et al. 1995). 
Two ARF1 GAP proteins from rat liver have been resolved and found to have different 
phospholipid dependencies (Randazzo 1997b). ARF-GAP 1 was activated by 
dioleoglycerols, whereas Ptdlns 4,5-P2 and phosphatidic acid activate ARF-GAP2 
(Randazzo 1997b). The yeast ARF-GAPs, Gcsl and Glo3, which act on yeast ARF1 
and ARF2, mediate retrograde vesicular transport from the Golgi to the ER (Poon et al. 
1996; Poon et al. 1999).
ASAP1 (so called because it is an ARF-GAP containing a SH3 domain, ANK repeats 
and a PH domain, also known as centaurin-p4) was the first peripheral ARF-GAP to be 
characterised. Identified in a screen for proteins interacting with the SH3 domain o f Src 
(Brown et al. 1998), ASAP1 has been shown to bind to Src and focal adhesion tyrosine 
kinase (FAK) and is localised to focal adhesions (Randazzo et al. 2000). 
Overexpression o f ASAP1 altered the morphology o f focal adhesions and inhibited both 
cell spreading and formation o f PDGF-induced dorsal membrane ruffles. ASAP1, in 
which a mutation was introduced that disrupts the GAP activity, had a reduced effect on 
spreading and increased the number o f  cells forming ruffles in response to PDGF 
(Randazzo et al. 2000). As ARF6 has been implicated in the cortical actin 
rearrangement, it would appear that ASAP might function as an ARF6 GAP. 
Interestingly, an ASAP1 construct (consisting o f the PH domain, zinc-finger motif and 
ankyrin repeat regions) was found to have Ptdlns 4,5-P2-dependent GAP activity for 
ARF1 and ARF5, and less activity for ARF6 (Andreev et al. 1999; Brown et al. 1998).
Closely related to ASAP1 is Pyk2-associated protein (PAP; also known as centaurin-p3)
which also displays strong GAP activity towards ARF1 and ARF5, and weak activity
for ARF6 (Andreev et al. 1999; Brown et al. 1998). There appears to be two splice
variants o f  the PAP, the larger human homologue designated PAPa and also known as
PAG3 (Kondo et al. 2000), and the shorter murine PAPp (Andreev et al. 1999). All
ARF-GAPs contain a conserved arginine residue within the GAP domain (five residues
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after the fourth cysteine residue) and in ASAP1 and PAPp mutation o f this arginine 
residue reduced GTPase activity by 100,000-fold (Mandiyan et al. 1999; Randazzo et 
a l  2000). Crystal structure analysis o f the GAP domain and ankyrin repeats o f  PAPp 
revealed that this conserved arginine was situated on the surface o f  the protein and not 
at the site o f  ARF interaction (Goldberg 1999).
AC API and ACAP2 (for ARF-GAP with coiled coil, ankyrin repeat and PH domains; 
also known as centaurin-pl and centaurin-p2 respectively) have been grouped with 
ASAP1 and PAP as they share the general domain structure but lack the SH3-domain 
(Jackson et al. 2000a). The GAP activity o f  the ACAP proteins was found to be 
dependent on Ptdlns 4,5-P2 and phosphatidic acid. However in contrast to ASAP1 and 
PAP, ACAP proteins possess GAP activity for ARF6 in preference to ARF1 and ARF5 
(Jackson et al. 2000a). As for ASAP1, studies have demonstrated the recruitment o f  
ACAP proteins to focal adhesions, and overexpression produced similar results altering 
the morphology o f  the focal adhesions (Jackson et al. 2000a). Another ARF-GAP 
protein to be identified through its interaction with focal adhesion proteins was Pkl 
(paxillin-kinase-linker), which as its name suggests, interacts with paxillin (Turner et al.
1999).
A distinct family o f ARF-GAPs has been discovered, the GITs are G-protein-coupled 
receptor kinase interacting proteins whose GAP activity is stimulated by Ptdlns 3,4,5- 
P 3 . GIT1 was identified in a yeast two-hybrid screen with G-protein coupled receptor 
kinase-2 (GRK-2). Overexpression reduced p2-adrenergic receptor signalling and 
increased receptor phosphorylation, these effects result from reduced receptor 
internalisation and resensitisation (Premont et al. 1998). Later studies have revealed 
GIT1 to be specific for receptors internalised via clathrin-coated vesicles, but was not 
limited to G protein-coupled receptors as the EGF receptor was similarly affected by 
overexpression (Claing et al. 2000). Interestingly GIT1 and its shorter splice variant 
GIT2 stimulate GTP hydrolysis on all five ARFs tested (ARF1-3 and ARF5-6) (Vitale 
et al. 2000). The findings o f these studies suggest the involvement o f  this ARF-GAP 
subfamily in the regulation o f agonist-stimulated receptor internalisation including 
Ptdlns 3-kinase activating receptors such as EGF.
The PH domain o f  ASAP1 corresponds to that o f group I and would therefore be 
expected to bind Ptdlns 3,4,5-P3 with high affinity. Studies have shown that although
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Ptdlns 3 ,4 ,5 -P3 was sufficient for membrane recruitment it did not induce GAP activity 
(Kam et al. 2000). Activation o f  ASAP1 was mediated by Ptdlns 4 ,5 -P2 which induced 
a specific conformational change in ASAP1, and possibly ARF as well (Kam et al.
2000). Surprisingly ASAP1 mutants, which do not bind phosphoinositides, or which 
completely lack the PH domain, are recruited to membrane ruffles. This suggests that 
although the PH domain may contribute to targeting, it is not required. Therefore, 
phosphoinositides appear to play different roles in ARF-GAP and ARF-GEF function.
Finally, there is a group o f zinc-finger containing proteins, the centaurin-as, for which 
ARF-GAP activity has not been detected {Figure 1.7 & 1.8; Section 1.6.5.1). These 
proteins have been grouped together on the basis o f sequence homology and size. Rat 
centaurin-a, the first to be cloned and characterised, is the least conserved o f the group 
and contains ankyrin repeats and one PH domain (Hammonds-Odie et al. 1996). The 
remaining proteins, which are more closely related, possess two PH domains. Although 
ARF-GAP activity has not been demonstrated for any o f  the centaurin-a proteins to date 
(Jackson et al. 2000b; Tanaka et al. 1999; Venkateswarlu and Cullen 1999), human 
centaurin-a 1 was shown to functionally complement the yeast ARF-GAP, G csl 
(Venkateswarlu et al. 1999b).
1.6.5.1 The Centaurin-a Protein Family
In 1996 Hammonds-Odie et al. described the identification and cloning o f centaurin-a. 
Affinity chromatography, using aminopropyl-Ins 1 ,3 ,4 ,5 -P4 linked to Affi-Gel 10 
matrix, was employed to purify potential Ptdlns 3 ,4 ,5 -P3 receptors from rat brain 
homogenates. Initial sequence analysis performed by Theibert and colleagues revealed 
a 419 amino acid protein with an N-terminal zinc-finger binding motif and ten divergent 
ankyrin-like repeats. The chimeric nature o f centaurin-a and its homology to GAP 
proteins appeared reminiscent o f  the chimaerins, and consequently the protein was 
named after the centaur (half-man, half-horse) o f Greek mythology (Hammonds-Odie et 
al. 1996). The high affinity binding o f Ptdlns 3 ,4 ,5 -P3 and homology to ARF-GAPs 
lead to the suggestion that Ptdlns 3-kinase receptors might act via centaurin-a to 
regulate ARF-dependent membrane trafficking events.
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Centaurin-a Rat whole brain Rat brain cDNA 419 46 kDa Hammonds-Odie et al., 1996
PBP3-BP Bovine brain Brain cDNA 373 43.2 kDa Tanaka et al., 1997




374 43.4 kDa Strieker et al., 1997
p42m - Rat brain 374 43.4 kDa Aggensteiner et al., 1998
Centaur in -a l Human blood 
cDNA
374 43.4 kDa Venkateswarlu et al. 1999.
Figure 1.8. Summary of the centaurin-a protein family. Rat centaurin-a (accession number U51013); bovine PIP3-BP (accession 
number D89940); porcine p42ff4 (accession number U88368); rat p42IP4 (accession number AJ007422); human centaurin-a! (accession 
number AJ006422).
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In 1997 two further members o f  the centaurin-a family were identified from cow and 
pig and were named PIP3-BP (Ptdlns 3 ,4 ,5 -P3-binding protein) and p42IP4, respectively 
(Strieker et al. 1997; Tanaka et a l  1997). Like rat centaurin-a, PIP3-BP was also 
purified from brain by affinity chromatography, but using a Ptdlns 3,4,5-P3 analogue. 
In 1999, the cloning and characterisation o f another orthologue, human centaurin-a 1 
was reported (Venkateswarlu and Cullen 1999). PIP3-BP, p42IP4 and centaurin-a 1 
share high homology (> 90% identity) and as such are considered to be orthologues, the 
same protein from different species, and are collectively referred to as centaurin-a 1 . 
Although centaurin-a shares relatively high homology to centaurin-a 1 (-75-79%  
identity) there are two regions o f distinction. Firstly, centaurin-a contains ankyrin 
repeats in the PH-N region o f centaurin-a 1. Secondly, centaurin-a has an extended 
sequence that terminates approximately 46 amino acids later than centaurin-a 1. Thus 
the centaurin-a sequence encodes a protein with a predicted molecular mass o f  48 kDa 
protein in comparison to centaurin-a 1 42-43.5 kDa {Figure 1.8). Doubt was cast on the 
authenticity o f  the rat centaurin-a sequence by the findings o f  Reiser and colleagues. 
Reverse transcription-polymerase chain reaction (RT-PCR) and western blotting 
approaches were employed to search for the presence o f  centaurin-a in rat brain 
(Aggensteiner et al. 1998). Several clones were identified that were analogous to p42IP4 
in both the PH-N domain and termination position. Furthermore, none o f  the clones 
contained the sequence characteristics o f rat centaurin-a. The anti-peptide antiserum 
designed to both centaurin-a and p42IP4 detected a single 42 kDa protein band that 
comigrated with pig p42IP4 (Aggensteiner et al. 1998). Thus, no molecular or 
biochemical evidence to support the presence o f centaurin-a was found in this study.
Centaurin-a and centaurin-a 1 transcripts are highly abundant in brain, and much lower 
levels o f  expression have been detected in other tissues, such as lung, spleen, kidney 
and peripheral blood leukocytes (Hammonds-Odie et al. 1996; Tanaka et al. 1997; 
Venkateswarlu and Cullen 1999). For the centaurin-als whose tissue-distribution has 
not been investigated, they were either purified from brain tissue and/or cloned from 
brain cDNA (Aggensteiner et al. 1998; Strieker et al. 1997).
Western blot analysis and phospholipid binding assays suggest that the centaurin-a 1 
proteins are both membrane-associated and cytosolic. However, the distribution varies
quite considerably between studies, for example, rat centaurin-a and pig p42IP4 are
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reported to have membrane:cytosol distribution ratios o f  1:2 and 3:1, respectively 
(Hammonds-Odie et al. 1996; Strieker et al. 1997). Immunostaining with a monoclonal 
PIP3-BP antibody indicated PIP3-BP to be localised in nuclei o f neuronal cells and 
similar results were observed with GFP-tagged constructs o f  the N-terminal 14 amino 
acids and full-length PIP3-BP (Tanaka et al. 1999). Similarly GFP-tagged centaurin-al 
was found to be localised in the nucleus and cytoplasm o f PC 12 cells (Venkateswarlu et 
al. 1999b). These results were reproduced with the nuclear localisation o f both HA- 
tagged and GFP-tagged human centaurin-al in CHO.T cells (Venkateswarlu and Cullen 
1999). Interestingly EGF-stimulation caused translocation o f human centaurin-al to 
the plasma membrane in PC12 cells (Venkateswarlu et al. 1999b). Membrane 
recruitment o f  centaurin-al was also observed in CHO.T cells co-transfected with the 
constitutively active, membrane targeted p i 10 catalytic subunit o f  Ptdlns 3-kinase 
(Venkateswarlu and Cullen 1999). The transient nature o f  this membrane recruitment is 
consistent with the generation o f Ptdlns 3 ,4 ,5 -P3 and appears to be dependent on Ptdlns 
3-kinase (Venkateswarlu et al. 1999b).
Although all centaurin-a proteins have been shown to bind Ptdlns 3 ,4 ,5 -P3, the 
specificity and selectivity characterisation o f  these proteins remains incomplete. 
Comparison o f  data is complex due to the differences in assay conditions used by the 
various groups. For example, Tanaka and colleagues investigated the ability o f  
phospholipids to displace glutathione ^-transferase (GST)-tagged PIP3-BP from the 
Ptdlns 3 ,4 ,5 -P3 analogue resin used for its purification (Tanaka et al. 1997). In this 
technique the two PH domains behave individually, and therefore it may be possible for 
a phospholipid to bind to one PH domain while PIP3-BP remains bound to the resin via 
the second PH domain. Hammonds-Odie et al. assessed the relative binding affinities 
o f  native centaurin-a using [3H]-/?-benzoyldihydrocinnamoyl- ([3H]BZDC-) Ins 1,3,4,5- 
P 4 , a photoprobe that covalently links to the protein to which it was bound (Hammonds- 
Odie et al. 1996). Despite the differing investigative approaches, the general consensus 
o f  the binding data shows that the centaurin-a proteins possess high affinity for Ptdlns
3 ,4 ,5 -P3 and 1 ,3 ,4 ,5 -P4 (Hammonds-Odie et al. 1996; Strieker et al. 1997; Tanaka et al. 
1997; Venkateswarlu and Cullen 1999).
As stated above no ARF-GAP activity has been shown for any o f  the centaurin-a 
proteins to date (Jackson et al. 2000b; Tanaka et al. 1999; Venkateswarlu and Cullen
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1999). However, Cullen and colleagues have shown human centaurin-al to 
functionally complement the yeast ARF-GAP G csl (Venkateswarlu et al. 1999b). This 
study utilised a Gcsl deleted yeast strain Ag csl, which was unable to grow on fluoride 
containing media. Transformation o f the Ag csl yeast strain with centaurin-al or Gcsl 
rescued growth indicating that centaurin-al may function as an ARF-GAP despite the 
lack o f  in vitro activity. More recently centaurin-al was found to copurify with casein 
kinase-Ia (CKIa) (Dubois et al. 2001). Upon investigation it was discovered that 
centaurin-a and centaurin-al associate specifically and directly with CKIa within the 
kinase domain, which is well conserved in all seven CKI isoforms. However, the data 
suggest that CKIa does not phosphorylate centaurin-a, and centaurin-a had no affect o f  
the activity o f  this serine/threonine protein kinase. The CKI isoforms are implicated in 
a diverse range o f  cellular function including membrane trafficking and CKIa has 
recently been shown to associate with the clathrin adaptor AP-3 in synaptic vesicle 
coating (Faundez and Kelly 2000). CKIa represents the first protein partner identified 
for the centaurin-a proteins, however the physiological relevance o f this association 
remains to be demonstrated.
1.7 The Role of Ptdlns 3-kinase and Ptdlns 3,4,5-P3 in 
Insulin-Stimulated Glut4 Translocation
Glut4 is unique among the glucose transporter isoforms in that its subcellular 
localisation is regulated by insulin. In insulin-sensitive tissues, such as muscle and 
adipose tissue, Glut4 is sequestered in perinuclear tubulovesicular structures and 
vesicles known as Glut4 storage vesicles when in the basal, non-stimulated state (Rea 
and James 1997). However, upon stimulation with insulin, Glut4 is released from its 
storage sites and translocates to the plasma membrane. Cell surface levels o f  Glut4 
increase by approximately 2 0 -fold, resulting in increased transport o f glucose into the 
muscle and adipose cells with concurrent reduction in blood glucose levels (Holman et 
al. 1990).
Insulin binds to and activates the insulin receptor, which then initiates the signalling 
cascade (Figure 1.9). There is considerable evidence supporting the role o f Ptdlns 3- 
kinase in Glut4 translocation and the concomitant increase in glucose transport
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F ig u re  1.9. A  sim p lified  m o d e l fo r  in su lin -s tim u la te d  G lu t4  tra n s lo c a tio n .
Insulin stimulates glucose uptake into skeletal muscle, heart and adipose tissue. 
This effect begins with the interaction o f insulin with its receptor, which triggers 
autophosphorylation o f the receptor and cellular substrates including the insulin 
receptor substrate (IRS) proteins. Tyrosine phosphorylated IRS interacts with the 
SH2 domain o f the p85 regulatory subunit o f Ptdlns 3-kinase and serves both to 
activate the pi 10 catalytic subunit and to appropriately target the Ptdlns 3-kinase to 
its subcellular site o f action. Ptdlns 3-kinase phosphorylates phosphoinositides at 
the D-3 position on the inositol ring. The synthesis o f Ptdlns 3,4,5-P3, the major 
product o f Ptdlns 3-kinase is illustrated. Multiple lines o f evidence, including the 
use o f the Ptdlns 3-kinase inhibitor wortmannin, demonstrate the requirement for 
Ptdlns 3-kinase activity in the insulin stimulation o f glucose transport through the 
translocation o f Glut 4.
36
(reviewed in Shepherd et al. 1998). Ptdlns 3-kinase inhibitors, wortmannin and 
LY294002, block insulin-stimulated glucose transport and the translocation o f Glut4 to 
the plasma membrane (Kotani et al. 1995; Okada et al. 1994). Membrane permeant 
analogues o f  Ptdlns 3 ,4 ,5 -P3 were able to restore glucose uptake in insulin-stimulated 
cells inhibited with wortmannin, however this phosphoinositide had no effect in the 
absence o f  insulin (Jiang et al. 1998). An alternative approach using the dominant 
negative form o f the p85 subunit o f Ptdlns 3-kinase which was shown to be unable to 
stimulate glucose uptake (Hara et al. 1994). Overexpression o f  wild-type or 
constitutively active form o f p i 10 catalytic subunit o f  Ptdlns 3-kinase was sufficient to 
stimulate the translocation o f Glut4 to the plasma membrane o f cultured 3T3-L1 
adipocytes (Katagiri et al. 1996; Martin et al. 1996) and isolated rat adipocytes (Tanti et 
al. 1996). Therefore it is generally accepted that the generation o f the Ptdlns 3-kinase 
product Ptdlns 3 ,4 ,5 -P3 mediates Glut4 translocation, although the precise mechanisms 
are unclear.
One important characteristic is that other growth factors activate Ptdlns 3-kinase, but 
are unable to stimulate Glut4 translocation or glucose uptake. It has been proposed that 
the specificity o f  insulin activation may be mediated by differential 
compartmentalisation o f  Ptdlns 3-kinase. In support o f  this hypothesis, subcellular 
fractionation analysis in 3T3-L1 adipocytes has revealed that insulin- and PDGF- 
stimulated Ptdlns 3-kinase activities are localised in the high speed pellet and plasma 
membrane, respectively (Clark et al. 1998). This study also suggested the potential 
involvement o f  the actin cytoskeleton in targeting o f Ptdlns 3-kinase to Glut4 vesicles. 
This was supported by Klip and colleagues who used cytochalasin D, a fungal 
metabolite, to prevent polymerisation o f actin filaments and inhibit glucose transport 
(Wang et al. 1999). Other studies have indicated that microtubules may also function in 
the trafficking o f  Glut4 vesicles. For example the microtubule protein a-tubulin and the 
intermediate filament protein vimentin were identified as components o f  purified Glut4 
storage vesicles (Guilherme et al. 2000). Furthermore, disruption o f the microtubule 
network with the depolymerising agent nocodazole inhibited insulin-mediated Glut4 
translocation by more than 80% in 3T3-L1 cultured adipocytes (Olson et al. 2001). By 
using in vitro microtubule binding, the group demonstrated that Glut4 vesicles bind 
specifically to microtubules, implicating microtubules in both insulin signalling and 
Glut4 translocation. Moreover Emoto et al. have reported Glut4 translocation to be 
dependent on both microtubule and actin-based cytoskeletal structures in 3T3-L1
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adipocytes suggesting the co-operative action o f F-actin and microtubules in Glut4 
translocation (Emoto et al. 2001).
The missing link between Ptdlns 3 ,4 ,5 -P3 production and Glut4 translocation is still to 
be established. The discovery o f new Ptdlns 3 ,4 ,5 -P3 binding proteins, such as the 
ARF-GEFs and ARF-GAPs, may provide some exciting new advancement in this area.
1.8 Experimental Aims and Approaches of the Research 
Described Herein
The discovery o f  the Ptdlns 3 ,4 ,5 -P3-binding centaurin-a proteins together with the 
known importance o f Ptdlns 3-kinase in insulin-stimulated Glut4 translocation 
prompted us to investigate whether centaurin-a related proteins were present in insulin- 
sensitive tissues.
Initial experiments were focused on the cloning o f  a centaurin-a related clone from an 
adipocyte cDNA library using RACE protocols. Following the identification and 
cloning, sequence analysis was performed to confirm the sequence identity o f  the novel 
homologue and compare it with the published centaurin-a sequences. Northern blot 
analysis was used to examine the expression and distribution o f  the transcript and 
determine whether this was specific to insulin-sensitive tissues. Characterisation o f  the 
protein expression o f  the centaurin-a homologue was undertaken using 
immunochemical techniques. These were used to investigate the tissue distribution and 
subcellular distribution o f the native protein. Recombinant protein was generated for 
use in phosphoinositide binding assays to analyse the specificity o f the PH domains. 
Point mutations were introduced into the PH domains, by site-directed mutagenesis, to 
further characterise the binding properties o f  this novel centaurin-a family protein.
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2.0 M a ter ia ls  an d  M e t h o d s
2.1 Materials
2.1.1 General Materials
All general laboratory chemicals were purchased from either Sigma-Aldrich Chemical 
Company, Fisons Scientific UK Ltd. or BDH Laboratory Supplies unless otherwise 
specified. Other reagents were acquired from:
Amersham Pharmacia Biotech Ltd.
ECL Western blotting detection reagents 
Hybond N  
Hyperfilm ECL 
Hyperfilm MP 
Micro Spin Columns 
Multiprime DNA Labelling System 






Advantage cDNA PCR Kit 
Dpnl restriction enzyme 
Marathon-Ready cDNA  
P/wTurbo DNA Polymerase 
TALON Metal Affinity Resin 
Novagen




BCA Protein Assay 
Reacti-Gel
Slide-A-Lyser Dialysis Cassettes 
Qiagen Ltd.
QIAprep Miniprep Kit 
QIAquick Gel Extraction Kit 
Roche Molecular Biochemicals
DIG Luminescent Detection Kit 
DIG RNA Labelling Kit
DNA Molecular Weight Markers III, VI, XIV and XVII
Expand Long Template PCR System
Positively Charged Nylon Membrane
Restriction enzymes
RNA Molecular Weight Marker II
TriPure Isolation Reagent
Oligonucleotides were purchased from either Perkin Elmer or Eurogentec. PolyATtract 
mRNA Isolation System IV was obtained from Promega. ProtoGel was purchased from 
National Diagnostics, BioTrace NT nitrocellulose membrane from Gelman Sciences 
Ltd., and BioDesign GelWrap from BioDesign Inc.
2.1.2 Antibodies
Rabbit anti-centaurin-a2 antisera were raised at AstraZeneca using a fourteen amino 
acid peptide coupled to ovalbumin. The peptide was designed to a region o f the rat 
centaurin-a2 sequence located at the C-terminus o f  the PH-C domain. Glut4 antiserum 
was raised in the laboratory o f  Dr. S. Cushman (National Institutes o f  Health, Bethesda, 
USA) using C-terminal peptides produced in our laboratory (Holman et al. 1990).
The source o f  antibodies and their appropriate dilutions for western blotting {Section 
2.4.6) and confocal microscopy {Section 2.4.7) are shown in Table 2.1.
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Table 2.1. Antibodies utilised in this study. The primary (1°) and secondary (2°) 
antibodies used in western blot analysis and confocal microscopy are indicated along 
with their appropriate dilutions and the source o f the antibody.





1 ° Western blotting 
and confocal
1:60 - 




1 ° Western blotting 1 :2 , 0 0 0 Qiagen
Rabbit
anti-Glut4




1 ° Western blotting 
and confocal
1 : 2 2 0  
- 1 , 0 0 0
Sigma
Goat anti-rabbit IgG 
peroxidase conjugate
2 ° Western blotting 1:4,000 Sigma
Goat anti-mouse IgG 
peroxidase conjugate
2 ° Western blotting 1 :1 , 0 0 0 Sigma
Fluorescein labelled 
anti-rabbit IgG




2 ° Confocal 1:60 Jackson
Laboratories
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2.1.3 Phosphoinositides and Inositol Phosphates
D -[3H]Ins 1 ,3 ,4 ,5 -P4 ( 7 7 7  GBq/mmol) was purchased from NEN Life Science Products 
and DL-myo-Ins l , 3 ,4 ,5 -P4 -tetrapotassium salt and D-rayo-Ins l , 4 ,5 -P3-hexasodium salt 
were purchased from Alexis Biochemicals. The photoaffinity labels, [3H]BZDC- 
phosphatidylinositide triesters o f  Ptdlns 3 ,4 -P2 and Ptdlns 3 ,4 ,5 -P3 {Figure 2.1) were a 
gift from Professor G. Prestwich (University o f Utah, USA) (Thum et al. 1996; Chen et 
al. 1996). The D-wyo-dipalmitoyl phosphatidylinositides: diC^Ptdlns 3,4-P2, 
diC^Ptdlns 3,5-P2, diC^Ptdlns 4,5-P2 and diC^Ptdlns 3 ,4 ,5 -P3 were purchased from 
Echelon.
2.2 General Molecular Biology Techniques
2.2.1 Small Scale Plasmid Preparation from E. coli using the 
QIAprep Miniprep Kit
Single colonies o f  E. coli were used to inoculate 10 ml Luria-Bertani broth (LB broth: 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 1% (w/v) NaCl) containing ampicillin (100 
pg/ml) and shaken overnight at 37°C. Cells were pelleted and the DNA isolated using 
the manufacturer’s protocol. The purified DNA was eluted from the spin columns using 
50 pi autoclaved double-distilled H20  (ddH20 ).
2.2.2 Agarose Gel Electrophoresis
A  1% (w/v) agarose gel was prepared using 1 g o f agarose which was heated in 100 ml 
o f  IX TAE buffer (40 mM Tris-acetate, pH 7.6, 1 mM EDTA). Once dissolved, the 
solution was allowed to cool slightly, ethidium bromide (0.5 pg/ml) was added and the 
gel poured into a cast. DNA samples were prepared by adding 1 pi loading dye (30% 
(v/v) glycerol, 0.25% (w/v) bromophenol blue) to 5 pi DNA and loaded into the wells. 
Electrophoresis was perfonned at 100 volts in IX TAE until the dye front had migrated 


















Figure 2.1. Structures of the phosphoinositide benzophenone photoaffinity 
probes. [3H]BZDC-phosphoinositide triesters o f Ptdlns 3,4,5-P3 and Ptdlns 3,4-P2. 
The phosphoinositide group is attached via a flexible linker to the photophore 
benzophenone group, which is activated at 350-360 nm. Photoaffinity labelling 
produces a covalent attachment and the labelled proteins can be denatured and 
resolved by SDS-PAGE.
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transilluminator. RNA integrity was also examined by agarose gel electrophoresis 
using a gel tank pre-treated with 3% (v/v) H2O2 to remove any contaminating 
ribonuclease (RNase) activity.
2.2.3 Extraction of DNA from Agarose Gels
DNA fragments were extracted from agarose gel using the QIAquick Gel Extraction Kit 
using the manufacturer’s protocol. In brief, DNA bands were excised from agarose gels 
and placed in pre-weighed microcentrifuge tubes. The weight o f  the gel slice was 
determined and converted into an equivalent volume, with 1 0 0  mg equating to 1 0 0  pi. 
The gel slice was solubilised in 3 volumes o f QG buffer (components not disclosed) and 
heated at 50°C for 10 min with occasional vortexing. One volume o f isopropanol was 
added to the gel solution, mixed and applied to the QIAquick spin column. All wash 
steps were performed as outlined in the protocol and the DNA eluted in 30 pi 
autoclaved ddFLO.
2.2.4 Sequencing
Purified DNA from plasmid miniprep isolation or polymerase chain reaction (PCR) was 
sequenced using a PE Biosystems ABI 377 DNA Sequencer (Perkin Elmer). 
Sequencing reactions containing 7 pmol o f primer and template DNA (50-100 ng o f  
single-stranded DNA, 200-500 ng double-stranded DNA) were prepared in a 6  pi final 
volume in 0.5 ml microcentrifuge tubes.
2.2.5 Rapid Amplification of cDNA Ends
Rapid amplification o f cDNA ends (RACE) was performed in both the 5 ’ and 3 ’ 
direction using Marathon-Ready cDNA (Clontech). Firstly 5 ’RACE reactions were 
prepared using the components from the kit: 1.75 mM MgCl2, 400 pM dNTP, 200 nM 
adaptor primer-1 (API), 200 nM gene-specific primer-1 (GSP1), reaction buffer (the 
composition was not disclosed by the manufacturer) and Expand Long Template PCR 
enzyme mix. All components o f  the reaction were combined and the sample mix was 
overlaid with 30 pi mineral oil and heated to 94°C before the addition o f the enzyme
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and the initiation o f  the thermocycle programme (Section 3.2; Figure 3.2). Similarly 
3 ’RACE reactions were performed using API and GSP2 primers and the enzyme from 
the Advantage cDNA PCR Kit (Section 3.3; Figure 3.5).
2.2.6 Site-Directed Mutagenesis
Single amino acid changes were generated using the QuikChange Site-Directed 
Mutagenesis method (Stratagene). A complementary pair o f oligonucleotides, whose 
sequence contained the desired mutation, were used in the PCR reaction. Reactions 
were prepared in a thin walled PCR tube with the following reagents: 10 mM KC1, 10 
mM (NH4)2S 0 4, 20 mM Tris-HCl, pH 8.8, 2 mM M gS04, 0.1% (v/v) Triton X-100, 100 
pg/ml bovine serum albumin (BSA), 2.5 ng/pl o f  each o f the sense and antisense 
primers, 200 pM dNTP mix, 1 pi template (5-50 ng). PfuTxxxbo (2.5 U) was then added, 
and the 50 pi reaction was overlaid with 30 pi mineral oil. DNA amplification was 
performed using the following cycle parameters: an initial step o f 95°C for 30 sec, 16 
cycles o f  95°C for 30 sec, 55°C for 1 min and 68°C for 14 min. Following temperature 
cycling the reaction was cooled to approximately 37°C by incubation on ice for 2 min 
before the digestion o f  the amplified DNA with Dpnl (10 U) at 37°C for 1 h.
2.2.7 Preparation of Competent Cells
Competent cells were streaked onto a plate o f LB agar (LB broth and 1.5% (w/v) agar) 
and incubated overnight at 37°C. An overnight culture was prepared by inoculating 10 
ml LB broth with a single colony from the LB agar plate and incubating at 37°C in a 
shaking incubator. An aliquot o f 1 ml o f the overnight culture was used to inoculate 
100 ml LB broth that was incubated as above for approximately VA h until the optical 
density at 600 nm (OD600) reached an absorbance o f 0.5. The cells were harvested by 
centrifugation and resuspended in 10 ml ice-cold TSB buffer (1% (w/v) tryptone, 0.5% 
(w/v) yeast extract, 10% (w/v) polyethylene glycol (PEG)335o, 5% (v/v) DMSO, 100 
mM NaCl, 10 mM M gS04, 10 mM MgCl2, pH 6.1). Following a 10-min incubation on 
ice, aliquots were stored at -70°C.
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2.2.8 Transformation of Competent Cells
Competent cells were thawed on ice and 100 pi aliquots transferred into 1.5 ml 
microcentrifuge tubes. Plasmid DNA (1-10 ng) was added to the cells and the mixture 
was incubated on ice for 15 min. A negative control, using ddFLO in place o f the DNA  
was also prepared. The samples were heat shocked at 42°C for 30 sec. For cells 
transformed with ligation reactions (rather than intact plasmid DNA), an additional 
incubation o f  shaking at 37°C for 30 min was performed. An appropriate volume o f  
cells was plated onto LB agar plates containing the required antibiotics and incubated 
overnight at 37°C.
2.3 Northern Blotting
Two detection methods have been utilised in this research: 32P-labelled DNA probes, 
following the method outlined in Maniatis et al. 1982, and the digoxigenin (DIG) 
system used in accordance to the manufacturer’s guidelines (Roche Molecular 
Biochemicals). Some methods described below, such as RNA isolation and capillary 
transfer, are similar in both systems, whereas hybridisation and detection techniques are 
quite distinct and hence are explained separately.
2.3.1 Preparation of RNase-free ddH20 ,  Buffers and Apparatus
Buffers used for RNA analysis were generally treated with diethyl pyrocarbonate 
(DEPC) to inactivate ribonuclease (RNase) enzymes before being autoclaved. RNase- 
free ddfLO was prepared by adding DEPC to 1% (v/v) in ddFLO, mixing vigorously 
and incubating overnight at room temperature before autoclaving. Pipette tips, 
microcentrifuge tubes and glass Corex tubes were all autoclaved to reduce the risk o f  
RNase contamination. Apparatus including the gel electrophoresis tank, hybridisation 
bottles and Tupperware boxes were treated with 3% (v/v) H2O2 for 20 to 30 min and 
rinsed with DEPC-treated ddFLO prior to use.
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2.3.2 Isolation of Total RNA
Total RNA was isolated from rat tissues using the TriPure Isolation Reagent, a 
monophasic solution o f phenol and guanidine thiocyanate. Tissues were removed from 
male Wistar rats and snap frozen in liquid nitrogen. Using a pestle and mortar, 
approximately 1 g o f  tissue was ground to a fine powder under liquid nitrogen. TriPure 
reagent was added (1 ml per 100 mg tissue) and the samples were quickly homogenised 
using a Teflon plunger. The homogenates were transferred to autoclaved glass Corex 
tubes and incubated for 5 min at room temperature. Chloroform was added (0.2 ml per
1 ml TriPure reagent) and the samples were vortexed for 15 sec, and then incubated for
2 to 3 min at room temperature. Centrifugation at 12,000 x g for 15 min at 4°C 
separated the sample into three phases: a colourless upper aqueous phase containing 
RNA, a cloudy white interface containing DNA, and a pink lower organic phase 
containing protein. The colourless upper aqueous phase was transferred to a clean 
Corex tube and the RNA precipitated by the addition o f isopropanol (0.5 ml per 1 ml 
TriPure reagent). The samples were mixed by inversion, incubated for 10 min at room 
temperature and centrifuged at 12,000 x g for 10 min at 4°C. The supernatant was 
discarded and the pellet washed with 75% ethanol (1 ml per 1 ml TriPure reagent) and 
centrifuged at 7,500 x g for 5 min at 4°C. Excess ethanol was removed and the RNA  
pellets were briefly air-dried before resuspension in DEPC-treated ddlUO. The 
concentration and purity o f the RNA were determined by spectrophotometry. To 
calculate the RNA concentration it was assumed that 40 pg/ml RNA solution would 
have an absorbance o f 1.0 at 260 nm. RNA purity is indicated by the A 260/A 280 
absorbance ratio, with pure RNA having a ratio o f 2.0. The manufacturers predict a 
ratio o f  1.6-2.0 for RNA isolated using this method and this level o f purity is suitable 
for applications such as northern blot analysis. A small sample o f  RNA was also 
analysed by gel electrophoresis.
2.3.3 Purification of PolyA+ RNA from Total RNA
The PolyATtract mRNA Isolation System was used to purify PolyA+ RNA from total 
RNA using the method outlined by the manufacturer. In brief, 1 mg total RNA, in a 
final volume o f  500 pi, was heated for 10 min at 65°C. The biotinylated oligo dT probe 
(3 pi) and 13 pi 20X SSC (where IX SSC is 150 mM NaCl, 15 mM sodium citrate)
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were added to the RNA and left at room temperature until the samples had cooled. 
During this time the streptavidin magnetic particles were washed three times in 0.5X  
SSC, collecting the beads between each wash using a magnetic stand. The cooled RNA  
samples were incubated with the magnetic beads for 1 0  min at room temperature, with 
mixing by inversion every few minutes. The beads were collected as described above, 
the supernatant was discarded, and the beads washed a further four times with 0.1X  
SSC. PolyA+ RNA was eluted from the beads with 250 pi RNase-free water (included 
in the PolyATtract mRNA Isolation System). The RNA was then precipitated by the 
addition o f  25 pi 3M NaOAc (DEPC-treated), 250 pi isopropanol and incubated 
overnight at -70°C. The RNA was pelleted by centrifugation at 12,000 x g for 10 min, 
washed with 70% ethanol and resuspended in RNase-free water and stored at -70°C 
until required.
2.3.4 Formaldehyde Denaturing Gel Electrophoresis
The technique employed for RNA electrophoresis in formaldehyde containing gels 
followed that outlined by Maniatis et al. (1982). A denaturing formaldehyde gel (1% 
(w/v) agarose, 6 .6 % (v/v) formaldehyde, 20 mM 3-(A-morpholino)propanesulfonic acid 
(MOPS), 8  mM NaOAc, 1 mM EDTA) was prepared by melting the agarose in DEPC- 
treated ddtkO, cooling to 60°C, and adding the appropriate volumes o f  formaldehyde 
gel-running buffer (0.1 M MOPS; pH 7.0, 40 mM NaOAc, 5 mM EDTA; pH 8.0) and 
37% (v/v) formaldehyde. The formaldehyde gel used in the DIG system was prepared 
using virtually the same method although the component proportions were modified to 
produce a gel with the following composition: 1 % (w/v) agarose, 2 % (v/v) 
formaldehyde, IX MOPS buffer (20 mM MOPS, 5 mM NaOAc, 1 mM EDTA, pH 7.0).
Total RNA samples (20 pg) were made up to a final volume o f 4.5 pi with DEPC- 
treated ddH2 0 . In the case o f  PolyA+ RNA, the precipitated RNA was resuspended in 
4.5 pi RNase-free water. The RNA molecular weight marker II (10 pi) sample was 
prepared in the same way as the total RNA samples. A master mix o f  denaturing 
solution was prepared (1 part formaldehyde gel-running buffer, 1.75 parts formaldehyde 
and 5 parts formamide) and 15.5 pi was then added to each RNA sample before heating 
for 15 min at 65°C. Following a short incubation on ice and brief centrifugation, 2 pi 
formaldehyde gel-loading buffer (50% (v/v) glycerol, ImM EDTA, pH 8.0, 0.25%
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(w/v) bromophenol blue, 0.25% (w/v) xylene cyanol FF) was added to the samples. 
The gel tank was filled with formaldehyde gel-running buffer (diluted 1:5 in DEPC- 
treated ddH20 )  and the gel was pre-run for 5 min at 5 V/cm. The samples were 
carefully loaded with the markers in the outside lanes and the gel electrophoresis 
performed at 3-4 V/cm (70-92 V) for between 4-4lA h, until the furthest dye front had 
migrated about 3A the length o f  the tank. Following electrophoresis, the gel was 
transferred to a Tupperware box and washed in DEPC-treated ddH20  for 30 min.
PolyA+ RNA samples were prepared using the sample preparation protocol that 
accompanied the DIG-labelled RNA Molecular Weight Marker II. One volume o f  
polyA+ RNA (5 pi) was mixed with 4 volumes o f  freshly prepared sample buffer (62.5 
% (v/v) formamide, 7.7% (v/v) formaldehyde, 25 mM MOPS, 6.25 mM NaOAc, 1.25 
mM EDTA, pH 7.0, 0.01% (w/v) bromophenol blue). The gel tank was carefully filled 
with IX MOPS buffer until the buffer reached a height equivalent with the gel top, but 
did not submerge it. Heat-denatured samples were loaded into the wells and 
electrophoresis was performed at 100 mA for 5 min. Once the samples had entered the 
gel (i.e. migrated from the wells), additional MOPS buffer was added and the 
electrophoresis continued at 3-4 V/cm (70-92 V) for approximately 4 h.
2.3.5 Capillary Transfer of Denatured RNA onto a Membrane
The method employed for the capillary transfer o f  RNA from the gel onto a membrane 
was common to both detection systems utilised herein, albeit using different 
membranes. A  nitrocellulose membrane was used for the radioactively-labelled DNA  
probes, whereas the DIG detection system required a positively charged nylon 
membrane. Before constructing the transfer assembly, a sheet o f 3MM paper measuring 
160 x 300 mm was cut in order to create a wick. Two further pieces o f  3MM paper and 
a piece o f  nitrocellulose were cut to the size o f  gel, 110 x 165 mm. The three pieces o f  
3MM paper were briefly soaked in 20X SSC and the largest piece was placed on a glass 
platform with opposite ends submerged in a tray containing a large volume o f  20X SSC 
to create a wick. The gel was positioned on top o f the wick, base side up, and air 
bubbles were removed by rolling with a sterile plastic pipette. The nitrocellulose 
membrane was carefully placed on the gel and the air bubbles removed again. The 
edges o f  the membrane were covered with thin strips o f Saran wrap. The two pre-
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wetted pieces o f  3MM paper were then placed on top followed by a stack o f tissues cut 
to the same size as the gel. A glass plate and a 500 g weight were placed on the top o f  
the stack which was left overnight with in a sufficient volume o f 20X SSC.
The northern transfer assembly was carefully dismantled and the position o f  the wells 
marked on the membrane using a pencil. The RNA was fixed to the nitrocellulose 
membrane by baking for one h at 80°C, whereas the nylon membrane was UV  
crosslinked at 120,000 pJ/cm2. The outer marker lanes were cut o ff and stained with a 
solution o f  0.5 M NaOAc (pH 5.2) and 0.04% (w/v) methylene blue for 5 min at room 
temperature. Once rinsed under the cold water tap for about 5 min, the ribosomal bands 
and markers were visible and the positions were marked with pencil.
2.3.6 Random Labelling of DNA Probes with 32P
DNA probes labelled with 32P were synthesised using the Multiprime DNA Labelling 
System. Double-stranded template DNA was diluted to a concentration o f 2-25 pg/ml 
in 10 pi ddH2 0  and denatured by heating at 95 °C for 5 min, then chilled on ice. 
Random sequence hexanucleotides were used to prime DNA synthesis on the denatured 
template DNA at numerous sites along its length and [a -32P]dCTP incorporated by the 
Klenow fragment o f  DNA polymerase I. The reaction was prepared by the addition o f  
18 pi ddH2 0 , 10 pi 10X reaction buffer (Tris-HCl, pH 7.8, MgCl2, and 
2-mercaptoethanol, concentrations not disclosed), 5 pi primer solution, 5 pi 
[a -32P]dCTP (-3000 Ci/mmol) and 2 pi enzyme. The sample was incubated for 1 h at 
37°C and the unincorporated radioactivity was removed by gel filtration using 
MircoSpin columns. The columns were pre-centrifuged for 1 min at 750 x g and the 
samples were applied followed by 50 pi TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM 
EDTA) and centrifuged as above. The eluate was heat denatured at 95 °C for 5 min 
before use in the hybridisation reaction.
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2.3.7 Hybridisation and Detection of Radioactively-Labelled DNA 
Probes
Prehybridisation o f the nitrocellulose membrane was performed for 90 min at 65°C in 
15 ml 5X SSC, Denhardt’s Solution (0.02% (v/v) Ficoll, 0.02% (v/v)
polyvinylpyrrolidone, 0.02% (w/v) BSA), 100 pg/ml sheared-herring sperm DNA and 
0.5% (w/v) SDS. The denatured [a-32P]dCTP-labelled DNA probe (Section 2.3.6) was 
added directly into the prehybridisation buffer and hybridised overnight at 65°C. Two 
30-min post-hybridisation washes were performed at 65°C. Firstly, the membrane was 
washed in 100 ml 2X SSC, 0.1% SDS, followed by 100 ml 0.5X SSC, 0.1% (w/v) SDS. 
Some probes required more stringent washing conditions with 0.2X SSC and 0.1% 
(w/v) SDS for the second wash. Autoradiography was performed at -70°C with 
Hyperfilm MP for varying time intervals from 8-48 h.
Immediately after exposure to film the probe was stripped from the membrane by the 
addition o f  a boiling solution o f 0.5% (w/v) SDS, the membrane was then washed in 
this solution on a rocking platform until cool. The membrane was rinsed in 2X SSC and 
incubated in prehybridisation buffer prior to further hybridisation reactions using 
radioactively-labelled probes.
2.3.8 Generation of DIG-Labelled Riboprobes
A DIG RNA Labelling Kit was used to generate DIG-labelled, single-stranded RNA  
probes as described in the manufacturer’s protocol. DNA encoding the mRNA o f  
interest was subcloned into the multiple cloning site o f  the pSPT18 transcription vector 
(supplied in the kit), adjacent to the SP6 RNA polymerase promoter site. The DNA  
template was linearised with Smal and the DNA fragment was separated on an agarose 
gel and purified before quantification by spectrometry (A26o)- The DNA was 
precipitated by the addition o f  25 pi NaOAc and 625 pi ethanol and by incubation at 
-20°C overnight. After centrifugation the DNA was washed with 70% ethanol and 
resuspended in DEPC-treated ddH20 . RNA transcripts o f uniform length were 
synthesised by in vitro transcription, incorporating a DIG-labelled UTP residue every 
20-25 nucleotides. A standard labelling reaction comprised 1 pg purified linearised 
DNA template, NTP labelling mix (1 mM ATP, ImM CTP, 1 mM GTP, 0.65 mM UTP,
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0.35 mM DIG-11-UTP, pH 7.5), transcription buffer (components not disclosed), 20 U  
RNase inhibitor, and 40 U  SP6  RNA polymerase. The transcription reaction was 
incubated for 2 h at 37°C and stopped by the addition o f 2 pi 0.2 M EDTA. The yield 
o f  DIG-labelled RNA was determined in a spot assay {Section 2.3.9) and the riboprobes 
were stored at -70°C.
2.3.9 Estimation of DIG-Labelled RNA Yield
An estimation o f  the yield o f  DIG-labelled RNA was assessed using a spot assay in 
comparison to the DIG-labelled control RNA provided in the kit. In a standard reaction 
10 pg DIG-labelled RNA was transcribed from 1 pg DNA template. A  dilution series 
o f  the DIG-labelled sample and the RNA control were prepared and spotted on a piece 
o f  positively charge nylon membrane. The RNA was fixed to the membrane by UV  
crosslinking at 120,000 pJ/cm2 and then was directly detected using DIG Luminescent 
Detection Kit {Section 2.3.10). Concentration o f  the experimental probe was estimated 
by comparing the intensities o f the spot for the control and experimental dilutions.
2.3.10 Hybridisation and Detection of DIG-Labelled Riboprobes
Prehybridisation o f the nylon membrane was performed with at least 20 ml o f
hybridisation buffer (50% (v/v) formamide, 5X SSC, 2% (w/v) blocking reagent, 0.1%
(w/v) N-laurosyl-sarcosine, 0.02% (w/v) SDS) per 100 cm o f membrane in a 6 8 °C
hybridisation oven for 60-90 min. The prehybridisation buffer was replaced with fresh
hybridisation buffer (2.5 ml per 100 cm2) containing 50-200 ng/ml DIG-labelled RNA
and incubated at 6 8 °C overnight. After hybridisation the membrane was transferred to a
Tupperware box and washed twice with at least 50 ml o f 2X SSC, 0.1% (w/v) SDS per 
2 .
100 cm , for 5 mm on a rocking platform at room temperature. The membrane was 
placed in a clean hybridisation bottle and washed twice in 0.1X SSC, 0.1% (w/v) SDS 
at 6 8 °C for 15 min. The DIG Luminescent Detection Kit was used for the subsequent 
blocking, washing and detection stages, which were all performed on a rocking platform 
at room temperature. Following the post-hybridisation washes, the membrane was 
rinsed for 2 min with washing buffer (0.1 M maleic acid, 0.15 M NaCl, pH 7.5, 0.3% 
(v/v) Tween-20) and blocked by incubating in 1% (w/v) blocking buffer for 30 min.
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Anti-DIG-alkaline phosphatase conjugate was diluted 1:10,000 in Blocking Reagent 
(supplied in DIG Luminescent Detection Kit, components not disclosed) and the 
membrane was incubated in this antibody solution for 30 min. Following two 15-min 
washes in washing buffer the membrane was equilibrated in detection buffer (0.1 M 
Tris-HCl, pH 9.5, 0.1 M NaCl) for 2 min. CSPD (disodium 3-(4-methoxyspiro{l,2- 
dioxetane-3,2’-(5’-chloro)tricyclo[3.3.1.1.3,7]decan}-4-yl)phenyl phosphate) substrate 
was diluted 1:100 in detection buffer and added to the membrane for 5 min. The 
membrane was sealed in a bag, incubated for 10 min at 37°C and exposed to Hyperfilm- 
ECL for periods ranging from 10 sec to 1 h for visualisation o f  the chemiluminescent 
signal.
Immediately after exposure to film, the membrane was stripped o f hybridisation probe 
in preparation for hybridisation with a new probe. Firstly the membrane was rinsed in 
DEPC-treated dcft^O and the probes were stripped from the membrane by washing in 
boiling 0.1% SDS (w/v) and by leaving to wash on a rocking platform until cool. The 
membrane was washed in washing buffer for 5 min and twice in 2X SSC for 5 min. 
The stripped membrane was sealed in a clean bag and stored at 4°C until use in further 
hybridisation reactions.
2.4 General Protein Biochemistry Techniques
2.4.1 BCA Protein Assay
Protein concentrations were determined using the Pierce Bicinchoninic Acid (BCA) 
protein assay. A  standard curve (0.1-1 pg/pl BSA) was constructed by diluting a 1 
mg/ml stock solution o f  BSA in 0.1 M NaOH. Protein samples were either measured 
undiluted or diluted in 0.1 M NaOH. Triplicate 10 pi aliquots o f  both the standards and 
protein samples (neat or diluted in 0.1 M NaOH) were placed in a microtitre plate. 
Reagent A ( 1 % (w/v) BCA-NO2, 2 % (w/v) NaC0 3 .H2 0 , 0.16% (w/v) Na2tartarate, 
0.4% (w/v) NaOH, 0.95% (w/v) NaHCOs) and Reagent B (4% (w/v) CUSO4 .5 H2O) 
were mixed in the ratio 50:1 and 200 pi o f  this solution was added to each well. The 
plate was incubated at 37°C for 30 min or until sufficient colour development had 
occurred. The absorption was measured at 562 nm in a microplate spectrophotometer.
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2.4.2 SDS-PAGE
Generally protein samples were prepared for SDS-PAGE by the addition o f  0.5 volumes 
o f  3X electrophoresis sample buffer (where IX is 62.5 mM Tris-HCl, pH 6 .8 , 1% (w/v) 
SDS, 10% (v/v) glycerol and 0.01% (w/v) bromophenol blue). A 5X concentrate o f  
electrophoresis sample buffer was used for larger volumes o f  protein samples. 
Dithiothreitol (DTT, final concentration 100 mM) was added to the protein samples 
prior to heating at 95°C for 5 min.
Electrophoresis was performed following the discontinuous buffer system o f Laemmli 
1970, using the Protean II XI system for large gels and either the Mini-Protean II 
electrophoresis cell (Bio-Rad) or the Atto Dual Mini Vertical Page cell system for the 
smaller gels. The gels were prepared according to the manufacturer's instructions. The 
compositions o f  reagents for the Protean IIX I system are shown in Table 2.2. Volumes 
were scaled down appropriately for the mini gels. Resolving gels consisted o f  0.375 M 
Tris-HCl, 0.1% (w/v) SDS and 10% (w/v) acrylamide, and the stacking gels were made 
to 0.125 M Tris-HCl and 0.1% (w/v) SDS with 6.375% (w/v) acrylamide. 
Polymerisation was initiated by the addition o f  the ammonium persulphate and 
TEMED.
The gel tank was filled with electrophoresis buffer (0.025 M Tris-HCl, 0.1% (w/v) SDS, 
0.192 M glycine, pH 8.3) and the samples and molecular weight markers were loaded 
into the wells. Large gels were run overnight at 12-15 mA for 1.5 mm thickness gels 
(24-30 mA for 3 mm gels) until the bromophenol blue tracking dye had run o ff the 
bottom o f the gel. Small gels were run at a constant voltage o f  150-200 Volts for 
approximately 90 min or until the dye front had run off. Following electrophoresis, the 
protein was either visualised by Coomassie staining {Section 2.4.3) or transferred to 
nitrocellulose membrane {Section 2.4.4).
2.4.3 Coomassie Staining
Protein bands were visualised by staining with Coomassie brilliant blue reagent (0.2% 
(w/v) Coomassie brilliant blue R-250 in destaining solution (10% (v/v) glacial acetic 
acid, 30% (v/v) methanol, 60% (v/v) dcU^O)) for 20-30 min, followed by incubation in
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Table 2.2. Composition and preparation of resolving and stacking gels for 
SDS-PAGE. The component volumes indicated are those required for the prepara­
tion o f a 1.5 mm gel for the Protean II XI system using 16x18 cm plates. The 
volumes were doubled when preparing a 3 mm gel and scaled down for the smaller 
gels.





Acrylamide 30% (w/v) acrylamide/ 
methylene bisacrylamide
25 ml 3.4 ml
ddH20 25 ml 7.5 ml
Resolving gel 
buffer










10% (w/v) 500 pi 80 pi
TEMED N ,N ,N \N ’-
tetramethylethylenediamine
40 pi 20 pi
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destaining solution. Some analytical gels were dried so as to save the results. This was 
performed at room temperature by placing the gels between two layers o f  BioDesign 
GelWrap which were pre-soaked in destaining solution containing 8.7% (v/v) glycerol.
2.4.4 Electrotransfer of Protein from SDS-PAGE Gels to 
Nitrocellulose
Following SDS-PAGE, the gel was soaked in SDS transfer buffer (0.0375% (w/v) SDS, 
48 mM Tris-HCl, 39 mM glycine, pH 8 .8 ) for 2 min together with a piece o f  
nitrocellulose membrane and 18 sheets o f  electrode paper, all cut to the size o f the gel. 
The transfer assembly was constructed by placing nine sheets o f electrode paper onto 
the electroplate, followed by the nitrocellulose. The gel and finally another nine sheets 
o f  electrode paper were added, ensuring that any air bubbles were expelled. The second 
electrode plate o f  the Multiphor II NovaBlot electrophoretic transfer unit (Pharmacia) 
was placed on the top and completed the assembly. A constant current, proportional to 
the surface area o f  the blot (0.8 mA/cm2), was applied for 110 min. After 
electrotransfer, the nitrocellulose was rinsed in ddH2 0  before staining with 0 .1 % (w/v) 
Ponceau S in 3% (w/v) trichloroacetic acid. In the marker lanes, the positions o f  known 
molecular weight proteins were marked onto the nitrocellulose with a pencil. Western 
blotting could be performed directly after this or the membrane might be air-dried and 
stored at room temperature until required.
2.4.5 Affinity Purification of Antiserum
The centaurin-a2 antiserum was affinity purified using a column composed o f  the 
immunising peptide coupled to Reacti-Gel matrix (6 %, crosslinked agarose, Pierce). 
Coupling o f  the peptide to the matrix was performed according to the manufacturer’s 
instructions. In brief, the Reacti-Gel was prepared by filtering 4 ml 50% slurry o f gel 
through filter paper in a Buchner funnel connected to a vacuum and then by washing 
three times with 15 ml ice-cold d d ^ O  and once with 15 ml ice-cold borate buffer (0 .1  
M sodium borate, pH 8.5). Coupling was performed by rotating the gel matrix with 4 
mg peptide in borate buffer for 48 h at 4°C. The gel matrix was pelleted and washed 
once with 10 ml ice-cold borate buffer. Free imidazoyl-carbamate groups were then
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blocked by rotating in 2 ml 1 M ethanolamine in borate buffer at room temperature for 3 
h. A column was packed and washed successively with 1 M NaCl, ddH20  and 
phosphate-buffered saline (PBS; 12.5 mM Na2HP0 4 .1 2 H20 , pH 7.2, 154 mM NaCl). 
The column was stored between use in PBS, 0.02% (w/v) sodium azide at 4°C.
Before use the column was washed extensively with PBS. A small volume o f antiserum 
(500 pi) was diluted in PBS to generate sufficient volume for recirculation through the 
column. This was then placed at 4°C and the antiserum solution recirculated overnight. 
The column was extensively washed with PBS and 2 M NaCl in 10 mM Na2HP0 4 , pH
7.2. The bound antibodies were eluted with 15 ml o f  3.5 M NaSCN, 10 mM Na2HP(>4 , 
pH 6 . 6  and immediately transferred into dialysis tubing. Dialysis was performed for at 
least 18 h with several changes o f  PBS. The antibody solution was concentrated using 
P E G 2o,ooo whilst in the dialysis tubing and was then extracted and stored at 4°C.
2.4.6 Western Blotting
The standard western blotting protocol described here employs the use o f  Tris-buffered 
saline (TBS; 10 mM Tris-HCl, pH 7.4, 154 mM NaCl) containing Tween-20 at a final 
concentration o f 0.1% (v/v) (TBS-T). However, for some western blotting experiments 
the Tween-20 was omitted from the TBS buffer at all stages including washing (Section 
4.3.2). Following electrophoretic transfer the nitrocellulose was rinsed briefly in 
TBS-T. Dry membranes that had been stored were re-hydrated in SDS-transfer buffer 
before rinsing with TBS-T. Blocking was performed in 5% (w/v) Marvel dried 
skimmed milk in TBS-T for 30 min. All incubations were performed on a rocking 
platform at room temperature. Following a brief rinse with TBS-T, the nitrocellulose 
was incubated with the primary antibody at the required dilution, in TBS-T with 1% 
(w/v) BSA for 60 min. After six 5-min washes with TBS-T, the nitrocellulose was 
incubated with the secondary antibody at the required dilution in blocking solution (5% 
(w/v) Marvel in TBS-T) for 30 min. The nitrocellulose was then washed as above and 
the bound antibodies were visualised using enhanced chemiluminescence (ECL) which 
was used as described by the manufacturers. The nitrocellulose was placed between 
two transparency sheets before exposure to autoradiography film (Hyperfilm ECL) for 
varying lengths o f  time and until a sufficient signal was detected upon development.
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2.4.7 Confocal Microscopy
Rat cardiomyocytes were isolated by Dr A Gillingham and Dr J Yang using a modified 
method o f  that originally described by Fischer et al. (1991). The isolated 
cardiomyocytes were allowed to recover at 37°C for 20-30 min before fixation in 4% 
(w/v) paraformaldehyde in PBS pH 7.2 for 20 min. Unless otherwise stated, all 
incubations were performed with gentle agitation on a rocking platform at room 
temperature. The cells were washed twice in PBS, permeabilised by incubation in 
methanol at -20°C for 5 min and then washed three times with wash buffer (1% (v/v) 
BSA in PBS, pH 7.2). Before incubation with the primary antibodies, the cells were 
transferred to microcentrifuge tubes and were incubated in blocking buffer (3% (v/v) 
goat serum, 1% (v/v) BSA in PBS pH 7.2) for 30 min. Primary antibodies, in blocking 
buffer, were incubated with the cells for 1 h. The cells were washed three times in wash 
buffer before incubating with the rhodamine-labelled anti-mouse IgG antibody and/or 
fluorescein-labelled anti-rabbit IgG antibody (1:60 and 1:100 dilutions respectively; 
Table 2.1) in blocking buffer for 30 min. Washing (in wash buffer) was performed 
overnight and the cells mounted onto a glass coverslip using Vector Shield mounting 
medium (Vector Laboratories). Cardiomyocytes were viewed using a Zeiss LSM 510 
confocal scanning microscope with a 458/488 nm laser (for fluorescein-labelled 
samples) or a 543 nm laser (for rhodamine-labelled samples).
2.4.8 Expression and Purification of 6xHis-tagged Proteins
To assist the purification o f  recombinant centaurin-a2, the protein was expressed with 
an N-terminal six-histidine (6 xHis) tag using the bacterial expression system pET15b. 
LB broth containing 100 pg/ml ampicillin and 34 pg/ml chloramphenicol was 
inoculated with BL21(DE3)pLysS cells that had been transformed with pET15b- 
centaurin-a2. This culture was shaken overnight at 37°C until the optical density at 600 
nm ( O D 60o) reached an absorbance o f  0.5. Once the cells were at the appropriate 
density, expression was induced by the addition o f 0.5 mM isopropyl-p-D- 
thiogalactopyranoside (IPTG) for 2 h. The cells were harvested by centrifugation at 
1,000 x g for 10 min at 4°C and resuspended in 2 ml lysis buffer (20 mM Tris-HCl, pH 
8.0, 100 mM NaCl) per 25 ml o f cell culture. The bacterial cell walls were disrupted by 
flash freezing the cell suspension in a dry ice-ethanol bath. This was followed by
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thawing in cool water. The cells were sonicated using eight 15-sec pulses with 15-sec 
intervals and centrifuged at 12,000 x g for 10 min at 4°C.
The 6xHis proteins were purified using a batch/gravity-flow column method with Talon 
Metal Affinity Resin as described by the manufacturers. The resin was prepared by 
washing in five volumes o f  lysis buffer and pelleted by centrifugation at 700 x g for 5 
min. The washed resin was incubated with the cleared lysate for 20 min at room 
temperature with gentle agitation. The resin was centrifuged as above and washed twice 
in 10 volumes o f lysis buffer for 10 min and transferred to a gravity column and washed 
with five volumes o f lysis buffer. Weakly binding proteins were washed from the 
column with five volumes 10 mM imidazole in lysis buffer and the 6xHis proteins were 
eluted with 100 mM imidazole in lysis buffer. Fractions o f 1 ml were collected, 20 pi 
o f  each fraction was analysed by SDS-PAGE and the remaining volume was placed into 
Slide-A-Lyser dialysis cassettes and dialysed against lysis buffer. The concentration o f  
the purified protein was calculated from the A280 and examined by SDS-PAGE. 
Molecular weight markers o f  known concentration were resolved alongside the protein 
samples to allow comparison o f both the protein size and quantity.
2.5 Protein Isolation and Subcellular Fractionation
2.5.1 Isolation of Rat Adipocytes
Adipocytes were isolated from whole epididymal fat pads removed from male Wistar 
rats (180-200 g) as described by Simpson et a l  (1983). The epididymal fat pads were 
quickly removed and washed in 1% (w/v) BSA/Krebs-Ringers-HEPES (KRH) buffer 
(140 mM NaCl, 4.7 mM KC1, 2.5 mM CaCl2, 1.25 mM M gS04, 2.5 mM NaH2P 0 4, 10 
mM HEPES, pH 7.6) at 37°C. The fat pads were placed in KRH buffer containing 
3.5% (w/v) BSA, 5 mM glucose and 0.7 mg/ml collagenase (4 fat pads/5 ml) and were 
finely chopped with scissors. Digestion was performed with vigorous shaking in a 37°C 
water bath for 40-50 min until a fine cell suspension was achieved. The cell suspension 
was filtered through 250 pm nylon gauze and the cells returned to 37°C and allowed to 
float. The infranatant buffer was removed using a 13 gauge x 10 cm needle, and the 
cells were gently resupended in 1% (w/v) BSA/KRH buffer, and then returned to 37°C
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and allowed to float. This wash step was repeated three times and the cell suspension 
was adjusted to 40% cytocrit.
For some preparations the cell suspension was divided and half o f  the suspension was 
treated with 20 nM insulin 1% (w/v) BSA/KRH buffer and incubated at 37°C for 30 min 
(basal cells incubated in 1% (w/v) BSA/KRH buffer). For all preparations, the cells 
were washed in HES buffer (20 mM HEPES, pH 7.4, 1 mM EDTA, 255 mM sucrose 
containing protease inhibitors: 100 pM (4-(2-aminoethyl) benzenesulfonyl fluoride 
(AEBSF) and 1 pg/ml antipain, aprotonin, leupeptin and pepstatin A) at 18°C to remove 
the BSA.
2.5.2 Subfractionation of Rat Adipocytes
Isolated adipocytes were washed in HES buffer (18°C) and resuspended to 40% 
cytocrit. The basal cells were homogenised with 10 strokes o f  a 55 ml Potter-Elvehjem 
homogeniser (Thomas Scientific). The procedure was then repeated for the insulin 
stimulated cells. Initially the homogenate was centrifuged at 1000 x g for 2 min at 4°C 
to pellet any unhomogenised tissue and the tubes were then placed on ice for a few  
minutes to allow the fat to solidify at the neck o f the tubes. The infranatants were 
removed with a syringe and needle before being subjected to centrifugation as described 
by Weber et al. (1988) (.Figure 2.2). All centrifugation steps were performed in a 
Beckman TL-100 bench-top ultracentrifuge with a TLA-100.3 fixed rotor (or a TLS-55 
swing-out rotor, where specified). The first spin at 17,500 x g for 20 min produced a 
crude plasma membrane pellet and a microsomal/cytosol fraction. The supernatant was 
then transferred to a new tube and centrifuged at 49,000 x g for 9 min to pellet the high- 
density microsomes (HDM). The post-HDM supernatant was centrifuged at 541,000 x 
g for 17 min to separate the low-density microsomes (LDM) from the cytosolic fraction. 
The HDM and LDM pellets were resuspended in HES buffer.
The crude plasma membrane pellet was resuspended in 300 pi HES, loaded on top o f  a 
600 pi sucrose cushion (1.12 M sucrose in HES buffer) and centrifuged at 105,000 x g 
for 20 min in the swing-out rotor. The supernatant was collected, resuspended in HES 
buffer to 3 ml and centrifuged at 74,000 x g for 9 min. The plasma membrane pellet 
was resuspended in 3 ml HES buffer and pelleted as before. The final plasma
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Figure 2.2. Subcellular fractionation protocol for isolated rat adipocytes. The
initial centrifugation step ( 1 0 0 0  x g for 2  min) was performed to separate the fat, 
which forms a cake at the surface and any unhomogenised tissue. The homogenate 
was then separated by sequential centrifugation using a Beckman TL-100 bench-top 
ultracentrifuge with a TLA-100.3 fixed rotor. The crude plasma membrane pellet 
was resuspended in HES buffer and overlaid on a sucrose cushion (1.12 M sucrose 
in HES buffer) and centrifugation using a TLS-55 swing-out rotor. HDM, high- 
density microsomes; and LDM, low-density microsomes.
61
membrane fraction was resuspended in HES buffer using a syringe and 25G needle and 
was assayed for protein content along with the other subcellular fractions {Section 
2.4.1). The fractions were divided into aliquots, which were stored at -20°C.
2.5.3 Separation of Total Particulate and Cytosolic Fractions
Tissues were removed from male Wistar rats (180-280 g) and placed in ice-cold HES 
buffer. The tissues were homogenised in HES buffer (5 ml per gram) and were 
centrifuged at 1,000 x g for 2 min at 4°C. The supernatant was centrifuged at 541,000 x 
g for 30 min. The cytosolic fraction was collected and the particulate fraction 
resuspended in HES buffer using a syringe and 25G needle. The protein content was 
assayed {Section 2.4.1) and the fractions stored at -20°C.
2.6 Analysis of PH Domain Binding Characteristics
2.6.1 Ins 1,3,4,5-P4 Binding Studies
Binding o f  Ins 1 ,3 ,4 ,5 -P4 to recombinant centaurin-a2 was performed using a 
modification to methods described by Strieker et al. (1996) and Cullen et al. (1995a). 
In brief, each 500 pi assay contained 500 ng recombinant centaurin-a2, binding buffer 
(25 mM sodium acetate/25 mM potassium phosphate, pH 5.0, 0.05% (w/v) Brij58, 1 
mM EDTA), 1 nM [3H]Ins 1 ,3 ,4 ,5 -P4 and varying concentrations o f  unlabelled Ins 
1 ,3 ,4 ,5 -P4 or other phosphoinositides as specified. The reactions were maintained on 
ice for 15 min, after which the receptor-ligand complex was precipitated by addition o f  
1 0 0  pi 5 mg/ml y-globulin and 1 ml 25% (w/v) P E G 3 3 5 0 .  The samples were then 
incubated on ice for a further 5 min and centrifuged at 13,000 x g for 10 min. The 
supernatants were removed and the pellets quickly washed with 500 pi 25% P E G 3 3 5 0 .  
The resulting pellets were resuspended in 100 pi 0.1 M NaOH and 7 ml o f  scintillation 
fluid (Optiphase Safe) was added the H counts determined using a Packard Tri-Carb 
1600 Scintillation counter.
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2.6.2 [3H] BZDC-PtdInsP„ Photoaffinity Labelling
'I
Recombinant centaurin-a2 (3 pg) was incubated with either 0.1 pCi [ HJBZDC-Ptdlns 
3 ,4 -P2 or [3H]BZDC-Ptdlns 3 ,4 ,5 -P3 probes in lysis buffer (20 mM Tris-HCl, pH 8.0, 
100 mM NaCl) using a modification o f  protocols described by Profit et al. (1998) and 
Chaudhary et al. (1998). Samples were equilibrated on ice for 10 min in a 96-well 
microtitre plate and UV-irradiated at 350 nM for four 5-min periods with 5-min 
intervals. Photolabelled protein samples were then subjected to electrophoresis on large 
3 mm thick 10% SDS-PAGE gels (>Section 2.4.2). After Coomassie staining and 
destaining {Section 2.4.3) the gels were cut into slices and dried in open scintillation 
vials in an 80°C oven for 2 h. The dried gel slices were solubilised in 500 pi alkaline 
hydrogen peroxide (2% (v/v) NH4OH in 30% (v/v) H2O2) in sealed vials at 80°C for a 
further 2 h. The samples were cooled before the addition o f  7 ml scintillation fluid 
(Optiphase Safe). The 3H counts measured using a Packard Tri-Carb 1600 Scintillation 
counter.
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3.0 Id e n t ific a t io n  A nd  C l o n in g  o f  C e n t a u r in -(x2
3.1 Introduction
In adipose tissue and muscle, insulin initiates a signalling cascade resulting in the 
translocation o f Glut4 from the internal storage compartment to the plasma membrane, 
where it transports glucose into the cell. It is now well established that Ptdlns 3-kinase 
plays a pivotal role in this response. Ptdlns 3 ,4 ,5 -P3, the major product o f this kinase, 
was shown to be specifically bound by centaurin-a and centaurin-al. In 1997, when 
this research project was initiated, very little was known about the function o f the 
centaurin-a proteins. Their abundant expression in brain tissue and high affinity for 
Ptdlns 3 ,4 ,5 -P3 lead to the suggestion that they might function in signal transduction and 
vesicle transport (Hammonds-Odie et al. 1996; Kreutz et al. 1997; Strieker et al. 1997; 
Tanaka et al. 1997). The discovery o f  this Ptdlns 3 ,4 ,5 -P3 binding ARF-GAP-related 
protein family inspired us to investigate the presence o f  related proteins in insulin- 
sensitive tissues.
3.1.1 The Discovery of a Novel Partial Clone with Homology to the 
Centaurin-a Family
At the outset o f  my research, a former member o f  our laboratory, Dr Sue Oldfield, had 
discovered a partial clone, relating to the C-terminal portion o f  the later identified 
centaurin-a2. This initial finding was achieved using a centaurin-a D N A  probe 
(encoding the majority o f  the coding region o f  rat centaurin-a) to screen a rat adipocyte 
>*gt 11 library (a gift from C. Londos, NIH, Bethesda) at low stringency. The rat 
centaurin-a 1218 bp DNA fragment was assembled into pBluescript from two PCR 
products amplified from rat brain cDNA. The centaurin-a fragment was excised and 
labelled with [a -32P]dCTP by random priming {Section 2.3.6). Almost all o f the high 
intensity positive plaques were found to contain identical inserts o f  approximately one 
kilobase. The sequence contained an incomplete open-reading frame coding for 193
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amino acids that had 58% identity to amino acids 184-376 o f centaurin-a, plus 405 
nucleotides o f 3 ’ untranslated region (.Figure 3.1, A).
3.1.2 Identification of the Human Centaurin-a2 Clone
A search o f the EMBL databases for nucleotide sequences showing similarity to rat 
centaurin-a identified several human ESTs. These sequences appeared to fall into two 
groups. The first set shared greater than 80% identity with the centaurin-a family and 
approximately 65% identity with the rat centaurin-a2 partial clone, whereas the second 
group had the converse relationship. From this latter group, one EST (accession no. 
AA256750) o f 451 bp was 63% identical to the 5 ’ region o f  centaurin-a and did not 
overlap with the centaurin-a2 partial clone. This clone was obtained from the UK  
HGMP Resource Centre, Hinxton, Cambridge. The complete sequencing o f  the clone 
revealed a 1.8 kb cDNA encoding for a protein with 81% identity to the centaurin-a2 
partial clone (Figure 3. IB).
3.2 5’RACE Using Marathon-Ready cDNA
A sample o f a rat liver Marathon-Ready cDNA library (a gift from Dr B Reaves, 
University o f  Bath, UK) was used as a template for the amplification o f  the 5 ’ terminus 
o f  rat centaurin-a2 as described in the manufacturer’s protocol (Section 2.2.5). A  gene- 
specific reverse primer (Figure 3.2, A) was designed to the 5 ’ sequence o f  the rat 
centaurin-a2 partial clone using the guidelines described in the Marathon-Ready cDNA  
User Manual. A  24 base oligonucleotide was designed with a G/C content o f  62.5% 
and a melting temperature (Tm) o f 74.5°C, as determined by nearest neighbour analysis. 
A high-stringency thermal cycling program was selected, which incorporated a high 
annealing/elongation temperature that was compatible with both the gene-specific 
primer and the enzyme (Expand Long Template PCR System) (Figure 3.2, B). A  
positive control reaction was performed using the control 5 ’RACE primer for 
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) in place o f  the gene-specific 
primer. Following amplification, the products were examined by agarose gel 
electrophoresis. Visualisation o f the gel with an UV transilluminator revealed that
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(A)
MAGELRRALLELLTRPGNSRCADCGAPDPDWAS YTLGVFICLS CSGIHRNIPQVS KVKS V
RLDAWDETQVEFMTSHGNEAARATFESKVPPFYYRPTFSDCQLLREQWIRAKYERQEFLH
VEKQEPYSTGYREGLLWKGGGPGQWTVLKSEVCADRTRGWRLKYFNKNDAKEPKAVMKIE
10 20 30  40  50
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Figure 3.1. Sequence alignment of the rat centaurin-a2 partial clone sequence 
with related centaurin proteins. (A) Rat centaurin-a2 partial clone sequence (top 
sequence) was aligned with the rat centaurin-a sequence (lower sequence; accession 
number U51013). (B) Rat centaurin-a2 partial clone sequence was aligned with the 
human centaurin-a2 sequence (accession number AJ238994) for the overlapping 
region (amino acids 186-376). The rat centaurin-a2 sequence is at the top, human 
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Marathon cDNA adaptor Adaptor primer-1 Gene-specific primer-1
(B) Protocol 1
• 94°C for 1 minute
• 30 cycles:
94°C 30 seconds 
68°C 4 minutes
Protocol 2
94°C for 1 minute
30 cycles:
94°C 30 seconds 
60°C 30 seconds 
68°C 4 minutes
68°C 10 minutes
Figure 3.2. Amplification of the 5’terminus of centaurin-a2 using 5’RACE. (A)
Overview o f the marathon protocol. The specificity o f marathon RACE reactions is 
enhanced by the absence o f an API binding site on the adaptor ligated cDNAs. This 
site is created on the cDNA o f interest by the extension from the gene-specific primer 
during the first RACE cycle. GSP1, gene-specific primer-1 (CGGGCTGCA CGGA- 
GAGCATTGAAC). (B) Thermal cycling programmes used to amplify centaurin-a2. 
Protocol 1 was used in the initial reaction and Protocol 2 outlines the conditions o f  the 
modified amplification programme.
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absence o f  DNA bands from both the sample and positive control lanes (data not 
shown). A 1.1 kb DNA fragment was expected for the G3PDH positive control, the 
absence o f  this band indicated that the amplification was unsuccessful.
A number o f modifications were made to the 5 ’RACE protocol. Firstly, the PCR 
product from the previous 5 ’RACE reaction was diluted (1:100 and 1:500 in ddtbO) 
and used as a template. Secondly, a lower annealing temperature was employed {Figure
3.2, B). Three sample reactions were prepared with different template conditions for 
each reaction; the first reaction contained 5 pi Marathon-Ready cDNA, whereas diluted 
5 ’RACE product was used in the other two reactions (1:100 and 1:500 dilutions, 
respectively). Analysis o f the products by agarose gel electrophoresis revealed a single 
band o f  approximately 800 bp in the reactions using the diluted 5’RACE product as a 
template {Figure 3.3, A). No bands were visible for the reaction performed with the 
Marathon-Ready cDNA template.
Triplicate reactions were performed using the 1:100 diluted 5 ’RACE product as a 
template. A negative control was also performed with the gene-specific primer omitted 
from the reaction. These samples were run on an agarose gel {Figure 3.3, B) and gel 
slices containing the DNA fragment were excised and the DNA purified {Section 2.2.3).
3.2.1 Cloning of the 5’RACE Fragment into pT7Blue Cloning Vector
The purified DNA fragment was ligated into the pT7Blue cloning vector {Figure 3.4) 
using the Perfectly Blunt Cloning Kit. In brief, the ends o f the DNA fragment were 
converted to blunt, phosphorylated ends, by adding 5 pi End Conversion Mix to 3 pi 
purified 5 ’RACE product and making the final volume to 10 pi with ddtbO. The 
reaction was incubated at 22°C for 15 min then terminated by heating at 75°C for 5 min 
and briefly chilled on ice. Blunt pT7Blue vector, dephosphorylated at the EcoKV  site 
(50 ng) was added to the end conversion reaction and ligation was performed using T4 
DNA ligase (4U) for 2 h at 22°C. The ligase was heat inactivated at 60°C for 5 min and 
the reaction cooled prior to transformation into NovaBlue Singles Competent Cells 
{Section 2.2.8). In brief, 1 pi ligation reaction was added to the competent cells and 
chilled on ice for 5 min prior to a heat shock step for 30 sec at 42°C. The cells were 












Figure 3.3. Agarose gel electrophoresis of 5 ’RACE reactions. (A) 5’RACE 
amplification using liver Marathon-Ready cDNA. Three reactions were prepared 
with different templates; 1:100 and 1:500 dilutions o f product from the previous 
5’RACE reaction and the third reaction (Library) was prepared using liver 
Marathon-Ready cDNA as the template. (B) Multiple 5’RACE reactions were 
repeated using the 1:100 reaction conditions used in (A). The negative control 
reaction (Control) was performed with the omission o f the gene specific primer. 
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Figure 3.4. Vector map of the pT7Blue cloning vector. (A) Cloning map. (B) 
pT7Blue cloning/expression region. The ends o f the 5’RACE DNA fragment were 
converted to blunt ends and ligated with the linearised vector, thus inserting the 
5’RACE product into the blunt cloning site (EcoRY). These figures were reprinted 
with the kind permission o f Novagen, Inc.
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0.5% (w/v) yeast extract, 0.05% (w/v) NaCl, 2.5 mM KC1, 10 mM MgCL 20 mM 
glucose; included in the kit) was added and the cells transferred to a shaking incubator 
at 37°C for 30 min. The transformation reaction (10 |Lil and 90 pi) was spread onto LB 
agar plates that were prespread with 35 pi o f  20 mg/ml X-gal in dimethyl formamide 
and 20 pi 100 mM IPTG. The plates were inverted and incubated overnight at 37°C.
Recombinant colonies were identified using blue/white selection. The pT7Blue plasmid 
encodes a functional lacZ a-peptide that complements the lacZ co-fragment expressed 
by the host strain (NovaBlue). The resulting active p-galactosidase can cleave the 
chromogenic substrate X-gal to yield a blue colony phenotype. Inserts cloned into the 
multiple cloning site disrupt the open reading frame o f the a-peptide, resulting in the 
white colony phenotype. The plate that had been spread with 100 pi transformation 
reaction contained between 100-200 colonies with the ratio o f blue and white colonies 
at approximately 50:50. Plasmid DNA was purified from overnight cultures inoculated 
with single white colonies {Section 2.2.1).
3.2.2 Characterisation of the DNA Inserts
The purified recombinant DNA was digested with the endonuclease enzymes 7/mdIII 
and EcoRl, which cut either side o f  the EcoKV  restriction site, within the multiple 
cloning site o f pT7Blue {Figure 3.4). In the absence o f  internal restriction sites for 
these two enzymes within the DNA insert, two bands o f  2800 and 900 bp were expected 
for the vector and insert respectively. The majority o f  clones yielded similar DNA  
digest patterns consisting o f two DNA fragments, thus indicating the presence o f  an 
insert o f  similar size. However, the fragment length could not be determined due to 
poor visibility o f  the size markers (data not shown). Four o f  the clones were chosen for 
sequencing. Two clones (1 and 2) were selected because they shared the restriction 
pattern displayed by the majority o f the clones. The additional two clones were chosen 
for the opposite reason, as they displayed distinct digestion patterns. All four clones 
were sequenced in both directions using the vector primers M l3 universal primer and 
M l3 reverse primer.
Sequence analysis revealed that the two clones exhibiting unique restriction digest 
patterns were artefacts, as the gene-specific primer was present at both ends o f  the
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sequence. However, clones 1 and 2 contained the adaptor primer and gene specific 
primer located at the 5 ’ and 3 ’ ends respectively. The gene specific primer was situated 
within a 143 nucleotide overlapping region present at the 3 ’ end o f  the cDNA fragment 
and the 5 ’ sequence o f  the centaurin-a2 partial clone identified from the A.gt 11 library. 
The 5’RACE DNA fragment contained an open reading frame coding for 248 amino 
acids. The start codon was assigned at codon 18 based on a neural network prediction 
o f start codons (Pedersen and Nielsen 1997) and similarity to the centaurin-a protein 
sequences.
3.3 Generation of the Full-Length Rat Centaurin-a2 cDNA 
by 3’RACE
Following amplification o f the 5 ’ sequence it was possible to generate the full-length 
clone using two different approaches. Firstly the 5 ’ and 3 ’ fragments could be 
combined using basic cloning techniques. This simple procedure involves the digestion 
o f  the fragments at a restriction site located in the overlapping region, followed by 
ligation o f the compatible ends with T4 DNA ligase. However, caution should be noted 
when using this technique, as there is the possibility o f  creating a chimera by joining 
cDNAs derived from two different transcripts, as discussed later for the rat centaurin-a 
probe. Furthermore, the two cDNA fragments o f centaurin-a2 were amplified from 
different tissues (liver and adipocyte). Therefore, 3 ’RACE was selected for generation 
o f the full-length cDNA. Marathon-Ready cDNA libraries, from two tissues, adipocyte 
and brain (synthesised from polyA+ RNA by Dr P Whitley using the Marathon cDNA  
Amplification Kit, Clontech) were utilised for the 3 ’RACE reaction. The adaptor 
primer and a gene-specific primer designed to the 5 ’ terminus were used to amplify the 
full-length cDNA using a touchdown thermal cycling program (Figure 3.5, A and B).
A  1.8 kb band was successfully amplified from both the adipocyte and brain libraries,
with an additional 1.1 kb band from the brain template (Figure 3.6). The three DNA
fragments were cloned into pT7Blue and transformed into NovaBlue Singles (Section
3.2.1). Overnight cultures were prepared using colonies chosen by blue/white selection
and the plasmid DNA purified. Restriction digests with Pstl was performed to
determine the presence and orientation o f  the insert (data not shown). Sequence
analysis o f the 5 ’RACE product and the partial clone enabled the construction o f  a
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Marathon cDNA adaptor Adaptor primer-1 Gene-specific primer-2
•  9 4 ° C  f o r  1 m i n u t e
•  5  c y c l e s :
9 4 ° C  3 0  s e c o n d s  
7 2 ° C  4  m i n u t e s
•  5  c y c l e s :
9 4 ° C  3 0  s e c o n d s  
7 0 ° C  4  m i n u t e s
•  2 5  c y c l e s :
9 4 ° C  3 0  s e c o n d s  
6 8 ° C  4  m i n u t e s
•  7 2 ° C  1 0  m i n u t e s
Figure 3.5. Amplification of centaurin-a2 using 3 ’RACE. (A) Overview o f the 
marathon protocol. The full-length centaurin-a2 sequence was amplified using API 
and GSP2 (CCGGCCATGGGCGACCGTGAACG). As with the 5 ’RACE protocol, 
the API binding site is not created until extension o f the cDNA o f interest using 








Figure 3.6. Agarose gel electrophoresis of 3 ’RACE DNA fragments amplified 
from adipocyte and brain Marathon-Ready cDNA libraries. A 1.8 kb fragment 
was amplified from both the adipocyte and brain cDNA. An additional 1.1 kb band 
was detected in the brain sample. Molecular weight markers (MW) were run 
alongside and the appropriate size bands indicated.
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predicted restriction map for Pstl. Two internal sites were expected, with an additional 
site located in the multiple cloning site o f  the vector. The restriction pattern for both the 
adipocyte and brain 1.8 kb samples agree with the predicted fragment pattern. 
However, the 1.1 kb DNA fragment from brain was also analysed and did not contain 
an internal Pstl site.
3.4 Sequence Analysis
The restriction digest data enabled the selection o f suitable clones for sequencing. In 
addition to the vector primers described above, a series o f internal primers were used to 
sequence the 1.8 kb inserts in both directions. The adipocyte and brain sequences were 
identical to the sequence assembled from the combination o f 5 ’RACE sequence (from 
liver) and the partial clone isolated from the adipocyte A,gt 11 library. The predicted 
position o f  the initiation codon o f  rat centaurin-a2 was further strengthened by the 
presence o f  an in frame stop codon in the human cDNA, located 5 ’ o f  the proposed 
ATG start codon. The complete nucleotide sequence o f 1798 bp and predicted protein 
sequence o f  376 amino acids are shown in Figure 3 .7.
BLAST searches o f  the protein sequence databases revealed that this clone encodes a 
novel protein that is most similar to porcine p42IP4 (59% identity) (Strieker et al. 1997) 
and other centaurin-a family proteins (Hammonds-Odie et a l  1996; Tanaka et al. 1997; 
Venkateswarlu and Cullen 1999) {Figure 3.8 and 3.9). The protein has a deduced 
molecular mass o f  43.5 kDa and protein sequence analysis using ProfileScan (ISREC) 
detected the presence o f an N-terminal zinc-fmger motif (residues 21-82) with the 
consensus CX2CXi6CX2C and two PH domains, PH-N (residues 131-232) and PH-C 
(residues 254-360). The size and domain arrangement o f centaurin-a2 matches that o f  
the centaurin-a 1 proteins. Since the centaurin-a 1 proteins share approximately 90% 
identity to one another, it appears that the protein identified here is distinct. However, 
the structure o f  the other centaurin protein families, centaurin-p, -8, and -y , bare little 
similarity to this novel protein (see Section 1.5.4, Figure 1.7). Consequently it was 
decided that p42IP4, PIP3-BP and human centaurin-a 1 should collectively be referred to 
as the centaurin-a 1 proteins, which are closely related to rat centaurin-a. The novel rat 
and human centaurin proteins described herein should form a related subfamily o f  the 
centaurin-a proteins entitled centaurin-a2.
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ggaaccacagagttggcggggttgagccccgctgagacctctgggccggccatgggcgac 60
M G D 3
cgtgaacgcaacaagaagcggttgctggagctgctgcaggctgcgggcactggcaacggg 120
R E R N K K R L L E L L Q A A G T G N G  23
cactgcgccgactgcggggcagcggatcctgattgggcctcttacaagctgggggttttc 180
H C A D C G A A D P D W A S Y K L G V F  43
atctgtctccactgctctggcgtccatcgcaacttcccagacatcagcaaagttaaatcc 240
I C L H C S G V H R N F P D I S K V K S  63
gtgagactggacttctgggacgacagtatggtggagttcatgactcacaatgggaacctc 300
V R L D F W D D S M V E F M T H N G N L  83
agtgtgaaagccaagtttgaagctagagtcccaactttctactacgtccctcaggccagc 360
S V K A K F E A R V P T F Y Y V P Q A S  103
gactgcctggtcttaaaggaacaatggattcgagctaagtatgaaaggcaggagtttatg 420
D C L V L K E Q W I R A K Y E R Q E F M  123
gctgagaaagctgtctcgcccccaggtgatcgagaaggcttcctgtggaagcgaggaagg 4 80
A E K A V S P P G D R E G F L W K R G R  143
gacaactcccagttcctgaggagaaggtttgtccttctgtcaagggaaggcctgctgaag 54 0
D N S Q F L R R R F V L L S R E G L L K  163
tactacaccaaggaagagggtaaaaccccaaaggctatcatcaacatcaaggacttaaat 600
Y Y T K E E G K T P K A I  I N I K D L N  183
gccaccttccagacagagaagattggacatccccacgggctgcagattacctacaggaag 660
A T F Q T E K I G H P H G L Q I T Y R K  203
gagggccaaaccagaaatctgtttgtatatcatgacagtggaaaggagatagtggattgg 720
E G Q T R N L F V Y H D S G K E  I V D W  223
ttcaatgctctccgtgcagcccgcctgcaatacctaaaattggcctttcctgatctccca 780
F N A L R A A R L Q Y L K L A F P D L P  243
gagtctgagctcgtgcctctcatcaccaggaactacctcaaacaaggcttcatggagaag 84 0
E S E L V P L I T R N Y L K Q G F M E K  263
actggtccaaagcatagagaacccttcaagaaaaggtggtttgccttggatcctcaggag 900
T G P K H R E P F K K R W F A L D P Q E  283
cggaggctgctgtattataagaaccccctggacgcttttgagcagggccaggtttttctg 960
R R L L Y Y K N P L D A F E Q G Q V F L  303
ggaagcaatgagcagggatatgaagtatgggaaggcctgccccagggcatccgagggaac 1020 
G S N E Q G Y E V W E G L P Q G I R G N  323
cgctggaaggtcggactcacggtcatcactccggagcggaaattcgtcttcacctgcccc 1080 
R W K V G L T V I T P E R K F V F T C P  343
acggaaaaggagcagcgggaatggctggagagtctgcggggtgtcctgtccagtcccttg 1140 
T E K E Q R E W L E S L R G V L S S  P L  363
tcgcccctccacctcctcaccacatcagcaaagagtggctgaggcctgaggtgacccatc 1200 











Figure 3.7. Nucleotide and deduced amino acid sequence of the cloned cDNA of 
rat centaurin-a2. T h e  n u m b e r s  o f  t h e  n u c l e o t i d e  a n d  a m i n o  a c i d  r e s i d u e s  a r e  
i n d i c a t e d  o n  t h e  r i g h t  o f  t h e  s e q u e n c e .
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Figure 3.8. Alignment of rat and human centaurin-a2 amino acid sequences 
with those of the centaurin-a family; r a t  c e n t a u r i n - a 2  ( a c c e s s i o n  n u m b e r  
A J 2 3 8 9 9 3 ) ;  h u m a n  c e n t a u r i n - a 2  ( a c c e s s i o n  n u m b e r  A J 2 3 8 9 9 4 ) ;  r a t  c e n t a u r i n - a  
( a c c e s s i o n  n u m b e r  U 5 1 0 1 3 ) ;  r a t  p 4 2 lP4 ( a c c e s s i o n  n u m b e r  A J 0 0 7 4 2 2 ) ;  h u m a n  
c e n t a u r i n - a !  ( a c c e s s i o n  n u m b e r  A J 0 0 6 4 2 2 ) ;  p o r c i n e  p 4 2 IP4 ( a c c e s s i o n  n u m b e r  
U 8 8 3 6 8 ) ;  b o v i n e  P I P 3 - B P  ( a c c e s s i o n  n u m b e r  D 8 9 9 4 0 ) .  A  m u l t i p l e  s e q u e n c e  
a l i g n m e n t  w a s  g e n e r a t e d  u s i n g  M u l t A l i n  ( I N R A ,  P a r i s ,  F r a n c e )  a n d  B o x s h a d e  
( E M B n @ t . c h ) .  T h e  d o m a i n s  a r e  u n d e r l i n e d :
N - t e r m i n a l  z i n c  f i n g e r  m o t i f  
“  P H - N  d o m a i n
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Human Centaurin - a 2  358 
Rat Centaurin-a 355 
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Figure 3.9. Sequence identities of the centaurin-a family proteins. R a t  c e n t a u r i n - a 2  ( a c c e s s i o n  n u m b e r  A J 2 3 8 9 9 3 ) ;  h u m a n  c e n t a u r i n - a 2  
( a c c e s s i o n  n u m b e r  A J 2 3 8 9 9 4 ) ;  r a t  c e n t a u r i n - a  ( a c c e s s i o n  n u m b e r  U 5 1 0 1 3 ) ;  r a t  p 4 2 IP4 ( a c c e s s i o n  n u m b e r  A J 0 0 7 4 2 2 ) ;  h u m a n  c e n t a u r i n - a !  
( a c c e s s i o n  n u m b e r  A J 0 0 6 4 2 2 ) ;  p o r c i n e  p 4 2 IP4 ( a c c e s s i o n  n u m b e r  U 8 8 3 6 8 ) ;  b o v i n e  P I P 3 - B P  ( a c c e s s i o n  n u m b e r  D 8 9 9 4 0 ) .  T h e  p e r c e n t a g e s  w e r e  
c a l c u l a t e d  b y  p e r f o r m i n g  p a i r  a l i g n m e n t s  u s i n g  A L I G N  ( E x P A S y ) .
3.5 Discussion
In order to screen the adipocyte Xgt 11 library for centaurin-a related clones, the 
generation o f a suitable probe was required. The cloning and sequencing o f  the 
centaurin-a cDNA probe revealed three differences from the published rat centaurin-a 
sequence: two single base changes at positions 396 and 402 and a two base deletion at 
position 1232. The latter deletion caused a frameshift with respect to the published 
sequence (Hammonds-Odie et al. 1996), which introduced a stop codon. Consequently, 
the cDNA encoded a shorter protein o f 376 amino acids that terminated at the same 
point as the centaurin-al proteins. Although sharing similarity in size, our rat 
centaurin-a clone differed from the centaurin-al proteins within the PH-N region 
(amino acids 139-161). In this region the identity was interrupted and our centaurin-a 
clone was identical to the published rat centaurin-a sequence. This occurrence can be 
explained by the method employed in the generation o f the clone, which was assembled 
from two PCR products. Therefore, it would appear this cDNA is a hybrid generated 
from transcripts encoding the 5 ’ portion o f  centaurin-a and the 3 ’ region o f  
centaurin-al.
Until now, centaurin-a was the only member o f the centaurin-a protein family to have 
ankyrin repeats in place o f the PH-N domain (Hammonds-Odie et a l  1996). In 1998, 
Reiser and colleagues investigated this anomaly using a variety o f molecular biology 
and biochemical approaches. Firstly, RT-PCR was employed to analysis the mRNA  
from rat brain using PCR primers complementary to the regions spanning the start and 
stop codons o f  rat centaurin-a. Several cDNA clones with identical sequence were 
identified and designated rat p42IP4 as the sequence was identical to pig p42IP4 between 
amino acids 139-161, terminated at the same position and shared 94.5% identity 
(Aggensteiner et al. 1998). Secondly, antiserum raised against an 18 amino acid 
peptide corresponding to amino acids 353-371 o f porcine p42IP4 and amino acids 355- 
373 o f  rat centaurin-a was used in western blot analysis. Protein fractions were purified 
using the chromatography methods employed for the purification o f  porcine p42IP4 from 
pig cerebellum (Donie and Reiser 1991). A  single 42 kDa protein band that comigrated 
with pig p42IP4 was observed (Aggensteiner et al. 1998). Although this study by Reiser 
and colleagues cast some doubt on the existence o f rat centaurin-a, our results
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strengthen the authenticity o f the ankyrin repeat region o f  the rat centaurin-a sequence. 
However, the position o f the stop codon o f rat centaurin-a remains questionable.
Attempts to isolate the full-length centaurin-a2 clone from the adipocyte Xgt 11 library 
were unsuccessful. The initial effort to amplify the 5 ’ region o f the partial clone using 
5 ’RACE was also unsuccessful. The absence o f G3PDH (positive control) signal 
indicated that the amplification conditions were unsuitable. Modification o f  the thermal 
cycling programme alone was not sufficient to yield amplified cDNA from the liver 
Marathon-Ready cDNA template. However, the 5 ’ fragment was successfully amplified 
in reactions where the template was changed to the diluted PCR product from the 
previous 5 ’RACE reaction (Figure 3.3, A). The reasons for these results remain 
ambiguous. No cDNA bands appeared to have been amplified in the first reaction, 
however dilution o f  the reaction product may simply have diluted the template cDNA to 
levels appropriate for amplification. Alternatively components that were inhibiting or 
interfering with the amplification reaction may have been diluted.
The rat and human centaurin-a2 sequences are on the EMBL Nucleotide Database, 
accession numbers AJ238993/4 respectively. Shortly before the release o f  these 
sequences into the public domain, an identical human centaurin-a2 sequence was 
released by another group, who also entitled the protein centaurin-a2 (accession number 
AJ272195). Jenne and co-workers identified the centaurin-a2 gene to be one o f  a 
common set o f  11 functional genes which were lost in the majority o f  neurofibromatosis 
type-1 patients with gross deletions (Jenne et al. 2000). Neurofibromatosis type-1 
(NF1), also known as von Recklinghausen disease, is an autosomal dominant disorder 
with an estimated prevalence o f 1 in 3000. It is caused by mutations o f  the NF1 gene 
(Rasmussen and Friedman 2000; von Deimling et al. 1995). Neurofibromin, the protein 
encoded by the NF1 gene, is a GAP protein for the ras oncogene, and has been 
suggested to act as a tumour suppressor (Xu et al. 1990). Neurofibromas, benign 
tumours, can arise in the skin or in fibrous tissue surrounding peripheral and cranial 
nerves and some o f  the characteristic symptoms include cafe-au-lait spots, optic glioma, 
Lisch nodules (iris hamartomas), distinctive osseous lesions and mental retardation (von 
Deimling et al. 1995). Jenne et al. proposed that most o f  the NF1 patients with the 
entire NF1 gene deletion also lacked the same set o f 11 genes (including centaurin-a2) 
which are adjacent to the NF1 gene located at chromosome 17ql 1.2 (Jenne et al. 2000).
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Centaurin-a2 contains the zinc-finger motif with the consensus CX2CXi6-i7CX2C that is 
conserved throughout the family o f  ARF-GAP proteins. The invariant arginine residue 
located five residues following the fourth cysteine residue is conserved in centaurin-a2. 
Although centaurin-al has been shown to functionally compliment Gcsl 
(Venkateswarlu et a l  1999b) no in vitro ARF-GAP activity has been detected for 
centaurin-a or the centaurin-al proteins (Jackson et a l  2000b). Jackson and colleagues 
went on to speculate that these proteins may require another cofactor, or may act on a 
different ARF or ARF-like (ARL) partner, or they may not be GAP proteins and have 
an alternative function (Jackson et a l  2000b). Interestingly the GAP domain o f  the 
Ras-GAP neurofibromin mentioned above has been shown to interact with microtubules 
as well as activating the GTPase activity o f Ras (Gregory et a l  1993).
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4.0 In v e st ig a t io n  o f  C e n t a u r in -cx2 m R N A  a n d  
P r o t e in  Ex pr e ssio n
4.1 Introduction
The transcripts for centaurin-a and several o f  the centaurin-a Is have been found to be 
highly abundant in brain, the tissue from which the majority o f these proteins were 
identified (Hammonds-Odie et al. 1996; Strieker et al. 1997; Tanaka et al. 1997; 
Venkateswarlu and Cullen 1999). Although centaurin-a was detected in lung, kidney 
and spleen and centaurin-al found in spleen, kidney and peripheral blood leukocytes, 
the level o f  expression was considerably lower than that observed for brain. Simply 
from the cloning o f  rat centaurin-a2, we expected a wider distribution o f  expression, as 
the 5 ’RACE product was amplified from a liver cDNA library and the full-length 
sequence from adipocyte and brain.
In order to determine the distribution o f  centaurin-a2 expression, studies were 
undertaken to examine the relative abundance o f  both the transcript and the protein, in a 
number o f  tissues, including insulin-sensitive tissues o f adipocytes, heart and skeletal 
muscle. Firstly the mRNA expression was examined using northern blot analysis. 
Secondly, centaurin-a2 antiserum was employed to determine the tissue distribution and 
subcellular localisation o f the native protein using western blot analysis. Finally, 
further analysis o f  the subcellular localisation was performed using confocal laser 
microscopy.
4.2 Northern Blot Analysis
Before the identification o f the full-length centaurin-a2 sequence, the expression o f  the 
partial clone was analysed using total RNA northern blots and radioactively-labelled 
DNA probes. Later experiments were performed using DIG-labelled RNA probes 
encoding the 5 ’RACE product o f  centaurin-a2 with polyA+ RNA blots. In order to 
ascertain the relative abundance o f centaurin-a2, normalisation o f  the signal, to
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compensate for differences in RNA loading, was required. Ubiquitous housekeeping 
genes, such as p-actin, an essential cytoskeletal protein, and the glycolytic enzyme 
G3PDH are among the most common genes traditionally employed for RNA  
normalisation.
4.2.1 Northern Blot Analysis using Radioactively-Labelled DNA 
Probes
4.2.1.1 Purification of Total RNA
Total RNA was isolated from nine rat tissues: adipose, brain, heart, kidney, liver, lung, 
skeletal muscle, spleen and testis. Following the determination o f RNA concentration 
by spectrophotometry, 10 pg o f the RNA was examined by agarose gel electrophoresis. 
The 18S and 28S ribosomal RNA bands were clearly visible in all the total RNA  
samples, with the exception o f  spleen where the bands were weak {Figure 4.1). The 
smear observed in the spleen sample might have resulted from poor sample loading. 
Alternatively the RNA may have been degraded, although the A 260/A 280 ratio was 1.78, 
well within the 1.6-2.0 range recommended for northern blot analysis (TriPure Isolation 
Reagent, Roche Molecular Biochemicals).
4.2.1.2 Preparation of 32P-Labelled DNA Probes
The cDNA encoding the partial centaurin-a2 sequence was excised from the cloning 
vector pBluescript using the restriction endonuclease EcoRl. Electrophoresis o f  the 
digested DNA showed a band at approximately 800 bp as expected {Figure 4.2). This 
band was cut from the gel and the DNA purified. Similarly, the centaurin-a cDNA  
(previously used to screen the rat adipocyte A,gt 11 library) was excised from 
pBluescript using Hindlll and Xbal, yielding a 1200 bp DNA fragment. Radioactively- 
labelled probes were generated by the incorporation o f [a-32P]dCTP during DNA  
synthesis primed with random sequence hexanucleotides {Section 2.3.6). Rat G3PDH 
cDNA was also labelled using this method.
4.2.1.3 Northern Blot Analysis using 32P-Labelled DNA Probes
Total RNA isolated from the rat tissues and RNA Molecular Weight Markers were
separated on a denaturing formaldehyde agarose gel. In additional sample o f  20 pg
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Figure 4.1. Agarose gel electrophoresis of total RNA. T o t a l  R N A  w a s  i s o l a t e d  
f r o m  r a t  t i s s u e s  u s i n g  T r i P u r e  I s o l a t i o n  R e a g e n t  a n d  1 0  p g  w a s  e x a m i n e d  b y  
e l e c t r o p h o r e s i s  o n  a  1 %  a g a r o s e  g e l  c o n t a i n i n g  0 . 5  p g / m l  e t h i d i u m  b r o m i d e .  T h e  
p o s i t i o n  o f  t h e  2 8 S  a n d  1 8 S  r i b o s o m a l  R N A  b a n d s  a r e  i n d i c a t e d  b y  t h e  a r r o w s .  A d ,  
a d i p o s e  t i s s u e ;  B r ,  b r a i n ;  H e ,  h e a r t ;  K i ,  k i d n e y ;  L i ,  l i v e r ;  L u ,  l u n g ;  M u ,  s k e l e t a l  
m u s c l e ;  S p ,  s p l e e n ;  a n d  T e ,  t e s t i s .
M W
C e n t a u r i n - a 2  
p a r t i a l  c l o n e
-2000 bp —  
1375 bp —  
947 bp —
C e n t a u r i n - a  M W
-2000  bp 
1375 bp 
947 bp
Figure 4.2. Restriction digestion of the centaurin-a2 partial clone and 
centaurin-a. C e n t a u r i n - a 2  c D N A  w a s  e x c i s e d  f r o m  p B l u e s c r i p t  u s i n g  Z s c o R I  
y i e l d i n g  a  f r a g m e n t  o f  a p p r o x i m a t e l y  8 0 0  b p .  S i m i l a r l y  t h e  c e n t a u r i n - a  c D N A  
f r a g m e n t  ( 1 2 0 0  b p )  w a s  c u t  o u t  o f  p B l u e s c r i p t  w i t h  Hindlll a n d  Xbal. M o l e c u l a r  
w e i g h t  m a r k e r s  ( M W )  w e r e  s e p a r a t e d  a l o n g s i d e  t h e  s a m p l e s  a n d  t h e  s i z e s  o f  t h e  
a p p r o p r i a t e  m a r k e r s  h a v e  b e e n  i n d i c a t e d .
85
liver total RNA was run alongside the markers. Following transfer and baking o f the 
nitrocellulose, the section o f  membrane containing the marker lanes was cut o ff and 
stained with methylene blue (Figure 4.3). The position o f the wells, the 18S and 28S 
ribosomal bands o f the total RNA, and the molecular weight marker bands were marked 
onto the nitrocellulose with a pencil. The migration distance was plotted against the 
transcript size (data not shown) and the mRNA transcript sizes calculated. 
Hybridisation reactions were performed sequentially using radioactively-labelled cDNA  
probes for the centaurin-a2 partial clone, centaurin-a and G3PDH.
The signal intensity was weak for all three probes and consequently the blots required 
long periods o f exposure to the film (> 48 h). Centaurin-a2 produced a particularly 
weak signal, resulting in high levels o f non-specific background. Although, faint bands 
o f approximately 4.0 kb were vaguely detectable in kidney, lung and spleen when using 
this probe {Figure 4.4, A). Unfortunately there was an intense spot o f non-specific 
binding, located between the adipocyte and brain lanes, that obscured these lanes in the 
region o f  the 4.0 kb centaurin-a2 band. As expected an intense band o f  2.5 kb was 
detected in brain for centaurin-a, with weaker signals observed in kidney, lung and 
spleen {Figure 4.4, B). The intensity o f the 1.6 kb G3PDH band varied considerably 
between the tissues, despite loading o f  equal quantities o f total RNA {Figure 4.4, C).
In an attempt to intensify the signal, the amount o f  poly-adenylated (polyA+) messenger 
RNA loaded onto the gel was increased using purified polyA+ RNA northern blots. 
Firstly, polyA+ RNA was isolated from 100 pg total RNA for each tissue, with an 
expected yield o f  1-2 pg. Loading total RNA (20 pg) and polyA+ RNA (1-2 pg) on the 
same gel enabled direct comparison o f the relative signal intensities {Figure 4.5). The 
blots probed with G3PDH and centaurin-a clearly indicated an increase in signal 
intensity when using polyA+ RNA, as compared with the total RNA {Figure 4.5, B and 
C). As before, high background levels obscured the centaurin-a2 signal, although 
indistinct bands were just about detectable in the polyA+ lanes. Although it was 
difficult to distinguish, there appeared to be two bands in the brain PolyA+ RNA  
sample. The position o f the lower band corresponded to that o f centaurin-a. Since the 
centaurin-a2 probe was used after the centaurin-a probe, the lower band may have been 
a result o f  residual centaurin-a probe. Following this observation, the centaurin-a2 








1.9 kb —  —  1 9  kb - 18S
1.6 kb —
Figure 4.3. Methylene blue stained nitrocellulose membrane containing RNA 
molecular weight markers and total RNA. RNA molecular weight markers and 
20 jag total RNA from liver were separated alongside the tissue total RNA samples 
on a denaturing g e l, and transferred to nitrocellulose generating a multi-tissue 
northern blot. Following baking, the outer marker lanes were cut away and the 
membrane was stained with a solution o f 0.5 M sodium acetate (pH 5.2) and 0.04% 
methylene blue. After rinsing with water the positions o f the marker bands and the 
ribosomal RNA bands were marked.
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(A) Centaurin-a2









Figure 4.4. Northern blot analysis of total RNA from rat tissues using 32P- 
labelled DNA probes. A multiple tissue northern blot was prepared using 20 pg 
total RNA from rat tissues. (A) Centaurin-a2 partial clone probe produced a 4.0 kb 
band; (B) Centaurin-a yielded an intense 2.5 kb band in brain; and (C) G3PDH 1.6 
kb band was detected in almost all the tissues. Ad, adipose tissue; Br, brain; He, 
heart; Ki, kidney; Li, liver; Lu, lung; Mu, skeletal muscle; Sp, spleen and Te, testis. 
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(C) G3PDH
Total PolyA+ 
Ad Br Ad Br
4.0 kb —
2.5 kb —
Figure 4.5. Northern blot analysis using polyA+ RNA and total RNA. Total 
RNA (20 pg) and polyA+ RNA (1-2 jug) were separated on the same formaldehyde 
denaturing gel and transferred to a nitrocellulose membrane. Hybridisation with 
32P-labelled DNA probes was performed. (A) Centaurin-a2 partial clone probe; (B) 
Centaurin-a; and (C) G3PDH. Ad, adipose tissue; Br, brain. RNA markers were not 
used so the positions o f the rat centaurin-a bands (2.5 and 4.0 kb) are marked.
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As the signal intensity was much improved with polyA+ RNA, a multiple tissue 
northern blot was generated and hybridised successively with the three 32P-labelled 
DNA probes. Despite the centaurin-a2 signal remaining fairly weak with high 
background levels, a 4.0 kb centaurin-a2 band was discernible in liver and kidney 
{Figure 4.6, A). In addition there appeared to be a very faint band o f approximately 5 
kb in these tissues. As shown previously, a very strong centaurin-a signal was detected 
in brain with weaker signals visible in kidney and lung {Figure 4.6, B). The intensity o f  
the G3PDH signal was strong and differed quite significantly between samples. Thus 
comparison o f  expression levels o f the centaurin proteins in the various tissues required 
normalisation {Figure 4.6, C).
4.2.2 Northern Blot Analysis using the DIG Detection System
The DIG system is a non-radioactive detection system that utilises digoxigenin, a 
steroid hapten, coupled to dUTP, UTP or ddUTP to label DNA, RNA or 
oligonucleotides for hybridisation and subsequent detection. There are several methods 
o f  generating DIG-labelled probes, however DIG-labelled RNA probes are the most 
sensitive for northern blot analysis. Detection o f the hybridised probe was achieved 
using an anti-digoxigenin antibody-alkaline phosphatase conjugate and the 
chemiluminescent alkaline phosphatase substrate, CSPD. The chemiluminescent signal 
was visualised upon exposure to Hyperfilm ECL. Single-stranded RNA probes were 
generated for centaurin-a2, centaurin-a, p-actin and G3PDH by in vitro transcription 
using the pSPT18 vector included in the DIG RNA Labelling Kit {Figure 4 .7).
4.2.2.1 Preparation of DIG-Labelled RNA Probes
The centaurin-a2 5 ’RACE product was excised from pT7Blue using Xba\ and Smal, 
restriction endonucleases that cut either side o f the EcoKV  insertion site {Figure 3.4). 
A single DNA fragment o f approximately 830 bp was cut from the pT7Blue vector 
(2887 bp) and extracted from the agarose gel {Figure 4.8). Likewise, the pSPT18 
vector was digested with Xbal and Smal and purified in preparation for the ligation 
reaction with the insert DNA. Following ligation with T4 DNA ligase, the DNA was 
transformed into the competent cells (NovaBlue Singles). Recombinant colonies were 
selected using blue/white screening and used to inoculate overnight cultures o f  LB
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Figure 4.6. PoIyA+ RNA northern blot analysis using 32P-labelled DNA probes.
A multiple tissue northern blot was prepared using polyA+ RNA. (A) Centaurin-a2 
partial clone probe, (B) Centaurin-a, and (C) G3PDH. Ad, adipose tissue; Br, brain; 
He, heart; Ki, kidney; Li, liver; Lu, lung; Mu, skeletal muscle; Sp, spleen and Te, 
testis. The positions o f the RNA molecular weight markers are indicated.
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Figure 4.7. Multiple cloning site and vector map of the transcription vector 
pSPT18. The pSPT18 vector was cut with Xbal and Smal separated on an agarose 
gel and purified. Centaurin-a2 5’RACE product was cloned into pSPT18. The 
recombinant plasmid was then linearised using Smal, and RNA transcripts o f  
uniform length were synthesised by in vitro transcription using SP6 RNA poly­
merase. Ampr, ampicillin selective marker. This diagram was reprinted with the kind 
permission o f Roche Molecular Biochemicals.
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broth. The purified plasmid DNA was analysed by restriction digestion with Xbal and 
Smal to confirm the presence o f  the 781 bp insert DNA and the 3106 bp pSPT18 vector 
{Figure 4.9).
The endonuclease Smal, cuts the pSPT18 vector at the 3 ’ end o f  the inserted DNA and 
was used to linearise the recombinant plasmid. RNA transcripts o f uniform length were 
synthesised by in vitro transcription using SP6 RNA polymerase. Quantification o f the 
DIG-labelled RNA yield was determined by direct comparison with the DIG-labelled 
control RNA in a spot assay. The centaurin-a2 probe yield was calculated to be 125 
ng/pl. {Figure 4.10). Likewise, Dr Paul Whitley generated RNA probes for centaurin-a 
(using the cDNA used to screen the rat adipocyte A.gt 11 library, Section 3.1.1), P-actin 
and G3PDH.
4.2.2.2 Northern Blot Analysis using DIG-Labelled RNA Probes
PolyA+ RNA was isolated from 1 mg total RNA, with a predicted yield o f 10-20 pg. A  
tenth o f this RNA (1-2 pg) was used for the first northern blot, which was probed with 
G3PDH and p-actin to determine which probe to use for the normalisation process. A  
single band o f 1.6 kb was produced with the G3PDH probe, and p-actin yielded two 
bands, the ubiquitously expressed 2.0 kb transcript and the 1.8 kb muscle type actin in 
heart and skeletal muscle {Figure 4.11, A and B). These blots, developed using the 
DIG-detection system, had very low levels o f  background signal and very little non­
specific spotting. The signal intensities were inconsistent between tissue samples, for 
example in lung the G3PDH expression appears to be considerably lower than in other 
tissues. In contrast the p-actin signal is quite abundant in lung. No bands were detected 
in the spleen samples using either o f  the normalisation probes. The total RNA from 
which the spleen polyA+ RNA was isolated appeared normal on examination by 
electrophoresis. However, degradation may have ensued, alternatively the isolation o f  
polyA+ RNA may have been unsuccessful.
A  study comparing transcript size, tissue-specific variation and the number o f  
hybridising bands o f  nine widely used housekeeping genes found P-actin to be the best 
choice for use in the normalisation process (Siebert et al. 1999). Since there was no 
obvious distinction between the two probes, p-actin was selected for the standardisation 





Figure 4.8. Excision of the centaurin-a2 5’RACE product cDNA from the 
pT7BIue cloning vector. The cloning vector pT7Blue containing the centaurin-a2 
5’RACE product cDNA was digested with Xbal and Smal. The digested recombi­
nant plasmid was separated by agarose gel electrophoresis. RD, restriction digested 
sample; MW, 100 bp molecular weight markers.
Figure 4.9. Restriction digestion of the recombinant plasmid, pSPT18- 
5’centaurin-a2 using Xbal and S m al. Positive recombinant clones, selected using 
blue/white screening were tested for the presence o f the centaurin-a2 cDNA insert 
(781 bp) using restriction digestion with Xbal and Smal. Molecular weight markers 
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Figure 4.10. Estimation of DIG-labelled centaurin-a2 RNA yield in a spot test 
with a DIG-labelled control RNA. The DIG-labelled centaurin-a2 RNA probe 
synthesised by in vitro transcription was quantified in a spot test. A dilution series o f the 
control DIG-labelled RNA and centaurin-a2 RNA were prepared and spotted onto 
nylon membrane. Detection was performed using the DIG-detection system.
(A) P-actin
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Figure 4.11. Northern blot analysis of the housekeeping genes P-actin and G3PDH.
Multiple tissue northern blots were generated using polyA+ RNA and the nylon 
membrane was then hybridised with DIG-labelled RNA probes for (A) p-actin and (B) 
G3PDH. P-actin yielded two bands, the ubiquitously expressed 2.0 kb transcript and the
1.8 kb muscle type actin in heart and skeletal muscle. A single band of 1.6 kb was 
produced with the G3PDH probe. Ad, adipose tissue; Br, brain; He, heart; Ki, kidney; 
Li, liver; Lu, lung; Mu, skeletal muscle; Sp, spleen and Te, testis. RNA molecular 
weight markers were separated alongside the samples and the sizes o f the appropriate 
markers have been indicated.
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the same stock o f polyA+ RNA as the previous samples. The signal intensity o f the 
p-actin 2.0 kb band was quantified for each tissue on the duplicate blots using 
Molecular Analyst/PC version 1.5, (Bio-Rad Laboratories). The quantity o f polyA+ 
RNA loaded onto subsequent gels was adjusted so that approximately equal p-actin 
signal intensities were observed. Sequential hybridisation reactions were then 
performed using the centaurin-a2, centaurin-a and p-actin probes (Figure 4.12). The 
migration distance was plotted against the logarithm o f the transcript size (Figure 4.13) 
enabling the mRNA transcript sizes o f  the centaurin and p-actin bands to be determined.
The centaurin-a2 probe yielded two mRNA transcripts o f 4.0 kb (major transcript) and
5.2 kb (minor transcript). These bands appeared to be ubiquitously expressed, although 
the abundance varied between tissues, with the highest levels observed in kidney and 
liver (Figure 4.12, A). Although the p-actin signal intensity appeared to be relatively 
uniform when examined by eye, computer analysis was used to accurately quantify the 
band density and the abundance o f  the 4.0 kb centaurin-a2 band was altered 
accordingly (Figure 4.14). Normalised data indicated centaurin-a2 expression to be 
most abundant in liver and with the levels decreasing in the following order, kidney > 
lung > heart > skeletal muscle > adipose tissue > brain > testis.
More than one transcript was detected using the centaurin-a probe, with the major 
transcript o f 2.5 kb depicted by the extremely intense band in brain {Figure 4.12, B). 
This major band was also present, although considerably less abundant in kidney and 
lung as described previously. Interestingly, longer exposure times revealed the presence 
o f  this band in adipose tissue, heart and skeletal muscle. The centaurin-a probe also 
produced a 4.0 kb band that appeared to be ubiquitous, however the abundance pattern 
was different to that o f the 2.5 kb transcript. Like the 2.5 kb transcript, the 4.0 kb 
transcript was most abundant in brain, it also appeared to be highly expressed in liver. 
This finding differs from that o f  the 2.5 kb transcript which has not been detected in 
liver, both in this study and those reported in the literature (Hammonds-Odie et al. 
1996; Strieker et al. 1997; Venkateswarlu and Cullen 1999). A  third band o f  
approximately 3.1 kb was also produced by the centaurin-a probe. The distribution o f  
this transcript appeared to follow that o f  the 2.5 kb band and was clearly visible in 
kidney, but in brain the band was not distinguishable as it is obscured by the broad and 
intense 2.5 kb band.
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Figure 4.12. Northern blot analysis using DIG-labelled RNA probes. A  m u l t i p l e  
t i s s u e  n o r t h e r n  b l o t  w a s  p r e p a r e d  u s i n g  p o l y A +  R N A .  (A) C e n t a u r i n - a 2  ( 5 ’ R A C E  
p r o d u c t ) ;  (B) C e n t a u r i n - a ;  a n d  (C) p - a c t i n .  A d ,  a d i p o s e  t i s s u e ;  B r ,  b r a i n ;  H e ,  h e a r t ;  K i ,  
k i d n e y ;  L i ,  l i v e r ;  L u ,  l u n g ;  M u ,  s k e l e t a l  m u s c l e ;  S p ,  s p l e e n  a n d  T e ,  t e s t i s .  R N A  
m o l e c u l a r  w e i g h t  m a r k e r s  w e r e  s e p a r a t e d  a l o n g s i d e  t h e  s a m p l e s  a n d  t h e  s i z e s  o f  t h e  
















Figure 4.13. Migration curve of RNA molecular weight markers. T h e  l o g a r i t h m  
o f  t h e  t r a n s c r i p t  s i z e  w a s  p l o t t e d  a g a i n s t  t h e  m i g r a t i o n  d i s t a n c e  ( m m )  f o r  t h e  R N A  
m o l e c u l a r  w e i g h t  m a r k e r s .  T h e  s i z e  o f  m R N A  t r a n s c r i p t s  w a s  e x t r a p o l a t e d  f o r  t h e  
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Figure 4.14. Graphical representation of rat centaurin-a2 tissue distribution.
D e n s o m e t r i c  a n a l y s i s  o f  t h e  P - a c t i n  a n d  c e n t a u r i n - a 2  s i g n a l  i n t e n s i t i e s  w e r e  u s e d  t o  
c a l c u l a t e  t h e  n o r m a l i s e d  t i s s u e  d i s t r i b u t i o n  f o r  t h e  e x p r e s s i o n  o f  t h e  c e n t a u r i n - a 2
4 . 0  k b  m R N A  t r a n s c r i p t .  F o r  e a c h  t i s s u e  t h e  r e l a t i v e  a b u n d a n c e  o f  c e n t a u r i n - a 2  
e x p r e s s i o n  w a s  e x p r e s s e d  a s  a  p e r c e n t a g e  o f  t h e  m a x i m u m  a b u n d a n c e  v a l u e  ( l i v e r ) .  
T h e  v a l u e s  a r e  t h e  m e a n s  ±  S . E . M  ( n = 2 ) .
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4.3 Western Blotting Analysis of the Tissue Distribution and 
Subcellular Localisation of the Centaurin-a2 Protein
In order to investigate the tissue distribution and subcellular localisation o f the 
centaurin-a2 protein, anti-centaurin-a2 antibodies were raised. A fourteen amino acid 
peptide, corresponding to the C-terminus o f  the PH-C domain o f  rat centaurin-a2 
(.Figure 4.15), was coupled to ovalbumin and used to immunise two rabbits. First bleed 
antisera samples were taken 38 days after the initial immunisation and the final bleed 
samples after 94 days.
Preliminary western blot analysis examining the first bleed antisera was performed as 
described in Section 2.4.6 , with the inclusion o f  0.1% (v/v) Tween-20 in the TBS buffer. 
The antisera from both rabbits appeared to recognise numerous proteins ranging in size, 
which were absent from the pre-immune sera blots {Figure 4.16). The full-length 
sequence o f  centaurin-a2 was still unknown at this time, thus preventing prediction o f  
the molecular weight, although this was expected to be similar to that o f  the 
centaurin-a 1 proteins (42-46 kDa).
4.3.1 Affinity Purification of the Antisera
In an attempt to increase the specificity o f  the anti-centaurin-a2 antisera, affinity 
purification was performed using the immunising peptide coupled to a column matrix 
{Section 2.4.5). Western blots containing samples o f  the four subcellular fractions (20 
pg protein) in duplicate were used to compare the antisera before and after purification 
{Figure 4.17). Affinity purification appeared to reduce the non-specific binding quite 
considerably, however several protein bands o f  varying sizes were still detected. The 
most prominent band detected by both antisera (rabbits A  and B) at approximately 100 
kDa was present in all subcellular fractions. In addition, antiserum B detected a 
cytosolic protein o f approximately 35 kDa and two intense bands at 43 and 56 kDa in 
the PM and HDM fractions {Figure 4.17). These latter two bands were also detected 
with antiserum A, although the intensity was much weaker.
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MGDRERNKKR LLELLQAAGT GNGHCADCGA ADPDWASYKL GVFICLHCSG 50
VHRNFPDISK VKSMRLDFWD DSMVEFMTHN GNLSVKAKFE ARVPTFYYVP 100
QASDCLVLKE QWIRAKYERQ EFMAEKAVSP PGDREGFLWK RGRDNSQFLR 150
RRFVLLSREG LLKYYTKEEG KTPKAIINIK DLNATFQTEK IGHPHGLQIT 200
YRKEGQTRNL FVYHDSGKEI VDWFNALRAA RLQYLKLAFP DLPESELVPL 250
ITRNYLKQGF MEKTGPKHRE PFKKRWFALD PQERRLLYYK NPLDAFEQGQ 300
VFLGSNEQGY EVWEGLPQGI RGNRWKVGLT VITPERKFVF 1CPTEKEQRE 350
WLESLRGVLS SPLSPLHLLT TSAKSG 386
ARF GAP domain PH-N domain PH-C domain Immunising Peptide
Figure 4.15. Amino acid sequence of centaurin-a2 illustrating the position of the 
immunising peptide. A  f o u r t e e n  a m i n o  a c i d  p e p t i d e  l o c a t e d  t o w a r d s  t h e  C - t e r m i n u s  
o f  t h e  P H - C  d o m a i n  o f  c e n t a u r i n - a 2  (CPTEKEQREWLESL) w a s  c o u p l e d  t o  o v a l b u m i n  
a n d  u s e d  f o r  t h e  i m m u n i s a t i o n  o f  t w o  r a b b i t s .  T h e  A R F - G A P  d o m a i n  a n d  P H  d o m a i n s  
a r e  i l l u s t r a t e d  i n  d i f f e r e n t  c o l o u r s .  T h e  n u m b e r s  o f  t h e  a m i n o  a c i d  r e s i d u e s  a r e  i n d i c a t e d  
o n  t h e  r i g h t .
Figure 4.16. Western blot analysis of the first bleed anti-centaurin-a2 antisera.
M u l t i p l e  s a m p l e s  o f  a d i p o c y t e  h o m o g e n a t e  ( 2 0  p g )  w e r e  r e s o l v e d  o n  a  1 0 %  S D S -  
P A G E  g e l  a n d  t r a n s f e r r e d  t o  n i t r o c e l l u l o s e  m e m b r a n e .  F o u r  i d e n t i c a l  m e m b r a n e  s t r i p s  
w e r e  b l o c k e d  i n  5 %  ( w / v )  M a r v e l  i n  T B S - T  f o l l o w e d  b y  a  1 h  i n c u b a t i o n  i n  t h e  
f o l l o w i n g  p r i m a r y  a n t i b o d y  s o l u t i o n s :  (A) f i r s t  b l e e d  a n t i s e r u m  f r o m  r a b b i t  A ,  (A-Pi) 
p r e i m m u n e  s e r u m  f r o m  r a b b i t  A ,  (B) a n d  (B-Pi) f r o m  r a b b i t  B .  A l l  f o u r  a n t i s e r u m  
s o l u t i o n s  w e r e  a t  a  f i n a l  d i l u t i o n  o f  1 : 2 , 0 0 0  i n  1 %  B S A - T B S - T .  D e t e c t i o n  w i t h  
a n t i - r a b b i t  I g G  a n d  E C L  r e a g e n t  w a s  p e r f o r m e d  a s  d e s c r i b e d  i n  S e c t i o n  2 . 4 . 6 .  T h e  
p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
1 0 0
Antiserum A p i n a l  B l e e d  A f e  A f f i n i t y  P u r i f i e d









116 k D a___
97 kDa —  
66 kDa —
56 kDa —  
43 kDa —  
37 k D a ___
27 k D a___
F i n a l  B l e e d  A b  A f f i n i t y  P u r i f i e d  
P M  H D M  L D M  C Y T  P M  H D M  L D M  C Y T
Figure 4.17. Western blot comparing anti-centaurin-a2 antisera before and after 
affinity purification. T h e  t w o  a n t i - c e n t a u r i n - a 2  a n t i s e r a  w e r e  a f f i n i t y  p u r i f i e d  u s i n g  a  
c o l u m n  c o m p o s e d  o f  t h e  i m m u n i s i n g  p e p t i d e  c o u p l e d  t o  R e a c t i - G e l  s u p p o r t  m a t r i x .  
A d i p o c y t e  s u b c e l l u l a r  f r a c t i o n s  ( 2 0  p g )  w e r e  r e s o l v e d  o n  d u p l i c a t e  1 0 %  S D S - P A G E  
g e l s  a n d  t r a n s f e r r e d  t o  n i t r o c e l l u l o s e .  P M ,  p l a s m a  m e m b r a n e ;  H D M ,  h i g h - d e n s i t y  
m i c r o s o m e s ;  L D M ,  l o w - d e n s i t y  m i c r o s o m e s ;  C Y T ,  c y t o s o l i c  f r a c t i o n .  W e s t e r n  b l o t  
a n a l y s i s  w a s  p e r f o r m e d  a s  d e s c r i b e d  {Section 2.4.6)  u s i n g  t h e  f i n a l  b l e e d  a n t i s e r a  
( 1 : 4 , 0 0 0  d i l u t i o n )  a n d  t h e  r e s p e c t i v e  a f f i n i t y  p u r i f i e d  a n t i s e r a  ( 1 : 1 , 0 0 0  d i l u t i o n )  i n  1 %  
B S A - T B S - T .  T h e  p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
1 0 1
Identification o f  the full-length centaurin-oc2 cDNA encoding the 396 amino acids 
allowed the predicted molecular mass to be calculated at 43.6 kDa, which was a very 
similar size to a band that was observed in the PM and HDM fractions {Figure 4.17). 
The absence o f centaurin-a2 from the cytosolic fraction was quite unexpected as 
western blot analysis o f  centaurin-a and the centaurin-a 1 proteins revealed its presence 
in both the soluble and membranous fractions (Hammonds-Odie et al. 1996; Strieker et 
al. 1997). The HES buffer used in the subcellular fractionation o f adipocyte cells had a 
relatively low salt content (20 mM HEPES) which may have affected the centaurin-a2 
distribution during the subcellular fractionation procedure. In order to investigate this 
hypothesis a KC1 buffer (100 mM KC1, 20 mM NaCl, 10 mM HEPES/NaOH, pH 7.0, 1 
mM EDTA) was used in place o f  the HES buffer during the fractionation o f basal and 
insulin-stimulated adipocyte cells. The alteration to the buffer composition did not 
appear to affect the subcellular distribution o f centaurin-a2. It was detected in the PM 
fractions and was absent from the both the LDM and cytosol {Figure 4.18). SDS- 
PAGE was performed using a large gel allowing greater resolution between protein 
bands and only the region approximately 10 kDa above and below the 45 kDa 
centaurin-a2 band was processed.
4.3.2 Optimisation of Western Blotting Conditions for Centaurin-a2 
Antisera
A number o f  modifications were made to the western blotting protocol in an attempt to 
increase the binding specificity o f the purified antisera. These included altering the 
blocking stage by replacing 5% (w/v) Marvel with varying dilutions o f  BSA, changing 
the dilutions o f the primary and secondary antibodies and the solutions in which they 
were diluted. None o f these alterations significantly improved the blotting results (data 
not shown). Finally the omission o f Tween-20 from the TBS buffer at all stages o f  the 
western blot development was found to have a remarkable effect. Virtually all non­
specific binding was removed, resulting in the detection o f only a single protein band o f  
approximately 45 kDa {Figure 4.19). All subsequent western blots were performed 
without the non-ionic detergent Tween-20 in the TBS buffer.
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C r u d e  P M  L D M  C Y T
B  I  B  I  B  I
56 kDa —
Figure 4.18. Western blot analysis of adipocyte subcellular fractions prepared 
using KC1 buffer instead of HES buffer. S u b c e l l u l a r  f r a c t i o n s  w e r e  p r e p a r e d  f r o m  
b a s a l  a n d  i n s u l i n - s t i m u l a t e d  a d i p o c y t e s  u s i n g  K C 1  b u f f e r  ( 1 0 0  m M  K C 1 ,  2 0  m M  N a C l ,  
1 0  m M  H E P E S / N a O H ,  p H  7 . 0 ,  1 m M  E D T A )  i n  p l a c e  o f  H E S  b u f f e r  ( 2 0  m M  H E P E S ,  
p H  7 . 4 ,  1 m M  E D T A ,  2 5 5  m M  s u c r o s e ) .  F r a c t i o n s  ( 2 0  p g )  w e r e  r e s o l v e d  o n  a  l a r g e  
1 0 %  S D S - P A G E  g e l .  W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  u s i n g  a f f i n i t y  p u r i f i e d  a n t i s e r u m  
B  d i l u t e d  1 : 1 0 , 0 0 0  i n  1 %  B S A - T B S - T .  C r u d e  P M ,  p l a s m a  m e m b r a n e ;  L D M ,  l o w -  
d e n s i t y  m i c r o s o m e s ;  a n d  C Y T ,  c y t o s o l i c  f r a c t i o n .  T h e  p o s i t i o n s  o f  t h e  m o l e c u l a r  
w e i g h t  m a r k e r s  a r e  s h o w n .







Figure 4.19. Effect of Tween-20 on western blotting with purified centaurin-a2 
antisera. T h e  a d i p o c y t e  t o t a l  p a r t i c u l a t e  f r a c t i o n  w a s  g e n e r a t e d  b y  c e n t r i f u g a t i o n  a t
5 4 1 , 0 0 0  x  g  f o r  3 0  m i n .  D u p l i c a t e  s a m p l e s  ( 2 0  p g )  w e r e  r e s o l v e d  o n  a  s m a l l  1 0 %  
S D S - P A G E  g e l .  F o l l o w i n g  t r a n s f e r  t o  n i t r o c e l l u l o s e ,  t h e  b l o t  w a s  d i v i d e d  a n d  t h e  t w o  
h a l v e s  p r o c e s s e d  i n  p a r a l l e l .  O n e  b l o t  w a s  p r o c e s s e d  a s  n o r m a l  ( + T w )  a n d  t h e  s e c o n d  i n  
t h e  a b s e n c e  o f  T w e e n - 2 0  f r o m  a l l  s t a g e s  ( - T w ) .  W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  u s i n g  
a f f i n i t y  p u r i f i e d  a n t i s e r u m  B  w a s  d i l u t e d  1 : 1 , 0 0 0  i n  1 %  B S A - T B S  ( + / - T w e e n - 2 0 ) .  T h e  
p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
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4.3.3 Tissue Distribution of the Centaurin-a2 Protein
Homogenates from adipose tissue, brain, heart, kidney, liver, lung and skeletal muscle 
were separated into total particulate and cytosolic fractions {Section 2.5.3). These 
fractions (20 pg) were then separated on a large 10% SDS-PAGE gel. Centaurin-a2 
was detected in the particulate fractions o f  all tissues tested {Figure 4.20) with highest 
abundance in heart, adipose tissue and skeletal muscle. Recombinantly expressed 
6xHis-tagged centaurin-a2 {see Section 5.2) was resolved alongside the tissue 
subcellular fractions as a positive control. This protein has a hexa-histidine tag on the 
N-terminus making the molecular weight slightly larger than that o f  native centaurin-a2 
at 45.7 kDa. Centaurin-a2 was not detected in any o f  the cytosolic fractions, even with 
extensive periods o f  exposure to film.
In adipose tissue, the total protein content isolated from the particulate and cytosolic 
fractions was calculated to have a ratio o f  approximately 1:1. However this ratio differs 
between tissues. Consequently the total protein was measured for the particulate and 
cytosolic fractions isolated from each tissue and the ratios calculated. A second western 
blot was performed with the protein o f  the particulate and cytosolic fractions loaded in 
the proportions representative o f the cellular distribution o f  each tissue. Nevertheless, 
the centaurin-a2 band was still not detected in the any o f the cytosolic fractions (data 
not shown).
4.3.4 Subcellular Localisation of Centaurin-a2 in Rat Adipocyte 
Subcellular Fractions
Subcellular fractions were previously used to examine the efficiency o f  antibody 
purification {Section 4.3.1) and although the quality o f  these blots was poor due to the 
inclusion o f  Tween-20, bands o f approximately 43 kDa were still discernible {Figure 
4.17). This band was present in the PM, HDM and LDM, but was not detected in the 
cytosolic fraction. However, when repeated without Tween-20 a weak centaurin-a2 
band was evident in PM upon long exposure to film {Figure 4.21), and no signal was 
detected in the HDM, LDM and cytosol fractions. The positive control (recombinant 
centaurin-a2) was clearly visible and hence the detection reaction was successful.
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W T  A d  B r  H e  K i  L i  L u  M u  
T m  C y t  T m  C y t  T m C y t  T m  C y t  T m  C y t  T m  C y t  T m  C y t
45 kDa
Figure 4.20. Western blot analysis of the tissue distribution of centaurin-a2 
protein expression. T o t a l  p a r t i c u l a t e  a n d  c y t o s o l i c  f r a c t i o n s  w e r e  p r e p a r e d  f r o m  t i s s u e  
h o m o g e n a t e s  b y  c e n t r i f u g a t i o n  a t  5 4 1 , 0 0 0  x  g  f o r  3 0  m i n .  T h e s e  f r a c t i o n s  ( 2 0  p g )  w e r e  
r e s o l v e d  o n  a  l a r g e  1 0 %  S D S - P A G E  g e l .  R e c o m b i n a n t  w i l d - t y p e  c e n t a u r i n - a 2  ( W T ;  
2 5 0  n g )  w a s  r e s o l v e d  a l o n g s i d e  t h e  t i s s u e  s a m p l e s  p r o v i d i n g  a n  i n d i c a t i o n  o f  s i z e  a s  
w e l l  a s  b e i n g  a  p o s i t i v e  c o n t r o l .  A d ,  a d i p o s e  t i s s u e ;  B r ,  b r a i n ;  H e ,  h e a r t ;  K i ,  k i d n e y ;  L i ,  
l i v e r ;  L u ,  l u n g ;  M u ,  s k e l e t a l  m u s c l e .  W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  i n  t h e  a b s e n c e  o f  
T w e e n - 2 0  u s i n g  a f f i n i t y  p u r i f i e d  a n t i s e r u m  B  w a s  d i l u t e d  1 : 5 0 0  i n  1 %  B S A - T B S .
W T  P M  H D M  L D M  C Y T  
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Figure 4.21. Western blot analysis of subcellular distribution of centaurin-a2 in 
rat adipocytes. S u b c e l l u l a r  f r a c t i o n s  w e r e  p r e p a r e d  a s  d e s c r i b e d  i n  Section  2 . 5 . 2 .  T h e  
f r a c t i o n s  ( 2 0  p g )  w e r e  r e s o l v e d  o n  a  s m a l l  1 0 %  S D S - P A G E  g e l .  W e s t e r n  b l o t t i n g  w a s  
p e r f o r m e d  i n  t h e  a b s e n c e  o f  T w e e n - 2 0  u s i n g  a f f i n i t y  p u r i f i e d  a n t i s e r u m  B  w a s  d i l u t e d  
1 : 5 0 0  i n  1 %  B S A - T B S .  P M ,  p u r i f i e d  p l a s m a  m e m b r a n e ;  H D M ,  h i g h - d e n s i t y  m i c r o ­
s o m e s ;  L D M ,  l o w - d e n s i t y  m i c r o s o m e s ;  C Y T ,  c y t o s o l i c  f r a c t i o n .  T h e  p o s i t i o n s  o f  t h e  
m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
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As centaurin-oc2 was abundant in the particulate fraction o f  adipocytes we expected this 
protein to be present in at least one o f the membranous fractions generated by the 
subcellular fractionation. The absence o f  centaurin-a2 signal might be explained by 
protein degradation during the longer procedure required for the full subcellular 
fractionation. Alternatively centaurin-a2 could be displaced from the membrane and 
discarded during the purification o f  the plasma membrane fraction. To investigate these 
possibilities further, another adipocyte subcellular fractionation was performed, and 
every component was retained for analysis.
In all the previous adipocyte subcellular fractionations the pellet resulting from the 
sucrose cushion centrifugation {Figure 2.2, centrifugation step d) was discarded. 
However, this pellet was retained and resuspended in HES buffer. The supernatant was 
transferred to a new tube and processed as normal with the addition o f  more HES buffer 
to a final volume o f 3 ml and centrifugation as described {Figure 2.2, centrifugation 
step e). The supernatant from this step was normally discarded and the pellet 
resuspended in HES buffer and centrifugation repeated. The resulting supernatant from 
the two centrifugation steps e and f  {Figure 2.2) were combined and centrifuged for 30 
min at 541,000 x g. The resulting pellet was resuspended in HES buffer. All fractions 
(20 pg protein) were resolved on a 10% SDS-PAGE gel for analysis by western 
blotting. Centaurin-a2 was detected in two fractions, the crude plasma membrane and 
the pellet recovered from the sucrose cushion centrifugation step, but not in the purified 
plasma membrane {Figure 4.22).
In order to examine the interaction o f centaurin-a2 with components o f  the sucrose 
cushion pellet fraction, aliquots o f this fractions were incubated in HES buffer 
containing a number o f  reagents, such as 1% Triton which is used to solubilise 
membranes. Incubation was performed on ice for 1 h (DNase sample incubated at 
37°C) before centrifugation at 17,500 x g for 20 min. Centaurin-a 1 proteins are known 
to bind Ins 1,3,4,5-P4, similarly our investigations have shown Ins 1,3,4,5-P4 to interact 
with the PH-N domain o f  centaurin-a2 {Section 5.4), thus Ins 1,3,4,5-P4 was added to 
one o f the samples at a final concentration o f 10 pM. High salt concentration (1M 
NaCl) was also tested as this was reported to dissociate porcine p42IP4 from the 
membrane fraction (Strieker et al. 1997). Histocytochemical evidence and confocal 
microscopy indicated that PEP3-BP and human centaurin-a 1 are expressed in the
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nucleus and cytosol (Tanaka et al. 1999; Venkateswarlu and Cullen 1999). To 
investigate the possible DNA interaction o f centaurin-a2, DNasel in 5 mM MgCh was 
added. The western blot showed that 1% Triton caused dissociation o f centaurin-a2 
from the sucrose cushion pellet fraction {Figure 4.23), however the other conditions 
tested had no detectable effect.
4.3.5 Comparison of (3-tubulin and Glut4 Subcellular Localisation 
with that of Centaurin-a2
The first o f  the confocal microscopy images using the centaurin-a2 antibody revealed a 
staining pattern similar to that reported for microtubules in cardiomyocytes (Park et a l  
1984) {Section 4.4; Figure 4.26). To ascertain the distribution o f  the microtubules in 
adipocyte subcellular fractions, western blot analysis was performed using monoclonal 
anti-P-tubulin antibodies. The intense p-tubulin band in the cytosolic fraction might 
result from the detection o f  unpolymerised monomers {Figure 4.24).
The distribution o f Glut4 in adipocyte subcellular fractions has been well documented 
(Weber et al. 1988), however we used anti-Glut4 antibodies to test for the presence o f  
this integral membrane protein in the sucrose cushion pellet. Plasma membrane 
samples isolated from basal and insulin-treated adipocytes were included as controls to 
demonstrate the increase in Glut4 at the PM following insulin-stimulation {Figure 4.25). 
A concurring decrease o f Glut4 in the LDM would normally be observed, however the 
HDM, LDM and cytosol fractions were not separated in order to reduce the time 
required for the fractionation procedure. The 45 kDa Glut4 band was not detected in the 
sucrose cushion pellet fraction on the film shown {Figure 4.25), but a faint band was 
visible on an overexposed film (data not shown). An intense Glut4 band was detected 
in the wash pellet fraction. However, it is important to note that an equal amount o f  
protein (20 pg) was loaded for each fraction on the gel, hence the protein ratios are not 
representative o f cellular conditions.
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Figure 4.22. All components of the adipocytes subcellular fractionation were 
analysed using western blot analysis with anti-centaurin-a2. R a t  a d i p o c y t e s  w e r e  
f r a c t i o n a t e d  i n  t h e  n o r m a l  w a y  {Section 2.5.2). I n  a d d i t i o n  t o  t h e  f o u r  s u b c e l l u l a r  
f r a c t i o n s  (PM, p u r i f i e d  p l a s m a  m e m b r a n e ;  HDM, h i g h - d e n s i t y  m i c r o s o m e s ;  LDM, 
l o w - d e n s i t y  m i c r o s o m e s ;  CYT, c y t o s o l )  a n  a l i q u o t  o f  t h e  c r u d e  p l a s m a  m e m b r a n e  
p e l l e t  (cPM), t h e  s u c r o s e  c u s h i o n  p e l l e t  (SP) a n d  t h e  p e l l e t  f r o m  t h e  p l a s m a  m e m b r a n e  
w a s h e s  (WP) w e r e  r e t a i n e d .  C e l l u l a r  f r a c t i o n s  ( 2 0  p g )  a n d  2 5 0  n g  r e c o m b i n a n t  
w i l d - t y p e  c e n t a u r i n - a 2  w e r e  r e s o l v e d  o n  a  1 0 %  S D S - P A G E  g e l .  W e s t e r n  b l o t t i n g  w a s  
p e r f o r m e d  i n  t h e  a b s e n c e  o f  T w e e n - 2 0  u s i n g  a f f i n i t y  p u r i f i e d  a n t i s e r u m  B  w a s  d i l u t e d  
1 : 5 0 0  i n  1 %  B S A - T B S .  T h e  p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .  
R e s u l t s  a r e  f r o m  a  s i n g l e  e x p e r i m e n t
P a r t i c u l a t e  P e l l e t  S u p e r n a t a n t




Figure 4.23. Analysis of the sucrose cushion pellet. T h e  i n t e r a c t i o n  o f  c e n t a u r i n - a 2  
w i t h  t h e  s u c r o s e  c u s h i o n  p e l l e t  w a s  a s s e s s e d  b y  i n c u b a t i n g  t h e  r e s u s p e n d e d  p e l l e t  w i t h  
d i f f e r e n t  r e a g e n t s .  (1) c o n t r o l ,  u s i n g  w a t e r  i n  p l a c e d  o f  r e a g e n t ,  (2) 1 0  p M  I n s
1 , 3 , 4 , 5 - P 4 ,  (3) 1 M  N a C l ,  (4) 1% T r i t o n  a n d  (5) D N a s e l  i n  5  m M  M g C l 2 . T h e s e  r e a g e n t s  
w e r e  a d d e d  t o  t h e  p r o t e i n  f r a c t i o n  t o  g i v e  t h e  f i n a l  c o n c e n t r a t i o n s  i n d i c a t e d .  T h e  
r e a c t i o n s  w e r e  i n c u b a t e d  o n  i c e  f o r  1 h ,  w i t h  t h e  e x c e p t i o n  o f  r e a c t i o n  5  w h i c h  w a s  
i n c u b a t e d  a t  2 5 ° C .  A l l  r e a c t i o n s  w e r e  c e n t r i f u g e d  a t  1 7 , 5 0 0  x  g  f o r  2 0  m i n  a n d  t h e  p e l l e t  
w a s  r e s u s p e n d e d  i n  H E S  b u f f e r  t o  a  f i n a l  v o l u m e  o f  5 0  p i .  T h e  s u p e r n a t a n t ,  p e l l e t  
f r a c t i o n s  a n d  2 5 0  n g  r e c o m b i n a n t  w i l d - t y p e  c e n t a u r i n - a 2  w e r e  r e s o l v e d  o n  a  1 0 %  
S D S - P A G E  g e l .  W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  i n  t h e  a b s e n c e  o f  T w e e n - 2 0  u s i n g  
a f f i n i t y  p u r i f i e d  a n t i s e r u m  B  w a s  d i l u t e d  1 : 5 0 0  i n  1 %  B S A - T B S .  T h e  p o s i t i o n s  o f  t h e  





Figure 4.24. Western blot analysis of (3-tubulin in adipocytes subcellular fractions.
R a t  a d i p o c y t e s  w e r e  f r a c t i o n a t e d  i n  t h e  n o r m a l  w a y  (Section 2.5.2). T h e  f o u r  s u b c e l l u ­
l a r  f r a c t i o n s  ( P M ,  H D M ,  L D M  a n d  c y t o s o l )  a n d  t h e  a d d i t i o n a l  f r a c t i o n s  ( c r u d e  P M  
p e l l e t ;  s u c r o s e  c u s h i o n  p e l l e t ;  w a s h  p e l l e t  f r o m  t h e  p l a s m a  m e m b r a n e  w a s h e s )  w e r e  
r e s o l v e d  o n  a  1 0 %  S D S - P A G E  g e l  ( 2 0  p g  o f  e a c h  f r a c t i o n ) .  W e s t e r n  b l o t t i n g  w a s  
p e r f o r m e d  u s i n g  ( 3 - t u b u l i n  m o n o c l o n a l  a n t i b o d y  d i l u t e d  1 : 1 , 0 0 0  i n  0 . 2 %  B S A - T B S .  
T h e  p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
Figure 4.25. Western blot analysis o f GIut4 distribution in rat adipocytes subcellu­
lar fractions. T h e  p l a s m a  m e m b r a n e  ( P M )  s a m p l e s  f r o m  t h e  b a s a l  a n d  i n s u l i n -  
s t i m u l a t e d  a d i p o c y t e s  s h o w n  t h e  i n c r e a s e d  l e v e l s  o f  G l u t 4  i n  t h e  i n s u l i n - s t i m u l a t e d  P M  
s a m p l e .  A  s e p a r a t e  s u b f r a c t i o n a t i o n  o f  b a s a l  a d i p o c y t e s  w a s  p e r f o r m e d  a n d  o m i t t i n g  
c e n t r i f u g a t i o n  s t e p s  b  a n d  c  s o  t h a t  t h e  H D M ,  L D M  a n d  c y t o s o l  r e a m i n e d  i n  a  s i n g l e  
f r a c t i o n  {Figure 2.4). A  s a m p l e  o f  t h e  c r u d e  p l a s m a  m e m b r a n e  w a s  r e t a i n e d .  T h e  
s u c r o s e  c u s h i o n  p e l l e t  w a s  i n v e s t i g a t e d  a s  w a s  t h e  w a s h  p e l l e t  f r o m  t h e  p u r i f i c a t i o n  o f  
t h e  p l a s m a  m e m b r a n e .  A l l  f r a c t i o n s  ( 2 0  p g )  w e r e  r e s o l v e d  o n  a  1 0 %  S D S - P A G E  g e l .  
W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  u s i n g  a f f i n i t y  G l u t 4  a n t i b o d y  d i l u t e d  1 : 4 , 0 0 0  i n  1 %  
B S A - T B S - T .  T h e  p o s i t i o n s  o f  t h e  m o l e c u l a r  w e i g h t  m a r k e r s  a r e  s h o w n .
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4.4 Subcellular Localisation of Centaurin-a2 in Rat 
Cardiomyocytes as Revealed by Confocal Microscopy
Due to its high level o f expression in heart, the subcellular localisation o f  centaurin-a2 
in isolated cardiomyocytes was investigated using immunofluroescence microscopy. In 
preliminary experiments cardiomyocytes were fixed by incubation in 4% 
paraformaldehyde {,Section 2.4.7), followed by permeabilisation with 0.1% saponin. 
Cells were incubated with purified rabbit anti-centaurin-a2 antibodies for 1 h, and then 
washed extensively before incubation with fluorescein-conjugated anti-rabbit 
antibodies. Following this incubation the cells were washed again, mounted and viewed 
using a Zeiss laser scanning microscope. Control samples, with the omission o f the 
primary antibodies, were performed in parallel to examine the non-specific staining o f  
the secondary antibodies (data not shown). The settings were optimised to yield distinct 
staining for the centaurin-a2 antibody and all subsequent images were captured using 
these settings. The depth o f  field at which the image was captured was also kept 
constant so that the image contained the sectional plane o f  the cell with the nuclei 
clearly visible. Over 80% o f rat cardiomyocytes are binucleate (Dow et al. 1981), and 
the two nuclei are clearly visible in the cells visualised using the transmissible lens 
{Figure 4.26, A). No centaurin-a2 staining was detected in the nuclei, which were 
clearly discernible as two black circular areas {Figure 4.26, B). Centaurin-a2 displayed 
punctate staining in a pattern that followed the striations o f  the myofibrils and was 
concentrated in the region extending longitudinally from the poles o f  the nuclei through 
the length o f  the cell.
4.4.1 Dual Labelling of Centaurin-a2 and p-tubulin
To further investigate the possible interaction with microtubules, the distribution o f  
centaurin-a2 and P-tubulin in cardiomyocytes was analysed by confocal microscopy. 
Dual labelling was performed with monoclonal mouse anti-p-tubulin antibodies and the 
purified anti-centaurin-a2 antiserum. Rhodamine-conjugated anti-mouse antibodies 
were used to detect the P-tubulin antibodies. Examination o f the cells revealed the 




Figure 4.26. Indirect immunofluorescence analysis of centaurin-a2 distribution in 
cardiomyocytes. Isolated rat cardiomyocytes were fixed in 4% paraformaldehyde and 
permeabilised with 0.1% saponin. Cells were incubated with rabbit anti-centaurin-a2 
antibodies (affinity purified antiserum B, 1:60 final dilution) for 1 h, which was then 
detected using fluorescein-conjugated anti-rabbit polyclonal antibodies. (A) Image 




Figure 4.27. Indirect immunofluorescence analysis of centaurin-a2 and p-tubulin 
distribution in cardiomyocytes. Isolated rat cardiomyocytes were fixed in 4% 
paraformaldehyde and permeabilised with 0.1% saponin. Cells were incubated with 
rabbit anti-centaurin-a2 antibodies (affinity purified antiserum B, 1:60 final dilution) 
and monoclonal anti-p-tubulin antibodies (1:220 final dilution). The primary antibodies 
were detected using anti-rabbit and anti-mouse polyclonal antibodies coupled to fluo­
rescein and rhodamine, respectively. (A) Cross section through the centre o f  the cell, 
two nuclei visible; (B) section at the surface o f the same cell. The results shown are 
representative o f 10 cells selected at random.
1 1 2
located throughout the cell as expected. Changing the permeabilisation conditions from 
0.1% saponin to incubation in methanol at -20°C (Section 2.4.7) appeared to improve 
the penetration o f the p-tubulin antibodies, without affecting the staining o f  the 
centaurin-a2 antibodies. Although the pattern o f  p-tubulin staining observed was very 
similar to that o f centaurin-a2, the dual labelling showed only limited co-localisation 
(Figure 4.28, A and B). No staining was detected in the negative control that tested the 
non-specific binding o f the two secondary antibodies (Figure 4.28, C and D)
4.4.2 The Effect of Insulin-Stimulation and Colchicine Treatment on 
the Distribution of Centaurin-a2
Previous confocal immunofluorescence studies performed on cardiomyocytes in our 
laboratory by Dr A Gillingham, revealed that in the basal state, Glut4 was located in 
latitudinal striations with intense staining concentrated in the perinuclear region (TGN). 
Although both Glut4 and centaurin-a2 staining patterns are punctate, the distributions 
appear to be quite different. Nevertheless the abundance o f  centaurin-a2 in insulin- 
responsive tissues (Section 4.3.3) prompted the investigation o f insulin-stimulation on 
centaurin-a2 distribution. In addition the microtubule depolymerising drug, colchicine, 
was used to investigate the effect o f microtubule network disruption on centaurin-a2 
distribution.
Cardiomyocytes were isolated, left to recover and divided into two aliquots, one 
fraction remained untreated while the other was treated with 2 pM colchicine and both 
were incubated at 37°C for 30 min. The two cell suspensions were further divided, one 
pool from each was left untreated (basal) and the other was stimulated with 30 nM 
insulin for a further 30 min. The four cell suspensions (basal cells ±  colchicine 
treatment and insulin-stimulated cells ± colchicine treatment) were examined using anti- 
centaurin-a2 and anti-p-tubulin antibodies (Figure 4.29).
All images were collected using identical settings on the laser microscope to enable 
direct comparison between the different treatment conditions. Upon comparison o f a 
number o f  cells from each condition it was clear that there was no distinct difference in
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Figure 4.28. Indirect immunofluorescence analysis o f centaurin-a2 and (3-tubulin 
distribution in cardiomyocytes using a modified permeabilisation procedure.
Isolated rat cardiomyocytes were fixed in 4%  paraformaldehyde and permeabilised by 
incubation in methanol at -20°C for 5 min (Section 2.4.7). The cells were then washed 
and incubated with rabbit anti-centaurin-a2 antibodies (affinity purified antiserum B, 
1:60 final dilution) and monoclonal anti-p-tubulin antibodies (1:220 final dilution). The 
primary antibodies were detected using anti-rabbit and anti-mouse polyclonal antibod­
ies coupled to fluorescein and rhodamine, respectively. (A) Dual labelling; (B) higher 
magnification (as indicated by the scale bar); (C) control sample with no primary 
antibodies performed to examine the non-specific staining o f the secondary antibodies, 
(D) same cell as (C) observed with the transmissible lens. The results shown are 




Figure 4.29. Indirect immunofluorescence analysis of centaurin-a2 and [3-tubulin 
distribution following insulin-stimulation and colchicine treatment. Isolated car­
diomyocytes were divided into two cell suspensions, one was left untreated (A and B) 
and the other was treated with 2 pM colchicine (C and D) for 30 min. The two sets o f  
cells were further divided. One sample from each set was left untreated (basal; A and C) 
and the other stimulated with 30 nM insulin (B and D) for an additional 30 min. The 
four groups o f cardiomyocytes were washed and fixed as normal (Section 2.4.7). The 
cells were incubated with rabbit anti-centaurin-a2 antibodies (affinity purified anti­
serum B, 1:60 final dilution) and monoclonal anti-(3-tubulin antibodies (1:220 final 
dilution). Primary antibodies were detected using anti-rabbit and anti-mouse polyclonal 
antibodies coupled to fluorescein and rhodamine, respectively. (A) Basal; (B) insulin- 
stimulated; (C) basal and colchicine-treated; (D) insulin-stimulated and colchicine- 
treated. The results shown are representative o f at least 10 cells selected at random.
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the localisation o f  centaurin-a2 in the basal and the insulin-stimulated cells (.Figure
4.29, A and B). Some o f  the insulin-stimulated cardiomyocytes appeared to have more 
intense centaurin-a2 staining, particularly concentrated in the perinuclear region. 
However this finding was not indicative o f all cells and was not reproducible in repeat 
experiments.
As expected, colchicine appeared to disrupt the microtubule network quite considerably, 
reducing the intensity o f  P-tubulin staining throughout the cell. However, the strong 
staining surrounding the nuclear membrane remained fairly intense {Figure 4.29, C and 
D). The level o f centaurin-a2 and p-tubulin staining varied notably between cells. 
Hence, the selection o f a single cardiomyocyte as a representative o f  the cell population 
was difficult. Consequently two cells o f  differing signal intensities were selected for 
the colchicine treated cardiomyocytes.
In the cells with very weak p-tubulin staining a concomitant reduction in centaurin-a2 
signal was observed, for both the basal and insulin-stimulated cardiomyocytes {Figure
4.29, Ci and Di). In these cells, little or no centaurin-a2 staining was present in the 
region between the nuclei.
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4.5 Discussion
cDNA libraries from a number o f tissues were utilised in the generation o f  the full- 
length centaurin-a2 sequence. The partial centaurin-a2 clone was isolated from an 
adipocyte library, whereas a liver library was used for 5 ’RACE and the full-length clone 
was amplified from adipocyte and brain libraries. Consequently the tissue distribution 
o f centaurin-a2 was expected to be more widespread than that observed for centaurin-a 
and centaurin-al (Hammonds-Odie et al. 1996; Tanaka et al. 1997; Venkateswarlu and 
Cullen 1999). Our prediction was confirmed with the ubiquitous expression o f  the 
centaurin-a2 mRNA transcripts.
The major mRNA transcript (4.0 kb) was larger than that expected for the size o f  the 
centaurin-a2 cDNA clone. The size was considerably greater than the 2.5 kb 
centaurin-a transcript and was more befitting to that expected for the larger 
multidomain centaurin proteins o f the centaurin-p, -8 and -y families. The 4.0 kb 
centaurin-a2 transcript was detected using both the radioactively-labelled partial clone 
(Figure 4.6, A) and the RNA probe (encoding the 5 ’RACE product) with the DIG 
detection system (Figure 4.12, A). In addition the presence o f  an in-frame stop codon in 
the human centaurin-a2 cDNA, located 5’ o f the proposed ATG start codon, 
strengthened the predicted position o f the start codon. Thus, there was no clear 
explanation for the unexpected transcript size apart from the presence o f  a large 5 ’ 
untranslated region that was absent from the centaurin-a2 cDNA clone.
Interestingly a 4.0 kb minor transcript was detected in brain when using the centaurin-a 
probe, as previously reported by Theibert and colleagues (Hammonds-Odie et al. 1996). 
Although the centaurin-a and centaurin-a2 4.0 kb bands were superimposable in brain, 
they displayed distinct tissue distributions and therefore presumably do not result from 
cross-hybridisation o f the two probes. In addition to the 2.5 and 4.0 kb transcripts 
already reported for centaurin-a (Hammonds-Odie et al. 1996), our findings indicated 
an additional minor transcript o f  approximately 3.1 kb (Figure 4.12, B). Minor 
transcripts were not reported for human centaurin-al, which was detected as single 2.5 
kb transcript in brain (at a relatively high level) and peripheral blood leukocytes 
(Venkateswarlu and Cullen 1999). However, on examination o f the published rat
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centaurin-a northern blot (Hammonds-Odie et al. 1996), the 2.5 kb band was rather 
diffuse and might represent unresolved the 2.5 kb and 3.1 kb transcripts.
Although the signal intensity o f  different probes can not be compared directly, it should 
be noted that the centaurin-a2 signal was considerably weaker than centaurin-a. This 
result was seen using the probes from both detection systems. Thus, centaurin-a2 might 
be expressed at relatively low levels, which could explain the difficulty in detecting the 
transcript from total RNA.
In contrast to the tissue distribution o f mRNA, western blot analysis suggested that 
centaurin-a2 protein was highest in the insulin-sensitive tissues o f heart, adipose tissue 
and skeletal muscle, with similar levels o f expression also present in kidney. Consistent 
with the northern blot results, western blot analysis revealed centaurin-a2 expression in 
all o f  the tissues examined, although long exposure period was required for detection in 
lung. Due to the high abundance in brain, centaurin-a and centaurin-al were 
considered to be brain specific. However, Theibert and colleagues reported a 46 kDa 
protein (centaurin-a or related protein) that was specifically photolabelled with 
[3H]BZDC-Ins 1,3,4,5-P4 in the heparin-agarose fractions from the soluble fraction o f  
rat heart (Hammonds-Odie et a l  1996). This protein was absent from the detergent- 
extracted membrane fractions. This was the first evidence o f  a centaurin-a or related 
protein in non-neuronal tissues. However, it is unlikely that this photolabelled band was 
centaurin-a2, as our western blot studies were unable to detect centaurin-a2 in the 
soluble fraction.
Normally the non-ionic detergent Tween-20 is added to the TBS buffer at a final 
concentration o f 0.1% to reduce non-specific, low-affinity binding o f antibodies during 
western blot analysis. Antibodies specifically recognise epitopes and bind to the 
antigen via non-covalent and hydrophobic interactions. Tween-20 appeared to affect 
the binding specificity o f  anti-centaurin-a2. It is plausible that this detergent disrupts 
the paratopes o f  the antibodies, thus increasing the breadth o f specificity o f this primary 
antibody. However, the mechanisms o f  this occurrence remain ambiguous. 
Nevertheless, in the absence o f  Tween-20 the antibody appeared to be highly specific 
recognising a single protein band o f the correct size from total cell homogenates and the 
recombinant 6xHis-centaurin-a2.
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Surprisingly western blot analysis o f adipocyte subcellular fractions revealed 
centaurin-a2 to be concentrated in the pellet at the base o f  the sucrose cushion. The 
distribution o f  the major cellular organelles among the adipocyte subcellular fractions 
have been reported and this pellet was found to consist o f mitochondria, nuclei and cell 
debris (Simpson et al. 1983). Following incubation with the non-ionic detergent Triton 
(1%), which solubilises cellular membranes, centaurin-a2 was detected in the soluble 
fraction. Conditions o f  high ionic strength and DNasel and Ins 1,3,4,5-P4 addition did 
not alter the distribution o f centaurin-a2. These findings indicated that centaurin-a2 
was not retained in this fraction via ionic interaction, association with DNA or by Ins
1,3,4,5-P4 binding. Membrane solubilisation released the centaurin-a2 and therefore a 
nuclear or mitochondrial localisation is plausible. The initial confocal microscopy 
results dismiss the possibility o f nuclear localisation and imply a possible association 
with cytoskeletal elements such as microtubules. The pattern o f centaurin-a2 staining 
resembles the description o f that o f  microtubules in cardiomyocytes which are 
interspersed between the myofibrils and encircle the nucleus (Park et al. 1984). In most 
 ^ animal cells, microtubules radiate from a prominent centrosomal focus, the microtubule 
organising centre. However, striated muscle, such as skeletal muscle and 
cardiomyocytes, possess a circumnuclear distribution o f the microtubule-organising 
centre as seen in Figure 4.29 (Kronebusch and Singer 1987). The Golgi is reported to 
share this circumnuclear distribution and is usually concentrated at the ends or ‘poles’ 
o f the elongated nucleus (Rambourg et al. 1984). However, there was no evidence from 
the western blot results to indicate that p-tubulin fractionates with centaurin-a2. 
Furthermore very little co-localisation o f centaurin-a and p-tubulin was observed in the 
dual-labelling studies. Nevertheless, colchicine treatment did appear to reduce the 
intensity o f  centaurin-a2 staining along with that o f  P-tubulin.
It should be noted however, that the specificity o f  the anti-centaurin-a2 antisera has not 
been verified. It is possible that the centaurin-a2 antisera could interact with other 
proteins o f  similar size to centaurin-a2. The results o f the western blot experiments 
described earlier suggest that the centaurin-a2 antisera does not cross-react with 
centaurin-a or centaurin-al, as bands o f this size were not detected in the cytosolic 
fractions. Nevertheless it cannot be assumed that the centaurin-a2 antisera is specific 
and therefore western blotting and confocal microscopy results described herein may
not represent the true properties o f  endogenous centaurin-a2. Further characterisation 
o f  the antisera would be useful. For example, i f  another antibody raised to a distinct 
region o f  centaurin-a2 was available it might be possible to immunoprecipitate 
centaurin-a2 with one antibody and use the second antibody for verification o f  the 
protein. Alternatively it may be beneficial to perform immunofluorescence microscopy 
studies using cell lines transiently transfected with constructs expressing tagged- 
centaurin-a2.
The various groups that have analysed the distribution for centaurin-a and centaurin-al 
and found them to be both in cytosolic and membrane associated. However, on closer 
examination o f the methods employed, comparison with our results for centaurin-a2 
reveal some interesting similarities and distinctions. Western blot analysis indicated 
that p42IP4 was cytosolic and membrane associated, with a ratio o f 75% o f  the binding 
activity o f  the brain homogenate was present in the particulate fraction and the 
remaining 25% in the soluble fraction (Strieker et a l  1997). However, the preparation 
o f  membranes from pig cerebella homogenate involved four sequential centrifugation 
steps at 100,000 x g for 30 min each. It can therefore be assumed that the nuclei, 
mitochondria and cell debris were present in this membrane pellet. Similarly in the 
assessment o f  rat centaurin-a partitioning, the membrane-associated fraction generated 
from a single centrifugation step at 45,000 x g for 15 min would also contain the nuclei, 
mitochondria and cell debris (Hammonds-Odie et a l  1996). Interestingly use o f  
histocytochemical analysis led to detection o f PIP3-BP in the nucleus o f  neuronal cells 
(Tanaka et a l  1999). In support o f  this finding, the same group showed that in COS-7 
cells transfected with constructs for expression o f  PIP3-BP and constitutively active 
Ptdlns 3-kinase, PIP3-BP was found in the membrane and cytosolic fractions. Whereas 
in the absence o f  the active Ptdlns 3-kinase, PIP3-BP was located in the nucleus 
(Tanaka et a l  1999). Subsequently, confocal microscopy indicated a similar 
distribution pattern for human centaurin-al (Venkateswarlu and Cullen 1999).
A number o f phospholipids including Ptdlns 4-P and Ptdlns 4,5-P2 have been detected 
in the nuclear matrix and membrane along with the enzymes required for synthesising 
and metabolising these compounds. Interestingly Ptdlns 3,4,5-P3 production has also 
been detected by labelling studies in isolated nuclei (reviewed in D'Santos et a l  1998). 
Furthermore, CKIa has been found to be associated with cytosolic vesicles, the mitotic
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spindle and structures within the nucleus (Gross and Anderson 1998). Thus, although 
there is growing evidence to support a possible function for the centaurin-al proteins in 
the nucleus, this does not appear to be analogous with centaurin-a2. Furthermore, in 
contrast to centaurin-al, the subcellular localisation o f  centaurin-a2 did not appear to 
be affected by insulin-stimulation. So despite the conclusion that centaurin-al and 
centaurin-a2 have distinct subcellular distributions, the precise localisation o f  
centaurin-a2 remains unresolved.
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5.0 In v e st ig a t io n  of  th e  B in d in g  Sp e c if ic it y  o f
THE CENTAURIN-a2 PH  DOMAINS
5.1 Introduction
In the endeavour to understand the cellular functions o f  the centaurin-a proteins, several 
experimental approaches have been used to investigate the binding specificity o f  their 
PH domains. For instance the benzophenone photoaffinity label [ H]BZDC-Ins 1,3,4,5- 
P4 was employed by Theibert and colleagues to efficiently label a 46 kDa protein in 
fractionated brain extracts (Hammonds-Odie et al. 1996). Binding specificity was 
determined using displacement o f  the photoaffinity label with increasing concentrations 
o f  unlabelled inositol phosphate or phosphoinositide. Rat centaurin-a was shown to 
have highest affinity for Ptdlns 3 ,4 ,5 -P3, whereas Ins 1 ,3 ,4 ,5 -P4 and Ptdlns 4 ,5 -P2 bound 
with 5- and 12-fold lower affinity, respectively (Hammonds-Odie et al. 1996). An 
alternative approach, the Ins 1 ,3 ,4 ,5 -P4 displacement assay, was used to examine the 
binding specificity o f  native and recombinant p42IP4 (Hanck et al. 1999; Strieker et al. 
1997) and GST-tagged centaurin-al (Venkateswarlu and Cullen 1999). The Ptdlns
3 .4 .5 -P3 analogue column used for the purification o f  PIP3-BP was also utilised to 
investigate its binding specificity (Tanaka et al. 1997). The binding was efficiently 
blocked using Ptdlns 3 ,4 ,5 -P3, but not with Ins 1 ,3 ,4 ,5 -P4 or Ptdlns 4 ,5 -P2 . This finding 
differs from the other centaurin-al proteins, which were found to have high affinity for 
both Ins 1 ,3 ,4 ,5 -P4 and Ptdlns 3 ,4 ,5 -P3 (Strieker et al. 1997; Venkateswarlu and Cullen 
1999).
Mutagenesis studies using PIP3-BP indicated that both PH domains are required for 
binding to the Ptdlns 3 ,4 ,5 -P3 analogue resin (Tanaka et al. 1997). A  conserved 
arginine residue corresponding to that required for Ptdlns 3 ,4 ,5 -P3 binding in the Btk 
PH domain was replaced with a cysteine in each o f  the PH domains o f  PIP3-BP. 
Mutation o f  the equivalent arginine residue in the PH domain G aplm greatly reduced 
binding o f  Ins 1 ,3 ,4 ,5 -P4 (Fukuda and Mikoshiba 1996). More recently, the Ptdlns
3 .4 .5 -P3 dependent recruitment o f GFP-centaurin-al to the plasma membrane was 
reduced by mutagenesis o f  this conserved arginine residue in a single PH domain, while
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mutation o f  both PH domains resulted in complete inhibition (Venkateswarlu et al. 
1999b; Venkateswarlu and Cullen 1999).
Thus far, centaurin-a2 appears to have distinct tissue distribution and subcellular 
localisation from that o f  the centaurin-al proteins and it will be interesting to see if  
these differences are also observed with the binding properties. In order to investigate 
the binding characteristics o f rat centaurin-a2, recombinant protein was expressed using 
the pET15b expression system {Figure 5.1). A 6xHis tag was incorporated onto the N- 
terminus, which enabled simple purification using the Talon Metal Affinity Resin. 
Single point mutations (Arg—»Cys) were introduced into the PH domains o f  
centaurin-a2 using site-directed mutagenesis. These mutated proteins were then utilised 
in Ins 1,3,4,5-P4 competition studies and BZDC-PtdInsPn photolabelling experiments to 
aid investigation o f  the centaurin-a2 PH domains.
5.2 Production of Recombinant Centaurin-a2
5.2.1 Cloning of Centaurin-a2 into pET15b
It was not possible to directly subclone centaurin-a2 DNA from pT7Blue (cloning 
vector) into the pET15b expression vector. Despite the presence o f  Nde I and Bam HI 
sites in suitable positions in both pET15b and pT7Blue, the insert was in the wrong 
orientation for the expression o f  centaurin-a2. Consequently PCR primers were 
designed to amplify centaurin-a2 and incorporate Nde I and Xhol sites at the 5 ’ and 3 ’ 
ends, respectively {Figure 5.1, Q .  Amplification was performed using Advantage 
DNA polymerase and the following cycle parameters; an initial step o f 94°C for 30 sec, 
30 cycles o f 94°C for 30 sec, 60°C for 1 min and 72°C for 4 min, with a final elongation 
step at 72°C for 10 min. Restriction digestion o f the amplified cDNA and the pET15b 
vector, using Ndel and Xhol, generated compatible ends for ligation using T4 DNA  
ligase. The ligation reactions were then transformed into Singles (competent cells from 
the pT7Blue cloning kit). Recombinant clones were selected from which overnight 
cultures were prepared and the purified DNA was then analysed by restriction digestion 




B spL U 11 1(3820)
S a p  1(3704) 
B S I1107  1(3501) 
A cc  1(3590) 
B saA  1(3572) 
T th111  1(3565)
pET-15b
(5708bp)
B slE  11(1397) 
'  A pa 1(1427)
B ssH  11(1627) 
H p a  1(1722)
P sh A  1(2061)
B p u 1 0  1(2926) B s m  1(2704) 
M sc  1(2791)
E a g  1(2284) 
N ru  1(2319) 
B spM  1(2399)
(B)
T7 p ro m o * p r im e r  #69348-3 
►
Bgi II T7 prom oter
<■0* 1C 1 CGA ; CCCGCGAAAT1AATACSAC7CA( 
Nco I Mt**Tag
lac operator Xba  I
(AG6GGAAT7G1 - a c a a t ’ c c c c t c t a g * a a t a a t * r 
Nde I Xho I SamH I
rba
:>rT“ m  ;  r r t AAGAAg g
' A~AC; iTS3GC AGC*‘GCCATC4TCATCA’ Cf- *CACA3C £ 3CGolL T3G ■ GCCGC3C3GCA6CC A 5 A 'GCTCGAGGA TCCSGCTGC r AAC AAAQCCCGA
i , - i - -
8 p t / n 0 2 1 thrombin 77 term inator
A AG&AA6C ‘ j Ao  ' ’ fiGC *GCTGCCACCG." 'GA3CAATAAC TAGUAT*ACCCC7’ 63GGCCTCT AAACGS6T'  ' 1SAG6GGT1 T 1 
• s G l v *  : afi i  t : <jA I o A ; i nr A ‘ oG I -G i r>£f>0




5’ GAG CA4T ATG GGC GAC CGT GAA CGC AAC AAG 3 ’
Ndel M G D R R N K
Reverse
Primer
5’ GAG CT^CGAG TCA GCC ACT CTT TGC TGA TGT GGT 3’ 
Xhol Stop antisense coding region o f centaurin-a2
Figure 5.1. The cloning of rat centaurin-a2 into the pET15b expression vector.
(A) Vector map o f pET15b; (B) pET15b cloning/expression region; and (C) the 
sequences o f the primers used to amplify and incorporate the Ndel site ( C A ^ T A T G )  and 
Xhol site ( G A G C T ^ C )  onto the 5’ and 3’ ends o f centaurin-a2. The start methionine 
residue (ATG) and the stop codon (antisense o f TGA) are shown in bold. The vector 
map and cloning region diagrams were reproduced with the kind permission o f  
Novagen, Inc.
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5.2.2 Introduction of Point Mutations in the cDNA
The conserved arginine o f  the PH-N and PH-C domains o f centaurin-a2 (residues 151 
and 275) were mutated to cysteine residues using the method employed by the 
QuikChange Site-Directed Mutagenesis Kit {Section 2.2.6; Figure 5.2, A). 
Oligonucleotide primers, each complementary to opposite strands o f  the double­
stranded centaurin-a2 DNA were designed to contain the desired point mutations, 
R151C and R275C {Figure 5.2, B). The purified pET15b-centaurin-a2 recombinant 
plasmid was used as template DNA in the PCR reaction. Each o f  the primers annealed 
to the template and was extended during thermal cycling using P/wTurbo DNA  
polymerase. Following temperature cycling, treatment with Dpnl digested the parental 
strand leaving the mutated plasmid. The amplified DNA was examined by agarose gel 
electrophoresis revealing a band o f  the expected size (approximately 6.9 kb; Figure 
5.3). Following transformation into XLl-Blue competent cells the nicks in the mutated 
plasmid are repaired by the E.coli cells.
Plasmid DNA was purified and sequenced to confirm the introduction o f  the desired 
point mutation. A  fraction o f  the R151C plasmid DNA was then subjected to a second 
round o f mutagenesis (R275C) to generate centaurin-a2 containing point mutations in 
both PH domains (R151C/R275C).
5.3 Expression and Purification of Recombinant 6xHis- 
Centaurin-a2 Proteins
The plasmid DNA o f the four centaurin-a2 pET15b constructs, wild-type (non 
mutated), R151C (arginine—»cysteine mutation in PH-N domain), R275C 
(arginine-»cysteine mutation in PH-C domain) and R151C/R275C (arginine—^ cysteine 
mutation in both PH domains) was purified. These constructs were then transformed 
into the E.coli strain BL21(DE3)pLysS. These cells contain a chromosomal copy o f the 
gene for T7 RNA polymerase that is under the control o f  a promoter inducible by IPTG. 
Growing cultures were treated with IPTG, thus inducing T7 RNA polymerase, which in 
turn transcribed the target DNA in the pET15b vector {Section 2.4.8).
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Mutation Orientation Oligonucleotide Sequence
R151C
Sense C CAG TTC CTG AGG TGC AGG TTT GTC CTT CTG TCA AGG 
Q F L R C  R F V L L S R
Antisense CCT TGA CAG AAG GAC AAA CCT GCA CCT CAG GAA CTG G
R275C
Sense CCC TTC AAG AAA TGC TGG TTT GCC TTG GAT CC 
P F  K K C W F A L D
Antisense GG ATC CAA GGC AAA CCA GCA TTT CTT GAA GGG
Figure 5.2. Site-directed mutagenesis of centaurin-a2. (A) O v e r v i e w  o f  t h e  s i t e -  
d i r e c t e d  m u t a g e n e s i s  p r o c e s s .  O l i g o n u c l e o t i d e s  c o n t a i n i n g  t h e  t a r g e t  m u t a t i o n  a n n e a l  
t o  t h e  p l a s m i d  D N A .  U s i n g  t h e  n o n - s t r a n d  d i s p l a c i n g  a c t i o n  o f  P / w T u r b o  D N A  
p o l y m e r a s e ,  e x t e n s i o n  a n d  i n c o r p o r a t i o n  o f  t h e  m u t a g e n i c  o l i g o n u c l e o t i d e s  r e s u l t s  i n  
n i c k e d  c i r c u l a r  D N A .  T h e  m e t h y l a t e d  n o n - m u t a t e d  D N A  t e m p l a t e  w a s  d i g e s t e d  w i t h  
Dpnl. F o l l o w i n g  t r a n s f o r m a t i o n  i n t o  X L l - B l u e  c o m p e t e n t  c e l l s  t h e  n i c k s  i n  t h e  
m u t a t e d  p l a s m i d  w e r e  r e p a i r e d .  (B) T h e  s e n s e  a n d  a n t i s e n s e  o l i g o n u c l e o t i d e  p r i m e r s  
t h a t  c o n t a i n  t h e  d e s i r e d  p o i n t  m u t a t i o n s  f o r  t h e  P H - N  ( R 1 5 1 C )  a n d  P H - C  ( R 2 7 5 C )  







Figure 5.3. Agarose gel electrophoresis of site-directed mutagenesis products.
S i t e - d i r e c t e d  m u t a g e n e s i s  a m p l i f i c a t i o n  u s i n g  o l i g o n u c l e o t i d e  p r i m e r s  c o n t a i n i n g  
t h e  d e s i r e d  m u t a t i o n .  R 1 5 1 C  ( a r g i n i n e — ^ c y s t e i n e  m u t a t i o n  i n  P H - N  d o m a i n ) ,  R 2 7 5 C  
( a r g i n i n e — ^ c y s t e i n e  m u t a t i o n  i n  P H - C  d o m a i n )  a n d  R 1 5 1 C / R 2 7 5 C
( a r g i n i n e — ^ c y s t e i n e  m u t a t i o n  i n  b o t h  P H  d o m a i n s ) .  M o l e c u l a r  w e i g h t  m a r k e r s  
( M W )  w e r e  r e s o l v e d  a l o n g s i d e  t h e  s a m p l e s  a n d  t h e  s i z e s  o f  t h e  a p p r o p r i a t e  b a n d s  
a r e  i n d i c a t e d .
129
The recombinant proteins were then purified from the cleared bacterial cell lysates using 
Talon Metal Affinity Resin {Section 2.4.8), which consists o f electropositive transition 
metal ions linked to a Sepharose resin via a metal chelator. Histidine residues exhibit 
highly selective binding that can be reversed with the addition o f an elution buffer 
containing imidazole, which has a structure identical to the side chain o f  histidine.
Wild-type centaurin-a2 was the first protein to be expressed and purified. Samples 
were retained from each purification step for examination on SDS-PAGE gels stained 
with Coomassie Blue. The fractions that were analysed included the supernatant and 
pellet from the bacterial cell lysate, supernatant following incubation with the Talon 
resin, 10 mM imidazole wash and the five 1 ml eluted fractions (data not shown). The 
majority o f  centaurin-a2 appeared to be present in the soluble fraction and not in 
inclusion bodies, thus evading the need for denaturing purification conditions.
Subsequently all four centaurin-a2 constructs were expressed and purified, and the 
eluted fractions and 10 mM imidazole wash fraction were examined by SDS-PAGE and 
Coomassie staining {Figure 5.4). For all four proteins the 10 mM imidazole wash 
appeared to successfully remove the weak binding non-specific proteins and a single 
band at approximately 45 kDa was present in the eluted fractions. The majority o f  the 
45 kDa protein appears to be eluted in the first two 1 ml fractions. Consequently the 
first three fractions were pooled and placed inside Slide-A-Lyser cassettes and dialysed 
overnight in lysis buffer. Spectrophotometric analysis (A280) for the determination o f  
protein yield revealed that approximately 2 mg o f each centaurin-a2 protein per litre o f  
culture were purified. The proteins were then stored in 50% (v/v) glycerol at -20 °C.
Following the addition o f glycerol the protein levels o f the four centaurin-a2 proteins 
were compared by SDS-PAGE and staining with Coomassie Blue. Protein molecular 
weight markers o f known concentration were run along side the protein samples to aid 
comparison o f concentration as well as size {Figure 5.5, A). Purified 6xHis- 
centaurin-a2 was detectable as a single 45 kDa band using both monoclonal anti- 
pentaHis and the affinity purified anti-centaurin-a2 antiserum, thus confirming 
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Figure 5 . 4 .  SDS-PAGE analysis of the recombinant centaurin-a2 proteins. T h e
f o u r  6 x H i s - c e n t a u r i n - a 2  p r o t e i n s  ( w i l d - t y p e  a n d  t h e  t h r e e  m u t a t e d  p r o t e i n s  R 1 5 1 C ,  
R 2 7 5 C  a n d  R 1 5 1 C / R 2 7 5 C )  w e r e  p u r i f i e d  f r o m  t h e  c l e a r e d  b a c t e r i a l  c e l l  l y s a t e  u s i n g  
T a l o n  M e t a l  A f f i n i t y  R e s i n .  W e a k l y  b i n d i n g  p r o t e i n s  w e r e  w a s h e d  f r o m  t h e  c o l u m n  
u s i n g  1 0  m M  i m i d a z o l e  i n  l y s i s  b u f f e r  ( 5  b e d  v o l u m e s ,  1 0  m l ) .  T h e  6 x H i s - t a g g e d  
p r o t e i n s  w e r e  t h e n  e l u t e d  u s i n g  1 0 0  m M  i m i d a z o l e  i n  l y s i s  b u f f e r .  F r a c t i o n s  o f  1 m l  
w e r e  c o l l e c t e d  ( e l u a t e  1 - 3 ) .  1 0  m M  i m i d a z o l e  w a s h  a n d  t h e  f r a c t i o n s  ( 2 0  p i  o f  e a c h )  
w e r e  a n a l y s e d  o n  a  1 0 %  S D S - P A G E  g e l  s t a i n e d  w i t h  C o o m a s s i e  b r i l l i a n t  b l u e .  
M o l e c u l a r  w e i g h t  m a r k e r s  ( M W )  w e r e  r u n  a l o n g s i d e  t h e  s a m p l e s ,  w i t h  a p p r o p r i a t e  
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Figure 5.5. SDS-PAGE analysis of 6xHis-centaurin-a2. (A) A p p r o x i m a t e l y  2 0  
m g  o f  t h e  6 x H i s - c e n t a u r i n - a 2  p r o t e i n s  ( i n  5 0 %  ( v / v )  g l y c e r o l )  w e r e  r e s o l v e d  o n  a  
1 0 %  S D S - P A G E  g e l .  T h i s  w a s  t h e n  s t a i n e d  w i t h  C o o m a s s i e  b r i l l i a n t  b l u e  t o  a l l o w  
c o m p a r i s o n  o f  t h e  p r o t e i n  q u a n t i t i e s .  (B) T h e  s u p e r n a t a n t  f o l l o w i n g  i n c u b a t i o n  w i t h  
t h e  T a l o n  r e s i n  ( u n b o u n d  f r a c t i o n )  a n d  t h e  e l u t e d  p u r i f i e d  p r o t e i n  w e r e  r e s o l v e d  o n  
a  1 0 %  S D S - P A G E  g e l .  W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  u s i n g  a f f i n i t y  p u r i f i e d  
a n t i - c e n t a u r i n - a 2  ( s e r u m  B )  d i l u t e d  1 : 2 , 0 0 0  i n  1 %  B S A - T B S - T .  ( C )  C e l l  l y s a t e  
s u p e r n a t a n t  a n d  t h e  e l u t e d  p u r i f i e d  p r o t e i n  w e r e  r e s o l v e d  o n  a  1 0 %  S D S - P A G E  g e l .  
W e s t e r n  b l o t t i n g  w a s  p e r f o r m e d  u s i n g  a  m o n o c l o n a l  a n t i - p e n t a H i s  a n t i b o d y  d i l u t e d  
1 : 2 , 0 0 0  i n  1 %  B S A - T B S - T .  M o l e c u l a r  w e i g h t  m a r k e r s  ( M W )  w e r e  r u n  a l o n g s i d e  
t h e  s a m p l e s ,  w i t h  a p p r o p r i a t e  b a n d  s i z e s  i n d i c a t e d .
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5.4 Investigation of the Binding Specificity of Centaurin-a2
using [3H]Ins 1,3,4,5-P4
Long before the cloning o f p42IP4, Reiser and coworkers had detected [3H]Ins 1 ,3 ,4 ,5 -P4 
binding in pig cerebellar membrane fractions (Donie and Reiser 1989). The Ins 1,3,4,5- 
P4 binding assay was adapted over time and was recently used to determine the binding 
specificity o f recombinant p42IP4 (Hanck et a l  1999). In brief, 70-500 ng purified 
recombinant protein was incubated for 2 0  min on ice in a total volume o f  280 pi o f  
binding buffer (25 mM sodium acetate/25 mM potassium phosphate, pH 5.0, 0.05% 
(w/v) Brij58, 1 mM EDTA) containing approximately 1 nM [3H]Ins 1 ,3 ,4 ,5 -P4 . The 
bound and free ligands were separated by gel filtration using BioGel P-4 columns. 
Cullen and Irvine employed a Ins 1 ,3 ,4 ,5 -P4 binding assay for the investigation o f  
GAP1ip4bp, however different buffer conditions were used and the bound and unbound 
ligand were separated by PEG precipitation (Cullen et a l  1995a). This group had 
previously reported the presence o f  different types o f Ins 1 ,3 ,4 ,5 -P4 binding sites 
distinguished by acidic and neutral pH optima (Cullen and Irvine 1992). The Ins
1 ,3 ,4 ,5 -P4 binding specificity o f  GAP1ip4bp was shown to decline from pH 5.5 to pH 9.0 
(Cullen et a l  1995b). Likewise a sharp pH-dependence was detected for p42IP4, with 
maximum Ins 1 ,3 ,4 ,5 -P4 binding detected in the acetate/phosphate buffer at pH 5.0 
(Strieker et a l  1997). A 50% reduction in binding was observed when the buffer was 
switched to 20 mM NaCl/100 mM KC1 at either pH 7.0 or 5.5. Furthermore, no binding 
was detected using the low salt buffer at pH 7.4 (25 mM Tris-HCl, 1 mM EDTA, 0.5 
mM phosphate and 0.5 mM pyrophosphate), the buffer that was used in the 
photoaffinity labelling studies for rat centaurin-a, (Hammonds-Odie et a l  1996; 
Strieker et a l  1997).
5.4.1 Development of the Ins 1,3,4,5-P4 Displacement Assay
For centaurin-a2, preliminary binding assays were performed using two buffer 
conditions: 25 mM sodium acetate/25 mM potassium phosphate, pH 5.0, 0.05% (w/v) 
Brij 58, 1 mM EDTA (Strieker et a l  1996) and 100 mM KC1, 20 mM NaCl, 10 mM 
HEPES, pH 7.0, 1 mM EDTA (Cullen et a l  1995a). Duplicate reactions were prepared 
using 100 ng recombinant protein, 1 nM [3H]Ins 1 ,3 ,4 ,5 -P4 in a final volume o f  280 pi.
1 3 3
Bound ligand was separated from free ligand by centrifugation through BioGel P-4 
resin columns (1.2 ml packed resin) and measured by liquid scintillation counting. High 
levels o f radioactivity were detected in all samples including a sample with no protein 
(data not shown). The assay was repeated using 1 pg recombinant protein and an 
increased reaction volume o f 500 pi. Once more the bound fraction contained the same 
high level o f radioactivity in all samples including the negative control (no protein). 
The separation method appeared to be unsuccessful and consequently, separation by 
PEG precipitation was tested.
For the pH 5.0 and pH 7.0 buffers described above, reactions containing 1 pg 
recombinant protein and 1 nM [3H]Ins 1,3,4,5-P4 were prepared in a final volume o f  500 
pi. In addition, a control reaction without protein was prepared for each buffer 
condition. Following equilibration, protein-ligand complexes were precipitated by the 
addition o f  500 pg y-globulin (as carrier protein) and 1 ml 25% (w/v) PEG3350 as 
described by Cullen et al. (1995a) {Section 2.6.1). Centaurin-a2 appeared to bind Ins
1.3.4.5-P4 when using the acetate/phosphate buffer at pH 5.0, whereas levels equivalent 
to the non-specific control sample levels o f  binding (no protein) were observed with the 
pH 7.0 buffer {Figure 5.6). Hence, all subsequent reactions were performed using the 
acetate/phosphate buffer at pH 5.0 and with separation o f  bound ligand from free ligand 
by PEG precipitation.
Binding o f  [3H]Ins 1,3,4,5-P4 to centaurin-a2 was reversible and specific as shown by 
the following results. Firstly, the addition o f a 1000-fold molar excess o f  D/L-Ins
1.3.4.5-P4 inhibited [3H]Ins 1,3,4,5-P4 binding by approximately 95% {Figure 5.7). 
Secondly, the arginine to cysteine mutation introduced into both PH-N and PH-C 
domains o f  centaurin-a2 (R151C/R275C) resulted in almost complete loss o f  [3H]Ins
1.3.4.5-P4 binding {Figure 5.7).
The Ins 1,3,4,5-P4 binding increased proportionally with protein concentration with 
maximal binding at 500 ng, 220 nM {Figure 5.8). Subsequent reactions were performed 
using 500 ng recombinant protein for the investigation o f centaurin-a2 binding 
specificity (the optimised assay is detailed in Section 2.6.1).
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Figure 5.6. Comparison of [3H]Ins 1,3,4,5-P4 binding using different buffer 
conditions. B i n d i n g  r e a c t i o n s  w e r e  p e r f o r m e d  u s i n g  t w o  b u f f e r  c o n d i t i o n s :  2 5  m M  
s o d i u m  a c e t a t e / 2 5  m M  p o t a s s i u m  p h o s p h a t e ,  p H  5 . 0 ,  0 . 0 5 %  ( w / v )  B r i j  5 8 ,  1 m M  
E D T A  ( S t r i e k e r  et al. 1 9 9 6 )  a n d  1 0 0  m M  K C 1 ,  2 0  m M  N a C l ,  1 0  m M  H E P E S ,  p H  7 . 0 ,  
1 m M  E D T A  ( C u l l e n  et al. 1 9 9 5 a ) .  I n  b r i e f ,  d u p l i c a t e  r e a c t i o n s  c o n t a i n e d  1 p g  
r e c o m b i n a n t  c e n t a u r i n - a 2  ( w i l d - t y p e ) ,  b i n d i n g  b u f f e r ,  1 n M  [ 3 H ] I n s  1 , 3 , 4 , 5 - P 4 . N o n ­
s p e c i f i c  b i n d i n g  w a s  d e t e r m i n e d  w i t h  n o  p r o t e i n  p r e s e n t .  D a t a  t a k e n  f r o m  a  s i n g l e  
a s s a y .
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Figure 5.7. Preliminary [3H]Ins 1,3,4,5-P4 binding results. B i n d i n g  r e a c t i o n s  w e r e  
p e r f o r m e d  a s  d e s c r i b e d  a b o v e  u s i n g  t h e  p H  5 . 0  a c e t a t e / p h o s p h a t e  b u f f e r  a n d  1 p g  
w i l d - t y p e  c e n t a u r i n - a 2  ( W T ,  p e r f o r m e d  i n  d u p l i c a t e ) .  O n e  a s s a y  w a s  p r e p a r e d  w i t h  
t h e  a d d i t i o n  o f  1 0 0 0 - f o l d  e x c e s s  ( 1  p m )  u n l a b e l l e d  I n s  1 , 3 , 4 , 5 - P 4 ( W T  +  I P 4 ) .  A n o t h e r  
w a s  p r e p a r e d  u s i n g  1 p g  R 1 5 1 C / R 2 7 5 C  i n  p l a c e  o f  w i l d - t y p e  c e n t a u r i n - a 2 .  N o n ­
s p e c i f i c  b i n d i n g  w a s  d e t e r m i n e d  i n  a  c o n t r o l  w i t h  n o  p r o t e i n  p r e s e n t .  V a l u e s  s h o w n  
a r e  t h e  t o t a l  b i n d i n g ,  w h i c h  w a s  c o r r e c t e d  f o r  n o n - s p e c i f i c  b i n d i n g .  D a t a  t a k e n  f r o m  a  
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Figure 5.8. [3H]Ins 1,3,4,5-P4 binding with increasing protein concentrations.
Binding reactions were performed as before but with varying concentrations o f  
wild-type centaurin-a2: 0, 44 nM (100 ng), 110 nM (250 ng), 220 nM (500 ng), 330 
nM (750 ng) and 440 nM (1 pg). Data taken from a single assay.
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5.4.2 Determination of Phosphoinositide Binding Specificity of
Centaurin-a2 using the Ins 1,3?4,5-P4 Displacement Assay
Increasing concentrations o f  unlabelled inositol phosphates and phosphoinositides were 
included in the Ins 1,3,4,5-P4 binding assay to determine their ability to displace [3H]Ins
1,3,4,5-P4 from wild-type centaurin-a2 (Figure 5.9). The most effective ligand at 
displacing [3H]Ins 1,3,4,5-P4 was D/L-Ins 1,3,4,5-P4. This unlabelled ligand inhibited 
50% o f [3H]Ins 1,3,4,5-P4 binding (IC50) at a concentration o f  55 nM. The next most 
potent o f  the ligands tested were diC^Ptdlns 3,4,5-P3 and diC^Ptdlns 4,5-P2, which had 
similar IC50 values o f  154 nM and 160 nM, respectively. DiCi6PtdIns 3,4-P2 and 
diC^Ptdlns 3,5-P2 however, only competed at higher concentrations, with 940 nM and 
1.9 pM being required to give 50% displacement respectively. Interestingly Ins 1,4,5- 
P 3 (the inositol phosphate corresponding to Ptdlns 4,5-P2) was unable to displace 
[3H]Ins 1,3,4,5-P4, even when added at concentration o f  50 pM (50,000-fold molar 
excess, data not shown).
5.4.3 Determination of Phosphoinositide Binding Specificity of the 
Mutant Centaurin-a2 Proteins
Mutation o f  the conserved arginine residue in the PH-N domain (R151C), resulted in 
almost complete loss o f [3H]Ins 1,3,4,5-P4 binding, similar to that observed when both 
PH domains are mutated, R151C/R275C (Figure 5.10, A). Whereas the comparative 
mutation in the PH-C domain appeared to have little or no effect on [3H]Ins 1,3,4,5-P4 
binding. The displacement curve with unlabelled Ins 1,3,4,5-P4 revealed the binding 
activity o f  R275C to be essentially similar to that o f wild-type centaurin-a2 (Figure 
5.10, B). Thus, it would appear that Ins 1,3,4,5-P4 was binding predominantly to the 
PH-N domain o f centaurin-a2. As both Ptdlns 3,4,5-P3 and Ptdlns 4,5-P2 were able to 
displace Ins 1,3,4,5-P4 with high affinity, PH-N appeared to have specificity for these 















Figure 5.9. Displacement of [3H]Ins 1,3,4,5-P4 binding from recombinant 
wild-type centaurin-a2. U n l a b e l l e d  i n o s i t o l  p h o s p h a t e s  a n d  p h o s p h o i n o s i t i d e  w e r e  
a d d e d  t o  t h e  b i n d i n g  a s s a y  a t  i n c r e a s i n g  c o n c e n t r a t i o n s .  T h e  c o n c e n t r a t i o n  a t  w h i c h  
5 0 %  o f  [ 3 H ] I n s  1,3,4,5-P4 b i n d i n g  w a s  d i s p l a c e d  ( I C 50)  w a s  d e t e r m i n e d  f o r  e a c h  
l i g a n d .  T h e  r a n k  o r d e r  o f  a f f i n i t y  a n d  t h e i r  I C 50 v a l u e s  a r e  I n s  1,3 ,4 ,5-P4 (55 n M )  >  
d i C l 6 P t d I n s  3 , 4 , 5 - P 3 ( 1 5 4  n M )  >  d i C 16P t d I n s  4 , 5 - P 2 ( 1 6 0  n M )  >  d i C 16P t d I n s  3 , 4 - P 2 
( 9 4 0  n M )  >  d i C 16P t d I n s  3 , 5 - P 2 ( 1 . 9  p M ) .  I n s  1 , 4 , 5 - P 3 w a s  u n a b l e  t o  d i s p l a c e  [ 3H ] I n s  
1 , 3 , 4 , 5 - P 4 w h e n  a d d e d  t o  c o n c e n t r a t i o n s  o f  5 0  p M .  E a c h  v a l u e  r e p r e s e n t s  t h e  m e a n  
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Figure 5.10. Characterisation of [3H]Ins 1,3?4,5-P4 to the mutant 6xHis 
centaurin-a2 proteins. (A) C o m p a r i s o n  o f  t o t a l  o f  [ 3 H ] I n s  1,3,4,5-P4 b i n d i n g  t o  
w i l d - t y p e ,  t h e  t w o  s i n g l e  m u t a n t  ( R 1 5 1 C  a n d  R 2 7 5 C )  a n d  t h e  d o u b l e  m u t a n t  
( R 1 5 1 C / R 2 7 5 C )  c e n t a u r i n - a 2  p r o t e i n s .  B i n d i n g  v a l u e s  a r e  e x p r e s s e d  a s  a  p e r c e n t ­
a g e  o f  I n s  1 , 3 , 4 , 5 - P 4 b i n d i n g  t o  w i l d - t y p e  a n d  e a c h  v a l u e  r e p r e s e n t s  t h e  m e a n  ±  
S . E . M  o f  a t  l e a s t  f o u r  a s s a y s .  (B) C o m p a r i s o n  o f  t h e  d i s p l a c e m e n t  o f  [ 3 H ] I n s
1 . 3 . 4 . 5 - P 4 f r o m  w i l d - t y p e  a n d  f r o m  t h e  P H - C  m u t a n t  ( R 2 7 5 C )  b y  u n l a b e l l e d  I n s
1 . 3 . 4 . 5 - P 4 . E a c h  v a l u e  r e p r e s e n t s  t h e  m e a n  ±  S E M  f r o m  t w o  i n d e p e n d e n t  a s s a y s .
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5.5 Photoaffinity Labelling of Centaurin-a2 with [3H]BZDC- 
Ptdlns 3,4,5-P3 and -Ptdlns 3,4-P2
Benzophenone photoaffinity labels have previously been used successfully to label 
several PtdInsPn and InsPn binding proteins including synaptotagmin C2 domains, 
AP-3, COPI, CAPS, G csl and centaurin-a (Blader et al. 1999; Chaudhary et al. 1998; 
Hammonds-Odie et al. 1996; Hao et a l  1997; Loyet et a l  1998; Mehrotra et a l  1997). 
The benzophenone group has largely replaced earlier photoprobes as it is chemically 
more stable and does not decompose in ambient light. Activation at wavelengths o f  
350-360 nm causes the photoprobe to react with hydrophobic regions in the protein 
(Dorman and Prestwich 1994). The covalent attachment o f the photoaffinity label 
enables the protein fractions to be denatured and resolved by SDS-PAGE and the 
[3H]-label can then be detected by autoradiography.
5.5.1 Development of the Photoaffinity Labelling Assay
Initially photoaffinity labelling reactions were performed using 3 pg recombinant 
centaurin-a2 and [3H]BZDC-Ptdlns 3,4-P2 or [3H]BZDC-Ptdlns 3,4,5-P3 (0.1 |rCi, 47 
pM) using a modification o f  protocols described elsewhere (Chaudhary et a l  1998; 
Hammonds-Odie et a l  1996). Samples were equilibrated on ice for 10 min and 
exposed to UV-irradiation (350 nm) for six 5-min periods with 5-min intervals. The 
photolabelled proteins were then resolved on 10% SDS-PAGE gels and stained with 
Coomassie Blue. Exposing the gels to film for long periods o f time was inconvenient, 
consequently the gel was cut into slices and the radioactivity determined by liquid 
scintillation counting as described previously by Holman et a l  (1990). Wild-type 
recombinant centaurin-a2 bound both the [3H]BZDC-Ptdlns 3,4-P2 and -Ptdlns 3,4,5-P3 
photoaffinity probe {Figure 5.11). This binding was displaced by the addition o f  1000- 
fold molar excess o f the respective unlabelled ligand {Figure 5.11). The centaurin-a2 
double mutant R151C/R275C was unable to bind [3H]BZDC-Ptdlns 3,4-P2, thus 
indicating that with wild-type centaurin-a2 the photoaffinity label was binding 
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Figure 5.11. Photoaffinity labelling of centaurin-a2 using [3H]BZDC-Ptdlns 3,4-P2 
and -Ptdlns 3,4,5-P3 probes. (A) W i l d - t y p e  a n d  R 1 5 1 C / R 2 7 5 C  c e n t a u r i n - a 2  ( 3  p g )  
w e r e  l a b e l l e d  u s i n g  [ 3H ] B Z D C - P t d l n s  3 , 4 - P 2 ( 0 . 1  p C i ,  4 7  p M ) .  A  s e c o n d  r e a c t i o n  w a s  
p r e p a r e d  f o r  w i l d - t y p e  ( W T )  c e n t a u r i n - a 2  w i t h  t h e  a d d i t i o n  o f  1 0 0 0 - f o l d  m o l a r  e x c e s s  
o f  u n l a b e l l e d  P t d l n s  3 , 4 - P 2 . S a m p l e s  w e r e  e q u i l i b r a t e d  o n  i c e  f o r  1 0  m i n  a n d  e x p o s e d  
t o  U V - i r r a d i a t i o n  ( 3 5 0  n m )  f o r  s i x  5 - m i n  p e r i o d s  w i t h  5 - m i n  i n t e r v a l s .  T h e  s a m p l e s  
a n d  m o l e c u l a r  w e i g h t  m a r k e r s  w e r e  r e s o l v e d  o n  1 0 %  S D S - P A G E  g e l s  a n d  s t a i n e d  
w i t h  C o o m a s s i e  B l u e .  T h e  g e l  w a s  c u t  i n t o  s l i c e s ,  w h i c h  w e r e  d r i e d  a n d  s o l u b i l i s e d  
p r i o r  t o  l i q u i d  s c i n t i l l a t i o n  c o u n t i n g .  T h e  p o s i t i o n  o f  t h e  2 9 ,  4 5  a n d  6 6  k D a  m a r k e r s  
a r e  i n d i c a t e d .  T h e  v a l u e s  r e p r e s e n t  c o u n t s  p e r  m i n u t e  ( C P M )  w i t h  t h e  n o n - s p e c i f i c  
l e v e l  s u b t r a c t e d .  (B) T h e  t o t a l  b i n d i n g  w a s  c a l c u l a t e d  f r o m  t h e  a r e a  u n d e r  t h e  p e a k  a t  
4 5  k D a  ( p e a k  a r e a ) .  T h e  v a l u e s  f o r  t h e  d i s p l a c e m e n t  w i t h  u n l a b e l l e d  l i g a n d ,  a n d  
R 1 5 1 C / R 2 7 5 C  a r e  e x p r e s s e d  a s  a  p e r c e n t a g e  o f  t h e  w i l d - t y p e  b i n d i n g .  A l l  v a l u e s  a r e  
f r o m  a  s i n g l e  e x p e r i m e n t .
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Optimisation o f  the protein concentration showed the bound [3H]BZDC-Ptdlns 3,4-^2 to 
increase proportionally with protein concentration {Figure 5.12). The buffer conditions 
were tested by using lysis buffer (used for recombinant protein purification that was 
used in the previous photoaffinity labelling reactions) and the acetate/phosphate buffer 
at pH 5.0 employed in the [ H]Ins 1,3,4,5-P4 binding assay. However, the pH 
dependent binding that was observed for [3H]Ins 1,3,4,5-P4 was not detected for 
photoaffinity labelling using either probe {Figure 5.13). The effect o f  glycerol was also 
investigated as the storage o f centaurin-a2 in 50% (v/v) glycerol resulted in a final 
percentage o f up to 15% in the photoaffinity labelling reactions. Glycerol did not 
appear to affect the binding activity {Figure 5.14). Finally the optimal irradiation time- 
course was established using [3H]BZDC-Ptdlns 3,4-P2. Samples were irradiated for 5, 
10 and 30 min (i.e. one, two or six 5-min periods with 5-min intervals). The increase in 
bound label was proportional when the irradiation time was doubled from 5 to 10 min, 
but not when increased from 10 to 30 min {Figure 5.15). All further experiments were 
performed using the optimised assay with 3 pg recombinant centaurin-a2 in lysis 
buffer, pH 8.0, and irradiation for 20 min as described in Section 2.6.2.
5.5.2 Photoaffinity Labelling of Mutant Centaurin-a2 Proteins
The centaurin-a2 double mutant R151C/R275C was unable to bind [3H]BZDC-Ptdlns
3,4,5-P3 or -Ptdlns 3,4-P2 {Figure 5.16, A and B). However, the single mutants R151C 
and R275C produced differing results. The binding o f  [3H]BZDC-Ptdlns 3,4,5-P3 was 
unaltered by mutation o f  PH-C (R275C), and R151C displayed 50% reduction in 
binding {Figure 5.16, A). By contrast the mutation o f PH-N had no effect on 
[3H]BZDC-Ptdlns 3,4-P2 binding with R151C having similar activity to wild-type 
centaurin-a2 and the mutation o f PH-C greatly reduced binding {Figure 5.16, B).
The mutant centaurin-a2 proteins have enabled us to determine some binding 
characteristics o f the individual PH domains. Firstly the Ins 1,3,4,5-P4 binding studies 
suggest that Ins 1,3,4,5-P4 might bind exclusively to PH-N and the photoaffinity 
labelling experiments show similar binding preference for Ptdlns 3,4,5-P3, whereas 
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Figure 5.12. Relationship between wild-type centaurin-a2 protein concentration 
and photoaffinity labelling with [3H]BZDC-Ptdlns 3,4-P2. P h o t o l a b e l l i n g  r e a c t i o n s  
w e r e  p e r f o r m e d  w i t h  a  r a n g e  o f  w i l d - t y p e  c e n t a u r i n - a 2  c o n c e n t r a t i o n s  ( 1 . 3  p M ,  3  p g  
-  0 . 4  n M ,  1 n g )  u s i n g  [ 3H ] B Z D C - P t d l n s  3 , 4 - P 2 . A l l  v a l u e s  r e p r e s e n t  t o t a l  b i n d i n g  
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C Z 1  [3H]BZDC-Ptdlns 3.4.5-P3
Figure 5.13. Comparison of photoaffinity labelling of centaurin-a2 with 
[3H]BZDC-Ptdlns 3,4-P2 using different buffer conditions. P h o t o l a b e l l i n g  r e a c t i o n s  
w e r e  p e r f o r m e d  w i t h  w i l d - t y p e  c e n t a u r i n - a 2  ( 1 . 3  p M ,  3  p g )  u s i n g  t w o  d i f f e r e n t  b u f f e r  
c o n d i t i o n s ,  p H  5 . 0  ( 2 5  m M  s o d i u m  a c e t a t e / 2 5  m M  p o t a s s i u m  p h o s p h a t e ,  p H  5 . 0 ,  
0 . 0 5 %  ( w / v )  B r i j  5 8 ,  1 m M  E D T A )  a n d  p H  8 . 0  ( 2 0  m M  T r i s - H C l ,  p H  8 . 0 ,  1 0 0  m M  
N a C l ) .  A l l  v a l u e s  r e p r e s e n t  t o t a l  b i n d i n g  e x p r e s s e d  a s  t h e  p e a k  a r e a  ( a t  4 5  k D a )  f r o m  
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Figure 5.14. The effect of glycerol on [3H]BZDC-Ptdlns 3,4-P2 photoaffinity 
labelling. A l i q u o t s  o f  t h e  w i l d - t y p e  c e n t a u r i n - a 2  f r o m  t h e  s a m e  p u r i f i c a t i o n  w e r e  
e i t h e r  s t o r e d  i n  g l y c e r o l  a t  - 2 0 ° C  o r  w i t h o u t  g l y c e r o l  a t  4 ° C .  P h o t o a f f i n i t y  l a b e l l i n g  
r e a c t i o n s  w e r e  p r e p a r e d  w i t h  w i l d - t y p e  c e n t a u r i n - a 2  ( 1 . 3  p M ,  3  p g )  ±  g l y c e r o l .  T h e  
f i n a l  g l y c e r o l  c o n c e n t r a t i o n  i n  +  g l y c e r o l  r e a c t i o n  w a s  1 4 . 5 %  ( v / v ) .  A l l  v a l u e s  
r e p r e s e n t  t o t a l  b i n d i n g  e x p r e s s e d  a s  t h e  p e a k  a r e a  ( a t  4 5  k D a )  f r o m  a  s i n g l e  
e x p e r i m e n t .
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Figure 5.15. Irradiation time course optimisation. W i l d - t y p e  c e n t a u r i n - a 2  a n d  
[ 3 H ] B Z D C - P t d l n s  3 , 4 - P 2 r e a c t i o n s  w e r e  i r r a d i a t e d  f o r  5 ,  1 0  o r  3 0  m i n  ( i . e .  o n e ,  t w o  
o r  s i x  5 - m i n  p e r i o d s  w i t h  5 - m i n  i n t e r v a l s ) .  A l l  v a l u e s  r e p r e s e n t  t o t a l  b i n d i n g  
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Figure 5.16. Photoaffinity labelling of centaurin-a2 mutants. R e c o m b i n a n t  
c e n t a u r i n - a 2  w i l d - t y p e  a n d  m u t a n t  p r o t e i n s  ( 3  p g )  w e r e  l a b e l l e d  w i t h  ( A )  
[ 3 H ] B Z D C - P t d l n s  3 , 4 , 5 - P 3 o r  (B) [ 3H ] B Z D C - P t d l n s  3 , 4 - P 2 a n d  i r r a d i a t e d  f o r  2 0  
m i n .  R 1 5 1 C  ( P H - N  m u t a n t ) ,  R 2 7 5 C  ( P H - C  m u t a n t )  a n d  R 1 5 1 C / R 2 7 5 C  ( m u t a t i o n s  
i n  b o t h  P H  d o m a i n s ) .  A l l  v a l u e s  r e p r e s e n t  t h e  t o t a l  b i n d i n g  ±  S . E . M  f r o m  a t  l e a s t  
t h r e e  i n d e p e n d e n t  e x p e r i m e n t s ,  a n d  a r e  e x p r e s s e d  a s  a  p e r c e n t a g e  o f  t h e  t o t a l  l i g a n d  
b i n d i n g  t o  w i l d - t y p e  c e n t a u r i n - a 2 .
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5.6 Discussion
A number o f  the studies investigating the binding properties o f  the centaurin-al 
proteins used heterogeneous membrane fractions isolated from brain homogenates. For 
example, photoaffinity labelling experiments were performed on brain homogenate 
purified using a heparin-agarose column, which is thought to act as a pseudo-affinity 
resin for inositol phosphate binding proteins (Hammonds-Odie et al. 1996). Several 
proteins o f  different sizes were specifically photolabelled with [ H]BZDC-Ins 1,3,4,5-P4 
using this membrane fraction. Although the photolabelled band at 46 kDa was assumed 
to correspond to centaurin-a, it may not be homogenous and could result from other 
proteins o f  similar size. The authors also reported the discovery o f a specifically 
photolabelled 46 kDa band in fractionated heart extracts (purified using heparin- 
agarose), however the centaurin-a transcript was absent from the northern blot analysis 
(Hammonds-Odie et al. 1996). These findings further strengthen the possibility o f  an 
additional protein o f  similar size being present in the heart and brain membrane extracts, 
both o f  which were specifically photolabelled. Another example was the use o f  
cerebellum membranes to establish the Ins 1,3,4,5-P4 binding activity o f  pig p42IP4. 
This membrane fraction might contain other inositol phosphate and phospholipid 
binding proteins or enzymes that could convert or metabolise the phospholipids, which 
may well interfere with the results o f the binding assay (Strieker et al. 1997). Thus, in 
our study we have utilised bacterially expressed recombinant centaurin-a2 protein to 
eliminate the possible contamination o f associated mammalian proteins in the 
phospholipid binding assays.
During the optimisation o f  the Ins 1,3,4,5-P4 binding assay, centaurin-a2 was found to 
display pH dependent Ins 1,3,4,5-P4 binding similar to that shown for p42IP4, with high 
levels o f binding at pH 5.0, but not at pH 7.0 (Strieker et al. 1996). The pH dependence 
o f  Ins 1,3,4,5-P4 binding has been addressed previously by Cullen and Irvine (1992). 
These authors detected specific Ins 1,3,4,5-P4 binding in rat cerebellar microsomes and 
bovine adrenal-cortical microsomes at both pH 5.5 and 7.0 (100 mM KC1, 20 mM 
NaCl, see Section 5.4.1). However, when assayed using a low ionic strength acetate 
buffer at pH 5.0, cerebellar microsomes retained their binding specificity, whereas 
bovine adrenal microsomes displayed less specific binding. The addition o f  25 mM 
phosphate to the assay buffer had a small inhibitory effect on the amount o f  specific Ins
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1.3.4.5-P4 binding at pH 5.5 compared with that at pH 7.0, therefore a more acidic pH is 
favoured for binding in these assay conditions (Cullen and Irvine 1992). O f the two 
buffers, pH 5.0 and 7.0, initially used for the Ins 1,3,4,5-P4 binding assay with 
centaurin-a2, only the pH 5.0 buffer contained 25 mM acetate/25 mM phosphate. 
Therefore the lack o f detectable binding at pH 7.0 cannot be explained by this rationale.
The mutation o f arginine residues at positions 151 and 275 o f centaurin-a2 
(corresponding to Arg-28 o f Btk) affected Ins 1,3,4,5-P4, Ptdlns 3,4,5-P3 and Ptdlns 3,4- 
P2 binding to centaurin-a2. The application o f these mutated centaurin-a2 proteins in 
Ins 1,3,4,5-P4 binding studies lead to the hypothesis that this ligand might bind 
exclusively to the PH-N domain, as mutation o f R151C resulted in almost complete loss 
o f  Ins 1,3,4,5-P4 binding, whereas R275C had little or no effect. Furthermore, Ptdlns
3.4.5-P3 and Ptdlns 4,5-P2 displace [ H]Ins 1,3,4,5-P4 at low concentrations, indicating 
that these also bind to PH-N. Ptdlns 3,4,5-P3 appears to bind to both PH domains, but 
preferentially to PH-N. Mutation o f  this domain reduced binding by 50 %, whereas the 
corresponding mutation in PH-C did not inhibit binding. However, if  Ptdlns 3,4,5-P3 
was binding solely to PH-N then the amount o f binding observed for R151C should be 
consistent with that o f R151C/R275C. Mutational studies have shown Ptdlns 3,4,5-P3 
to bind to both PH domains o f PIP3-BP and centaurin-a 1 (Tanaka et al. 1997; 
Venkateswarlu and Cullen 1999). In this latter study the recruitment o f  GFP-centaurin- 
a l  to the plasma membrane was reduced with both single mutants, and completely 
inhibited with the double mutant.
Interestingly Ptdlns 3,4-P2 appeared to bind predominantly to PH-C, as indicated by the 
diminished binding o f  R275C in the photoaffinity labelling studies. Ptdlns 3,4-P2 was 
able to displace [3H]Ins 1,3,4,5-P4 although with 6-fold lower affinity than Ptdlns 3,4,5- 
P 3  and Ptdlns 4,5-P2. A model o f centaurin-a2 PH domain binding specificity is shown 
in Figure 5.17. The PH-N domain o f  centaurin-a2 displayed low affinity for Ptdlns
3.5-P2 compared to Ins 1,3,4,5-P4, Ptdlns 3,4,5-P3 and Ptdlns 4,5-P2. However, from 
the results o f  this study it was not possible to determine whether Ptdlns 3,5-P2 binds to 
the PH-C domain o f centaurin-a2.
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Figure 5.17. A model of centaurin-a2 PH domain binding specificity. T h e
p r e l i m i n a r y  b i n d i n g  d a t a  s u g g e s t s  t h a t  I n s  1 , 3 , 4 , 5 - P 4 ,  P t d l n s  3 , 4 , 5 - P 3 a n d  P t d l n s
4 , 5 - P 2 b i n d  p r e f e r e n t i a l l y  t o  P H - N ,  w h e r e a s  P t d l n s  3 , 4 - P 2 b i n d s  t o  t h e  P H - C  o f  
c e n t a u r i n - a 2 .
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One important point to consider is that Ins 1 ,3 ,4 ,5 -P 4 displacement studies were 
performed using wild-type centaurin-a2. Therefore, if  Ptdlns 3,4-P2 bound 
preferentially to PH-C the amount o f  free ligand competing with [3H]Ins 1,3,4,5-P4 at 
PH-N would be considerably lower than the concentration o f competitor added to the 
reaction. Hence it might be beneficial to express the PH domains individually, and 
determine the binding activities independently to corroborate these proposals.
There are advantages and disadvantages o f  expressing the PH domains separately as 
mentioned above. Firstly, when investigating proteins with multiple PH domains it 
simplifies the interpretation o f the data i f  each PH domain is investigated separately. 
The introduction o f a point mutation may only inhibit binding o f  certain 
phosphoinositides while others may be able to bind as normal, thus furthering the 
complexity o f  elucidation. In contrast, the isolated PH domain may not retain the 
binding characteristics o f  the integral protein. Other domains may interact and 
influence the PH domain. For example, the PH domain o f cytohesin-1 is followed by a 
17-residue polybasic sequence, which has been shown to be required for high affinity 
binding to Ptdlns 3,4,5-P3 (Nagel et al. 1998). Furthermore, only a small number o f  
proteins possess two PH domains and the significance o f which remains unknown. An 
interesting study led to the discovery that the PH-N domain o f TAPP1 does not bind 
phospholipids, but mutation o f the conserved arginine (R28L) in this domain affected 
the binding affinity o f  PH-C, which displayed selectively for Ptdlns 3,4-P2. 
Furthermore, the isolated PH-C domain bound Ptdlns 3,4-P2 with 5-fold lower affinity 
than the full length protein, suggesting that PH-N contributes to the affinity with which 
PH-C binds to Ptdlns 3,4-P2 (Dowler et a l  2000).
The results from the [3H]Ins 1,3,4,5-P4 displacement assay provide an indication o f the 
binding selectivity o f  centaurin-a2’s PH-N domain. However the IC50 values should be 
considered with some care, as there was a significant amount o f  ligand depletion in 
these assays. Furthermore, the phosphoinositides employed in all assays in this study 
were dipalmitoyl (Ci6), whereas dioctanoyl (Cg) derivatives are generally preferred as 
they are more water-soluble. Alternatively, some assays use the water-soluble inositol 
phosphate head groups rather than the phosphoinositide (Strieker et al. 1997). More 
recently these authors have compared the binding o f  the different lipids to p42IP4 and 
found Ins 1,3,4,5-P4 and diCgPtdlns 3,4,5-P3 to be equipotent, whereas diC^Ptdlns
3,4,5-P3 appeared to have an IC50 value 30-fold higher (Hanck et al. 1999).
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An anomaly in our study is the inconsistency between Ins 1 ,4 ,5 -P3 and Ptdlns 4 ,5 -P2 in 
the displacement o f  [3H]Ins 1,3,4,5-P4. If Ptdlns 4 ,5 -P2 binds to the PH domain in the 
opposite orientation to Ptdlns 3 ,4 ,5 -P3, as shown in the crystal structures o f  PLC6  and 
Btk (Baraldi et al. 1999; Ferguson et al. 1995), it is possible that the 1-phosphate o f Ins
1 .3 .4 .5 -P4 and Ins 1 ,4 ,5 -P3 are binding at distinct sites. If this is so, then the 1- 
phosphate o f  Ins 1 ,4 ,5 -P3 may not be accommodated in the PH domain o f  centaurin-a2, 
but Ptdlns 4 ,5 -P2 can bind without difficulty.
If we were to assign the individual centaurin-a2 PH domains to one o f  the four PH 
domain groups shown in Figure 1.4 on the basis o f  the binding characteristics, the PH-C 
domain would be in Group III, affinity for Ptdlns 3 ,4 -P2 and Ptdlns 3 ,4 ,5 -P3. PH-N 
would probably be placed in Group II, affinity for Ptdlns 4 ,5 -P2 as well as Ptdlns 3,4,5- 
P 3 . As PH-N binds Ptdlns 3 ,4 ,5 -P3 with high affinity it might be expected to fit the 
sequence models for Ptdlns 3 ,4 ,5 -P3 binding proteins. Sequence analysis o f  the p i and 
P2 regions o f  the centaurin-a2 PH domains revealed that the PH-N domain does not 
conform to the PPBM sequence or the more detailed “Signature M otif for 3- 
Phosphoinositide Binding” (.Figure 5.18). The centaurin-a2 PH-N domain contains a 
hydrophobic leucine residue (LI49) in place o f the conserved basic arginine/lysine 
residue in P2. Interestingly, the leucine residue (LI49) is conserved in the PH-N 
domains o f  centaurin-a 1. This arginine/lysine is one o f  four strictly conserved residues 
within the Signature Motif. However, structural analysis revealed this lysine residue o f  
GRP1 contributes ionic and water mediated interactions with the 1-phosphate o f  Ins
1.3.4.5-P4 and therefore does not appear to confer specificity for 3-phosphate 
phosphoinositides (Lietzke et al. 2000). Centaurin-a2 lacks the insertion in the p6/p7 
loop that is shared by the Ptdlns 3 ,4 ,5 -P3 binding GRP1, cytohesin-1 and ARNO. 
Furthermore, in the p l/p2 region both centaurin-a2 PH domains contain a single 
glycine residue that corresponds to the diglycine o f GRP1, which is Ptdlns 3 ,4 ,5 -P3 
selective, and triglycine o f ARNO and cytohesin-1, which bind Ptdlns 3 ,4 ,5 -P3 and 
Ptdlns 4,5-P2 (Klarlund et al. 2000).
If the centaurin-a 1 proteins bind Ins 1,3,4,5-P4 at only one o f  the PH domains, as we 
have shown to be the case for centaurin-a2 , the binding data will be dependent on the 
specificity o f  a single PH domain. Consistent with this possibility, Scatchard analysis
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Signature Motif for 3-Phosphoinositide Binding
[ L V I M F ] - X - K - X - [ G A S P ] -  X m  - [ W F A ] - ( K / R ) - X - R - X - [ F L ] - X - [ L M ] -  X n - [ L I F ] - X - Y  
PH-N domain
. — L - — W - - K - - R - G - R D N S Q — F ------- L— - R - R - R — F — V — L - L S R E G L - L - K - Y
140 149 151 164
PH-C domain
— M - — E - K - T — G - P K H R E P - F ................. K — K - R - W — F — A — L - D P Q E R R - L - L - Y
263 273 275 288
Figure 5.18. Sequence comparison of centaurin-a2 PH-domains and the Signature 
Motif for 3-Phosphate Binding. S i g n a t u r e  M o t i f  f o r  P H  d o m a i n s  k n o w n  a n d / o r  
p r e d i c t e d  t o  b i n d  3 - p h o s p h o i n o s i t i d e s  w i t h  h i g h  a f f i n i t y .  T h e  l i s t  o f  r e s i d u e s  i n  t h e  
s q u a r e  b r a c k e t s  r e p r e s e n t s  t h e  o b s e r v e d  r a n g e  o f  s e q u e n c e  v a r i a b i l i t y  a t  a  g i v e n  
p o s i t i o n .  X  d e n o t e s  a n y  r e s i d u e ;  m  =  5 - 1 0 ;  n  =  6 - 1 3 .  T h e  e x p a n d e d  m o t i f  s p a n s  t h e  
P 1 ~ P 3  s t r a n d s  a n d  c o n s i s t s  o f  f o u r  i n v a r i a n t  r e s i d u e s  ( r e d ) .  F o r  c e n t a u r i n - a 2  t h e  
r e s i d u e s  c o r r e s p o n d i n g  t o  t h e  c o n s e r v e d  r e s i d u e s  a r e  a l s o  i n d i c a t e d  i n  r e d  a n d  t h e  
a m i n o  a c i d  r e s i d u e  n u m b e r  i s  i n d i c a t e d  b e l o w .
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o f  [3H]Ins 1 ,3 ,4 ,5 -P4 binding suggested a one binding site model for p42IP4 and human 
centaurin-al (Strieker et a l  1997; Venkateswarlu and Cullen 1999). In view o f the 
proposed binding model o f  centaurin-a2 , some o f  the apparent anomalies in the 
literature can be explained. For example, Tanaka et a l  reported that Ins 1,3,4,5-P4 did 
not inhibit PIP3-BP binding to the Ptdlns 3 ,4 ,5 -P3 analogue resin and therefore 
concluded that this compound had at least a ten-fold lower binding affinity than Ptdlns
3 ,4 ,5 -P3 (Tanaka et a l  1997). Similarly, it was concluded that Ins 1,3,4,5-P4 had a five­
fold lower affinity for centaurin-a than Ptdlns 3 ,4 ,5 -P3 based on photoaffinity labelling 
experiments (Hammonds-Odie et a l  1996). Explanations for these data that are 
consistent with our model for centaurin-a2 can be postulated. Firstly, Ins 1,3,4,5-P4 
may not displace PIP3-BP from the Ptdlns 3 ,4 ,5 -P3 resin if  it only competes for the 
binding o f  one o f the PH domains (PH-N) while the other PH domain (PH-C) remains 
bound to the resin. Secondly, rat centaurin-a differs from the other centaurin-al 
proteins and centaurin-a2 in the PH-N domain region and therefore may exhibit a 
distinct binding specificity. Although the dual specificity model can account for data on 
the binding properties o f  centaurin-al, we can not rule out the possibility that 
centaurin-a2  has a fundamentally different binding interaction compared with the 
centaurin-al proteins.
Interestingly centaurin-a2 appeared to have similar affinity for Ptdlns 3 ,4 ,5 -P3 and 
Ptdlns 4 ,5 -P2, which is distinct from the centaurin-al proteins. Considering the relative 
cellular levels o f the different inositol phosphates and phosphoinositides it could be 
postulated that Ptdlns 4 ,5 -P2 is the most likely ligand for the PH-N domain o f  
centaurin-a2. In some proteins, such as ARNO/cytohesin-1/GRPl and human 
centaurin-al the PH domains have been shown to target the protein to the plasma 
membrane in response to Ptdlns 3-kinase activation (Langille et a l  1999; Nagel et a l  
1998; Venkateswarlu et a l  1998b; Venkateswarlu et a l  1999a). In addition to targeting 
the protein, PH domains have also been shown to be responsible for activation o f a 
proteins catalytic domain. For example, Ptdlns 4 ,5 -P2 has been shown to activate the 
ARF-GAP activity o f  ASAP1 (Kam et a l  2000). Further characterisation o f centaurin- 
a 2  binding, with emphasis on the properties o f  the individual PH domains, is required 
before the functional significance can be resolved.
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6.0 C o n c lu sio n s
The initial aim o f this study was to establish whether centaurin-a related proteins were 
present in insulin-sensitive tissues. The full-length centaurin-a2 clone was amplified 
from an adipocyte cDNA library, and in contrast to the brain specific centaurin-a, the 
mRNA o f  centaurin-a2 appeared to be ubiquitously expressed. Interestingly the 
western blot data indicated centaurin-a2  to be most abundant in the insulin-sensitive 
tissues, adipose tissue, heart and skeletal muscle.
Despite sharing 51% homology with centaurin-a and between 57-59% homology with 
the centaurin-al proteins, the investigations o f this study have revealed quite distinct 
characteristics for centaurin-a2. Although the specificity o f  the anti-centaurin-a2 
antisera has not been determined, if  the results shown herein reflect those o f  
centaurin-a2 , then it would appear that centaurin-a2  was located in the particulate 
fraction o f all tissues and not in the cytosolic fraction, which contrasts the distribution 
o f  centaurin-al. Further analysis o f the rat adipocyte subcellular fractions suggested 
that centaurin-a2 was concentrated in the mitochondria and nuclei fraction. However, 
confocal microscopy clearly indicated the staining o f the anti-centaurin-a2  antisera was 
not located in the nuclei. The staining pattern was indicative o f  microtubule 
distribution, but co-localisation was not detected using dual labelling for P-tubulin and 
centaurin-a2. As well as having a dissimilar subcellular localisation to centaurin-al, 
the distribution o f centaurin-a2  appears to be unaffected by insulin-stimulation, which 
causes plasma membrane recruitment o f  centaurin-al (Venkateswarlu and Cullen 
1999). Interestingly the difference in subcellular localisation can be rationalised by the 
preliminary binding data o f centaurin-a2. Although both centaurin-al and 
centaurin-a2 display high-affinity binding for Ptdlns 3 ,4 ,5 -P3 and Ins 1 ,3 ,4 ,5 -P4 , the 
centaurin-a2 PH-N domain was found to have similarly high-affinity for Ptdlns 4 ,5 -P2 . 
This finding suggests that centaurin-a2 might be constitutively associated with internal 
membranes, which might explain the lack o f response to insulin. Furthermore, Ins
1 ,4 ,5 -P3 was unable to displace Ins 1 ,3 ,4 ,5 -P4 in the binding assay and therefore 
hydrolysis o f Ptdlns 4 ,5 -P2 would probably not induce concomitant repartitioning to 
cytosol as displayed by PLC8  (Hurley and Misra 2000). This preliminary binding data
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has implicated centaurin-a2  to be distinct from the other centaurin-a proteins, however 
it would be beneficial to perform more extensive binding analysis using the centaurin- 
a l  PH domains expressed independently in conjunction with a more extensive range o f  
phosphoinositides and inositol phosphates.
Interestingly ARF-GAP activity has not been demonstrated for centaurin-a or the 
centaurin-a Is. Yet centaurin-al was found to functionally compliment the yeast ARF- 
GAP G csl, suggesting a possible ARF regulatory function for centaurin-al 
(Venkateswarlu et a l  1999b). Despite these investigations and the identification o f  
CKIa as the first protein partner for centaurin-al, the role o f centaurin-al is 
unresolved. The potential ARF-GAP activity was not investigated in this study o f  
centaurin-a2 , however this would be very interesting and might help ascertain the 
cellular function o f this novel centaurin-a protein. Identification o f interacting proteins 
for centaurin-a2 might also highlight its functional importance. Extensive research is 
required in order to establish a cellular function for the centaurin-a family o f  proteins.
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